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Abstract
Histone ubiquitylation is the post-translational covalent attachment of ubiquitin to histones.
Ubiquitylation of histones regulates chromatin-templated processes through a combination of
structural and functional effects. To date, several ubiquitylation sites have been mapped on
all histones, including residues from the flexible histone tails and residues from the structured
core domains. It is not yet clear if the different ubiquitylation marks are read separately of
each other or if they act in synchrony. How ubiquitylation of histones is recognised by the
nuclear proteome remains a standing question in the field of chromatin biochemistry. To
address this question, we prepared site-specifically ubiquitylated histones by native chemical
ligation and incorporated them into homogeneous nucleosomal arrays. Histone H2B ubiqui-
tylated at lysine 120 (H2BK120ub), H2BK34ub and H3K23ub nucleosomal arrays were used
in chromatin affinity purification experiments coupled with mass spectrometry to find the
proteins that were enriched by ubiquitylation. We showed that the different ubiquitylation
marks generally recruited unique proteins and protein complexes and that ubiquitylated hi-
stones needed to be embedded within nucleosomes for recognition by the nuclear proteome.
Three separate ubiquitylated constructs were prepared for the N-terminal ubiquitylation
of histone H3: H3K18ub, H3K23ub and H3K18/23ub2. On all templates, DNA methyl-
trasnferase I (DNMT1) bound directly the H3 ubiquitylation marks and recruited ubiquitin
specific protease 7 (Usp7) and Sex comb on midleg-like 2 (SCML2) to the modified chro-
matin. We showed that Usp7 could remove all three H3 ubiquitylation marks. SCML2
stimulated Usp7’s deubiquitylation activity when mononucleosomes and nucleosomal arrays
were used as substrates. We showed that SCML2 competed with DNMT1 for Usp7 binding
and proposed that SCML2 stimulated Usp7 by stabilising an activating conformation in the
enzyme directly on chromatin. We suggest that SCML2 controls DNMT1 recycling from
H3 ubiquitylated chromatin to insure faithful maintenance of DNA methylation across the
genome. Our work establishes native chemical ligation as an efficient method to prepare
site-specifically ubiquitylated histones and affirms chromatin affinity purification coupled
with mass spectrometry as a reliable tool for identification of novel interactors of modified
chromatin templates.
1
Chapter 1
Introduction
1.1 Packaging of genetic information
Genetic information is stored in polymers of deoxyribonucleic acid (DNA) [1]. The diploid
human genome is made of 46 DNA polymers which contain approximately 6 billion base pairs
(bp) [2]. 10 bp of DNA form a complete turn of a right-handed helix with a pitch of 34 A˚. If
connected end-to-end, the 46 human DNA polymers would stretch to reach 2 m in length. To
fit within the eukaryotic nucleus, the genetic material is stored in a specialised nucleoprotein
complex referred to as chromatin [3], whose repeating unit is the nucleosome [4].
A nucleosome contains two copies each of four proteins which organise 145-147 bp of DNA [5].
Consecutive nucleosomes are connected by stretches of linker DNA, which in humans vary
from 20 to 60 bp in length [7]. Histones are the architectural proteins that shape the nucleo-
some. Histones are small, highly basic and share a common fold referred to as the handshake
motif (Figure 1.1A) [8]. The handshake motif consists of three α-helices which are connected
by two short loops. This motif stabilises the interaction of histone H2A with histone H2B
and of histone H3 with histone H4 (Figure 1.1B). In addition to the handshake motif, for
stabilization of the H3/H4 tetramers, a four helix bundle forms between the C-terminal he-
lices of the two H3 copies (Figure 1.1B). A similar four helix bundle interaction is formed
between the C-terminal helices of histone H2B and H4. The interaction between H2B and
H4 is important for positioning of the two H2A/H2B dimers under the H3/H4 tetramer to
form a histone octamer (Figure 1.1B).
A nucleosome core particle organises 145-147 bp of DNA around the histone octamer into a
left-handed DNA superhelix (Figure 1.2). The nucleosome core particle is shaped as a flat
disk or a wedge with a height of approximately 100 A˚ and a length of 60 A˚ at its base and
25 A˚ at its apex [5] (Figure 1.2). The two H2A and H2B dimers are positioned in the lower
halves of the two DNA gyres that make up the DNA superhelix. The H3 and H4 tetramer
is positioned in the upper halves of the gyres, on each side of the nucleosome dyad axis.
Nucleosomes are pseudo-symmetric complexes and present two identical surfaces on either
side of the nucleosome dyad (Figure 1.2).
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Figure 1.1: Structural details of suboctameric histone complexes. (A) Primary and
secondary structure representations of ubiquitin and core histones. Histone cores share a common
fold composed of three central α-helices (1-3) connected by two short loops (L1-2). Ubiquitin has
a characteristic β-grasp fold containing a five-stranded β-sheet. Ubiquitin attaches to target lysine
residues (orange prints, orange bars) through its C-terminal diglycine anchor. (B) The histone fold
allows histone H2A to pair with histone H2B and form a dimer stabilised through hydrophobic
interactions. Similarly, H3 and H4 pair to form a heterotetramer. A four-helix bundle forms
between the two C-terminal helices of H2B and H4 and is responsible for the stabilisation of higher
order hexameric and octameric histone assemblies. Structural details were adapted from published
nucleosome (PDB 1AOI [5]) and ubiquitin (PDB 1UBQ [6]) crystal structures.
Genetic information is packaged into strings of nucleosomes. Chromatin is not uniform, as
the architecture of the nucleosome would suggest. It assumes different folds in different parts
of the nucleus. Several biological processes are only targeted to specialised chromatin areas.
Genes are expressed in a tissue-specific manner. Chromatin is a dynamic environment, which
integrates metabolic signals from within and environmental queues from outside of the cell.
The collection of all processes that shape chromatin to regulate gene expression, with no
direct interference to the DNA sequence, is referred to as epigenetic modifications.
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Figure 1.2: Nucleosome architecture. Representation of a 177 bp DNA template assembled
around a histone octamer as visualised from the front and from the side. The globular domains of the
two H2A/H2B dimers fit within the lower half of the nucleosome core particle, each heterodimer
being positioned in planes parallel to the nucleosome dyad axis. The globular domains of the
H3/H4 tetramer are positioned in the upper half of the nucleosome, diagonally with respect to
the H2A/H2B dimer planes. Structural details were adapted from the published tetranucleosome
crystal structure (PDB 1ZBB [9]).
1.1.1 Epigenetic modifications
The human embryo contains all genetic information that will be passed on to each of the
more than 200 types of cells that make up the fully developed man. During development,
cells differentiate and acquire lineage- and tissue-specific gene expression profiles. For long
it was believed that development was one-directional, following the path from pluripotentcy
to terminal differentiation [10]. Transcription factors are proteins that bind specific DNA se-
quences and control gene expression, maintaining thus cellular identity [11]. When scientists
treated terminally differentiated cells with pluripotency-specific transcription factors, they
managed to reprogram the differentiated cells back to pluripotency [12]. While the DNA se-
quence did not change in the process, chromatin must have reorganised in the reprogrammed
cells to allow for the expression of the factors that control pluripotency.
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Chromatin’s flexibility during differentiation and de-differentiation (reprogramming) results
from reversible chemical and physical changes to the DNA or to the histones.
In cytosine-guanine (CpG) dinucleotides, the carbon 5 of the cytosine base can be methy-
lated. An estimated 80% of all CpG dinucleotides are methylated in the genome [13], [14].
Most of these methylation sites are found in noncoding, repetitive or transposable DNA
elements. Methylation of DNA is read by dedicated protein complexes which possess addi-
tional enzymatic activities that silence chromatin. This mechanism is seen as an adaptation
to protect the small part of the coding genome from the invading transposable elements or
repetitive DNA sequences [15]. Promoter DNA elements contain high densities of CpG dinu-
cletodies, which form CpG islands. Differently than the repetitive or the non-coding regions
of the genome, most CpG islands are kept unmethylated [16]. This allows for uninterrupted
transcription of house-keeping genes and for the regulation of tissue-specific gene expression
profiles. DNA methylation is a modification that in mammals is erased pre-implantation
and needs to be set up de novo afterwards [17]. Maintenance DNA methylation refers to
the copying of already set CpG methylation marks during development [18]. Methylation of
DNA is not reversible per se, but dedicated mechanisms have evolved for the conversion and
removal of this mark from the genome [17].
Histones are subjected to many post-translational modifications [19]. The side-chains of
amino acids can be modified by small hydrophobic groups (methylation), by small nega-
tively charged groups (acetylation, phosporylation), by small negatively charged metabolites
(biotinylation, butirylation, crotonylation, malonylation, propionylation) and by small po-
lar sugars (glycosylation) [19], [20], [21]. These reversible modifications alter the chemical
properties of the marked amino acids. In addition to them, histones can also be modified by
conjugation of entire proteins: ubiquitin, SUMO and NEDD [20], [21]. In constrast to the
small modifications, the later reversible marks are thought to also induce physical (struc-
tural) changes to the chromatin template [22], [23]. The combined chemical and physical
modifications of histones make up a histone code [24] which is read, by specialised protein
complexes that coordinate downstream signaling events [20], [21]. Histone post-translational
modifications are reversible and specialised proteins have evolved to erase them [25], [26].
In addition to the chemical modification of cysotine (the 5th base) and the post-translational
modification of histones (the histone code), chromatin flexibility is regulated by remodeling of
nucleosome positioning, by incorporation of non-cannonical (variant) histones and by expres-
sion of non-coding RNAs [27], [28], [29]. All these epigenetic mechanisms are interconnected
and work to relay cellular or environmental signals to the chromatin template.
1.1.2 Cross-talk between DNA and histone modifications
Dedicated protein complexes have evolved to recognise and coordinate modifications on the
DNA template with modifications on the histone octamer core, such that chromatin func-
tions as a whole. As previously explained, at CpG sites, DNA may be found unmethylated,
hemi-methylated or fully methylated.
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Unmethylated CpG sites are recognized by proteins that contain a zinc finger cysteine-x-x-
cysteine (ZF-CxxC) domain [30], [31]. CxxC finger protein 1 (CFP1) binds unmethylated
CpG islands and recruits the SET1 methyltransferase which modifies the lysine 4 of histone
H3 (H3K4) [30]. Trimethylation of H3K4 (H3K4me3) directs the transcription machinery to
the 5’ ends of active genes. Lysine demethylase 2A (KDM2A) also contains a ZF-CxxC do-
main which binds unmethylated CpG islands [31]. Targeted KDM2A removes the H3K36me2
marks, which are found in every third histone across the genome [31]. CFP1 and KDM2A
coordinate at CpG islands to mark these as H3K4me3-enriched and H3K36me2-depleted,
transcriptionally poised regions [32].
Hemi-methylated DNA is recognised by proteins containing set and ring associated (SRA) do-
mains [33]. At replication forks, ubiquitin like domain containing plant homeodomain and re-
ally interesting new gene finger 1 (UHRF1) recognises using its SRA domain hemi-methylated
CpG sites [33], [34]. This stimulates the enzyme to ubiquitylate histone H3 at lysine 23 [35].
The ubiquitylation mark is read by DNA methyltransferase I (DNMT1), which copies the
CpG methylation pattern from the parental onto the daughter DNA strand [35], [36], [37].
Fully methylated CpG sites are recognised by methyl-binding domain (MBD) containing
proteins. MBD containing protein 2 (MeCP2) binds fully methylated CpG sites [38] and re-
cruits a complex of histone methltransferases and histone deacetylases to chromatin [39]. The
histone methyltransferases deposit the silencing mark H3K9me3 which is subsequently read
by heterochromatin protein 1 (HP1) [40]. This interaction creates a positive feedback loop
which attracts more methyltransferases and deacetylases at the marked sites to propagate
heterochromatin spreading [41].
1.2 Histone ubiquitylation
1.2.1 The serendipitous discovery of histone ubiquitylation
In 1975 a hormone which had the ability to induce B-cell differentiation was isolated from
bovine thymus [42]. The hormone was later found in several other tissues and in extracts
originating from yeast, plant and animal cells. This led the authors to refer to it as ubiq-
uitous immunopoietic polypeptide. In parallel, the non-histone chromosomal protein A24
was purified from bovine thymus with the belief that it may regulate gene expression. Pro-
tein A24 was present in nucleosomes and had an amino acid sequence similar to that of
histone H2A, but was larger than the later and had a unique architecture, containing two
N-termini [43], [44]. Independently, the ATP-dependent proteolytic factor-1 (APF-1) was
shown to be conjugated to proteins before these undergo degradation in rabbit reticulocyte
extracts [45], [46]. The three separate discoveries where connected in 1980 when it was shown
that the ubiquitous immunopoietic polypeptide, the H2A conjugate and APF-1 all share the
same amino acid sequence [47]. This led to the formation of the new research field of histone
ubiquitylation.
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1.2.2 Mapping of histone ubiquitylation sites
Soon after the discovery of ubiquitylated H2A, it was found that histone H2B was also
ubiquitylated. It was approximated that 10% of histone H2A and 1-2% of histone H2B
undergo ubiquitylation [48], [49]. If identification of the H2A attachment site was possible
already in 1977, the difficulty to produce sufficient amounts of ubiquitylated H2B delayed
the mapping of its conjugation site for one more decade [44], [50]. Later, it was found
that core histone H3, linker histone H1 and variant histones H2A.X and H2A.Z are also
ubiquitylated [51], [52], [53]. The identification of their conjugation sites had to wait for the
development of highly sensitive peptide sequencing techniques which came with the improve-
ment of ionisation, selection and detection methodologies used in mass spectrometry (Figure
1.1)(Table 1.1) [54], [55], [56], [57], [19]. While the global mass spectrometry investigations
provided comprehensive lists with putative histone ubiquitylation sites, it took careful muta-
genic approaches to map the involvement of the novel modifications in individual biological
processes (Table 1.1) [58], [59], [60], [61].
1.2.3 Properties of ubiquitylated histones
Histone ubiquitylation referes to the covalent attachment of ubiquitin, through its C-terminus,
to histone proteins [44]. All core and linker histones can be ubiquitylated (Figure 1.1)(Table
1.1). Ubiquitylation sites are found both in the flexible tails and in the structured histone fold
domains (Figure 1.1). Ubiquitin attachment increases the mass of histones by 8.5 kDa, which
is more than half of the mass of each individual histone. Ubiquitin contains 76 amino acids,
of which six conserved lysine residues are involved in poly-ubiquitin chain formation [62].
With one notable exception [59], histones are monoubiquitylated. While generally polar, the
ubiquitin surface contains a hydrophobic patch, centered on isoleucine I44. This serves as
a binding platform for many ubiquitin readers [6], [63], [64]. Ubiquitylation of histones is
a reversible process, which is controlled by ubiquitylation/deubiquitylation cycles [65], [66].
The ubiquitin deposited on histones is removed by ubiquitin C-terminal hydrolases and re-
cycled directly in the nucleus [67]. Monoubiquitylation adds up to the complexity of the
histone code by creating new possibilities for hierarchical signaling and cross-talk with other
epigenetic modifications.
1.2.4 Recognition of histone ubiquitylation
Ubiquitin is recognised by specialised proteins (ubiquitin readers) which bind either to the
I44 hydrophobic patch or ubiquitin’s C-terminal tail (in particular the two arginines R72 and
R74) [63]. When small variations to the substrate are presented to the ubiquitin readers, as
is the case with ubiquitylation of histones, discrimination between different ubiquitylation
marks is achieved by dedicated ubiquitin interaction motifs (UIMs), which fold either as
single elongated alpha helices (Rad18, RNF169, DNMT1) [68], [37] or disordered loops or
fingers (Usp7; 53BP1, UBP8, DNMT1) [69], [70], [71], [72].
The evolved UIMs contain several polar and negatively charged residues as well as a number
of hydrophobic amino acids. While the hydrophobic core of the motif binds the I44 patch
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of ubiquitin, the charged residues bind its basic side areas. Some UIMs contain additional
amino acids which probe the surface of the nucleosome (Figure 1.3). In the case of the tran-
scription factor 53BP1 and the E3 ligase RNF169, their respective UIMs contact both the
ubiquitin I44 patch and the nucleosome acidic patch [71], [68]. In the case of the ubiquitin
specific protease UBP8, its annotated UIM is anchored on the I44 patch but also contacts
the two C-terminal arginines of ubiquitin, probing the isopeptide linkage [72]. In the case
of DNMT1’s RFTS domain, which is able to bind two ubiquitin groups at once, the UIM
also contacts the underlying histone tail in its entirety [37]. The strength of the association
and the specificity of the interaction between the reader and ubiquitin may be fine-tuned by
the presence of adaptor subunits which contact both the reader and the nucleosome. In the
case of UBP8, the yeast SAGA - associated factor Sgf11 serves as an adaptor protein which
contacts both the reader and the nucleosome, at its acidic patch [72].
Even though all known histone ubiquitylation readers display a common binding pattern,
they share no consensus primary amino acid sequence in their ubiquitin interaction motifs.
Identification of novel histone ubiquitylation readers using in silico algorithms is limited by
the small number of known histone ubiquitylation-specific UIMs and the difficulty to assign
reliable defining features within them. Identification of new histone ubiquitylation readers
remains a challenging endeavour.
1.2.5 Representative histone ubiquitylation marks
This thesis aimed to prepare several site-specifically ubiquitylated histones in order to find
out how these post-translational modifications are read by the nuclear proteome. In par-
ticular, we wanted to resolve how different proteins and protein complexes, including direct
histone ubiquitylation readers, are interacting with the modified histone constructs. To un-
derstand how the histone ubiquitylation readout is achieved we aimed to find the proteins
that bind the modified histones and compare these with the proteins that bind modified
mononucleosomes or modified chromatin fibers.
More than two dozen histone ubiquitylation marks have already been described in the liter-
ature (Figure 1.1)(Table 1.1). To select the ubiquitylation sites to be used in the systematic
interactome analysis, several parameters were considered: the topology of the modification
within the nucleosome core particle, previous documented association of the modification
with a chromatin-templated process and the readiness to prepare the modification by ex-
pressed protein ligation. The thesis aimed to investigate if the different modifications recruit
similar or unique proteins. The identification of the histone ubiquitylation interactors would
help undestand how correct recognition of the modification is achieved and how this recog-
nition contributes to the specificity of the downstream signalling events.
H2AK119ub was the first histone ubiquitylation site described in the literature [44]. This
mark was the first post-translational modification found on histones and also the very first
ubiquitylated protein found in cells [73]. H2AK119ub is presently seen as a heterochromatic
modification. H2A ubiquitylated tetranucleosomes were used to describe a cross-talk be-
tween the polycomb repressive complexes PRC1 and PRC2 [74]. This connection was shown
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Figure 1.3: Recognition of histone ubiquitylation marks.(A) Recognition of ubiquitin by
RAD18 requires a single helix ubiquitin interaction motif (UIM) (PDB 5VF0 [68]). (B) RNF168 uses
an elongated UIM to recognise ubiquitin conjugated to a H2A/H2B heterodimer (PDB 5VEY [68]).
(C) The RFTS domain of DNMT1 (containing a single helix UIM) binds two ubiquitin molecules
conjugated to the N-terminal tail of histone H3 (PDB 5WVO [37]). (D) A single helix UIM in
53BP1 recognises both ubiquitin and the nucleosomal acid patch (PDB 5KGF [71]). (E) Sgf11
stabilises the interaction of Ubp8 with ubiuquitin and the nucleosome by contacting both Ubp8
and the nucleosomal acidic patch (PDB 4ZUX [72]).
to be needed for heterochromatin spreading by formation of a positive feedback loop between
H2AK119ub and H3K27me3 at unmethylated CpG islands (promoters) [75], [76]. H2AK119
is found on the C-terminal tail of histone H2A, which protrudes outside of the nucleosome
core particle, around the nucleosome dyad axis (Figure 1.4).
H2BK120ub was the second histone ubiquitylation mark described in the literature [49]. This
modification is presently associated with transcriptionally active chromatin. Already in 1989,
using the Tetrahymena model organism, H2BK120ub was found enriched in this organism’s
active macronucleus. Removal of the yeast ubiquitin conjugating enzyme RAD6 abolished
H3K4me3, a methylation mark that had been associated with active chromatin [77], [78].
H2BK120ub facilitated in vitro RNA Polymerase II transcript elongation in the presence of
the histone chaperone FACT and the regulatory PAF complex [79]. H2BK120ub activated in
vitro the histone methyltransferase responsible for deposition of H3K4me3 [80]. H2BK120ub
localised at actively transcribed gene bodies in live cells [81], [82]. The H2BK120ub interac-
tome contained proteins involved in transcription elongation and RNA editing [83]. Finally,
levels of H2BK120ub have been shown to respond rapidly to external stimuli, such as hor-
mones, cytokines and differentiation cues [82], [84], [85], [86]. H2BK120 is located in H2B’s
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Figure 1.4: Topology of ubiquitylation sites. Different views of a 147 bp nucleosome core
particle. The ubiquitylation sites prepared in this thesis (atoms highlighted as orange spheres) are
located proximal to the dyad axis within (H2BK34) and just above (H2AK119) of the two DNA
gyres, on the outer lower half of the nucleosome core (H2BK120) and away from it on one of the
histone tails (H3K18; H3K23). Structural details were adapted from the published nucleosome
crystal structure (PDB 1AOI [5]).
C-terminal α-helix, on a ridge close to the nucleosomal acidic patch (Figure 1.4).
H2BK34ub was discovered recently using modern mass spectrometry sequencing techniques.
H2BK34ub was enriched from histone extracts obtained from neuronal cultures [55]. This
ubiquitylation mark was also enriched by affinity purification using an antibody raised
against the di-glycine anchor of ubiquitin [87]. The MSL-MOF E3 ubiquitin ligase com-
plexes was proposed to be responsible for writing this modification [58]. It was suggested
that H2BK34ub may stimulate H3K4 and H3K79 methylation in a mechanism that resem-
bles the H2BK120ub transcriptional activation [58]. H2BK34 is located on the N-terminal
tail of histone H2B which is buried inside the nucleosome core, between the two DNA gyres
(Figure 1.4).
H3K23ub was recently associated with DNA replication [35]. The modification was found
to be written by UHRF1 and shown to affect the localisation of DNMT1 to replication
foci. With improved sequencing techniques and the identification of the E2 conjugating
enzyme it was shown that, besides H3K23, also residues H3K14 and H3K18 were targeted
by ubiquitylation [35], [36], [88]. Additional evidence suggested that the ubiquitylation mark
was in fact a two-mono ubiquitylation signal where H3K14 and H3K18 or H3K18 and H3K23
act in concert for DNMT1 recruitment [37]. These ubiquitylation marks are located on the
N-terminal tail of histone H3, which projects outside from the nucleosome, away from the
dyad axis (Figure 1.4).
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Figure 1.5: Primary structure of SCML2, Usp7 and DNMT1. (A) Schematic annotation
of domains in Sex comb on midleg-like 2 (SCML2), Ubiquitin-specific protease 7 (Usp7) and DNA
methyltransferase 1 (DNMT1). (B) Previously known interaction surfaces connecting SCML2 with
Usp7 and Usp7 with DNMT1 are displayed as dotted lines. (C) Previously documented roles of
individual domains in SCML2. MBT = malignant brain tumor; RBR = RNA-binding region;
DUF = domain of unknown function; SPM = sex comb on midleg and polyhomeotic; TRAF =
TNF receptor associated factor; UBL = ubiquitin like domain; UIM = ubiquitin interaction motif;
RFTS = replication foci-targeting sequence; CXXC = cysteine XX cysteine; AI = autoinhibitory
linker; BAH = bromo-adjacent homology domain; KG = lysine glycine rich linker; TRD = target-
recognition domain; Kme1 = monomethylated lysine; dsDNA = double-stranded DNA.
1.3 Maintenance DNA methylation
After DNA replication, the methylation pattern of CpG dinucleotides needs to be copied from
the parental DNA strand onto the daughter DNA strand. This process insures that areas of
the genome which need to be silenced (repetitive sequences and transposable elements) are
clearly marked. Maintenance DNA methylation differs from de novo DNA methylation in
the fact that the substrate is already hemi-methylated. DNA methyltransferase I (DNMT1)
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is the enzyme which performs most of the maintenance methylation [18].
Previously, targeting of DNMT1 to replication foci was shown to be mediated by the replica-
tion foci targeting sequence (RFTS) domain at the protein’s N-terminus [89]. This domain
was shown to be important for DNMT1’s interaction with UHRF1 [90], [91]. Through this
interaction, UHRF1, which contains a set and ring associated (SRA) domain, that recognises
hemi-methylated CpG sites, was proposed to target DNMT1 for methylation.
Following the discovery that UHRF1 ubiquitylates H3K14/K18/K23 at hemi-methylated
CpG sites it was suggested and then shown that DNMT1 is stimulated by these modifica-
tions [35], [36], [88], [37]. DNMT1 bound H3 ubiquitylation using an ubiquitin interaction
motif (UIM) within its RFTS domain [36], [37].
This strong interaction brought into question the fact that DNMT1 needs to be recycled
from the H3 ubiquitylated chromatin. It was suggested that the ubiquitin specific protease
7 (Usp7), which was known to interact both with UHRF1 and DNMT1 is responsible for
DNMT1’s recycling (Figure 1.5B) [90], [91], [92]. Inhibition of Usp7 or removal of the pro-
tease from frog extracts was shown to prolong DNMT1’s recruitment to H3 ubiquitylated
chromatin, which resulted in a loss of global DNA methylation [93]. It is currently unresolved
how Usp7 is recruited to the modified chromatin and what activates the protease to remove
the H3 ubiquitylation mark.
The isolated catalytic domain of Usp7 was previously shown to have a one hundred fold
lower activity in comparison with the activity of the full-length (FL) enzyme [94]. FL Usp7
was proposed before to reversibly shift between an inactive and an active conformation, for
which the presence of the ubiquitin like UBL4,5 domains was essential [95]. A peptide at the
C-terminus of Usp7 was shown to fold back onto the catalytic domain to stimulate the en-
zyme, suggesting that large conformational changes, affecting all five ubiquitin-like domains
of Usp7, are needed for enzymatic function [70].
The deubiquitylase was previously shown to be recruited to H2AK119ub and H2BK120ub
marked nucleosomes [74], [96]. The activity of the enzyme was stimulated on H2BK120ub
by guanosine 5’-monophosphate synthase (GMPS), which served as an allosteric regulator
that shifted the Usp7 equilibrium towards an active conformation [96], [95].
Besides GMPS, DNMT1 and UHRF1, Usp7 was previously shown in a large scale proteomics
study to bind a number of other nuclear factors [97]. The polycomb group protein Sex combs
on midleg-like 2 (SCML2) was one of the additional targets. More recently, SCML2 was co-
immunoprecipitated with Usp7 from live cells and shown recombinantly to interact with the
enzyme [98].
It is currently unknown if SCML2 plays a role in the control of maintenance DNA methy-
lation. SCML2 is a multidomain human homolog of Drosophila Scm (Figure 1.5A) [99].
The protein uses the different domains to receive various signals from its surrounding envi-
ronment. SCML2 binds long noncoding RNA and is thought to be recruited to chromatin
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Figure 1.6: Current model of the events happening on the H3 ubiquitylated chromatin.
UHRF1, DNMT1 and PCNA form a complex that travels with the DNA replication fork. UHRF1
senses hemi-methylated CpG sites and ubiquitylates histone H3. DNMT1 binds H3 ubiquitylated
nuclesomes, is activated by this modification and converts hemi-methylated DNA to fully methy-
lated DNA. Usp7 interacts with UHRF1 and DNMT1 and removes H3 ubiquitylation to facilitate
DNMT1’s recycling. DNMT1 = DNA methyltransferase 1; UHRF1 = ubiquitin-like containing
plant homeodomain and really interesting new gene finger 1; PCNA = proliferating cell nuclear
antigen; hemi-meCpG = hemimethyalted DNA; meCpG = fully methylated DNA.
through this interaction [100]. In vitro, the RBR domain of SCML2 binds at the same time
HOTAIR lncRNA and a nucleosome core particle [100](Figure 1.5C). SCML2 binds DNA
weakly with its DUF domain (Figure 1.5C) [101]. The second MBT domain of SCML2
recognises monomethylated lysine residues, in particular H4K20me1 (Figure 1.5C) [102].
SCML2 is expressed in two isoforms. The long SCML2 isoform, SCML2A, differs from the
shorter one, SCML2B, in the presence of the C-terminal SPM multimerisation domain (Fig-
ure 1.5B) [103]. In Drosophila, the Scm SPM domain is thought to play a role in chromatin
silencing [104]. SCML2 may achieve this silencing by interacting with itself or with SPM
domains from other polycomb group proteins [105], [106], [100].
Since GMPS could stimulate Usp7, it may be possible that also DNMT1, UHRF1 or SCML2
which interact with the protease, control its activity. How Usp7 coordinates with DNMT1
and UHRF1 to control their recycling from the H3 ubiquitylated chromatin DNA replication
and where SCML2 interferes in this cross-talk remains unresolved (Figure 1.6).
1.4 Protein engineering
The attempts to purify ubiquitylated histones from tissue or cellular extracts using tradi-
tional chromatography techniques have been very successful in obtaining the more abundant
H2A and H2B ubiquitylated species [44], [49]. Ubiquitylated histones purified in this way
were used to assemble ubiquitylated nucleosomes [107] and ubiquitylated nucleosomal ar-
rays [108] to test if the presence of ubiquitin influences the nucleosome structure and the
higher order folding. These protocols were not efficient at enriching for other less repre-
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sented ubiquitylated constructs. In addition, they yielded products with additional post-
translational modifications, which could interfere with the effects caused by ubiquitylation.
These limitations forced researchers to look for alternative ways to prepare ubiquitylated
histones.
The identification of the first E2 conjugating [77] and E3 ligase [109] enzyme pair allowed
for the development of in vitro ubiquitylation assays. Histone H2B was modified at lysine
K120 directly on a chromatin template to promote ongoing transcription [79]. The same
approach was later used with other E2/E3 enzyme pairs on recombinant histones or nucle-
osomes to generate H2BK34ub and H2AK13ub/K15ub or H2AK119ub [58], [59], [74]. Even
though quite efficient in producing H2BK120ub and H2AK119ub, this method fell short for
H2BK34ub and H2AK13ub/K15ub as those ubiquitylation reactions yielded also unspecific
products.
In parallel, site-directed mutagenesis of ubiquitin and histone H2B has been used for prepa-
ration of H2BK120ub through a disulfide linkage [22]. This approach produced a non-native
cystine that was incompatible with reducing buffers.
To circumvent the sensitive nature of the disulfide linkage and address all other previous
limitations, several semi-synthetic approaches for histone ubiquitylation have been described
(Figure 1.7A) [80], [110], [111], [61], [112]. The most successful strategy, which leaves a native
isopeptide linkage, was native chemical ligation and was independently adapted to histones
in the laboratories of Tom Muir and Ashraf Brick [80], [110].
1.4.1 Expressed protein ligation
Expressed protein ligation is a novel protein engineering tool that merges recombinant pro-
tein production with peptide chemistry to facilitate site-specific incorporation of difficult
post-translational modifications. At the centre of the native chemical ligation strategy lies
the specific chemical reaction between a thiol and a thioester [113]. As neither ubiquitin nor
any of the core histones contains a thiol-bearing amino acid, both reactive moieties needed
for native chemical ligation can be artificially added at the desired locations. To react ubiq-
uitin with target peptides or proteins by means of chemical ligation, a thioester is inserted
at its C-terminus and an unnatural lysine-mimic amino acid, containing a thiol on its penul-
timate carbon, is introduced at the target location in the (poly)peptide chain. The first
modification is achieved using intein splicing protocols [114], [80], the second modification is
incorporated using genetic code expansion or peptide chemistry [115], [80], [110].
Inteins are proteins with self-splicing activity [116]. Premature proteins, like precursor mes-
senger RNAs, contain external protein domains referred to as exteins and internal protein
domains known as inteins [117]. The catalytic properties of inteins lie in their horseshoe-like
shape which causes their N and C termini to be only 10 A˚ apart [118]. The splicing reaction
leads to the removal of the intein and the ligation of the N- and C-exteins. This is achieved
through the cleavage of two amide bonds and the formation of a novel peptide bond. The
reactions occur spontaneously and do not require any cofactor or energy source [119]. Purifi-
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Figure 1.7: Ubiquitylation of histones by expressed protein ligation. (A) Non-enzymatic
attachment of ubiquitin to histones was achieved using several different strategies: isopeptide link-
age (this thesis), thiirane linkage [112], disulfide linkage [22] and thioester linkage [111]. (B) Ubiq-
uitin thioester was prepared in this thesis by sodium mercaptoethanesulfonate (MESNa) treatment
of a purified ubiquitin-GyrA intein-chitin binding domain fusion construct.
cation of ubiquitin and histone C-terminal thioesters relies on thiol-mediated intein cleavage
(Figure 1.7B) [113], [114].
1.5 Mass spectrometry and discovery proteomics
1.5.1 Peptide sequencing
Mass spectrometry is a technique that calculates the mass of molecules as a function of
their charge state. Positive ion mass spectrometry is the analysis of molecules in an acidic
environment. In proteomic research, positive ion mass spectrometry is used to ionise the
amino acids lysine and arginine which have high pKa values. The most common analytes
used in proteomic research are peptides, whose mass and charge can be extracted from the
ions that fall within the scanning range of most mass analysers. The peptide mass refers to
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the sum of the individual masses of amino acids and accounts for the loss of 18 Da during
formation of amide bonds. The total peptide charge is the sum of all lysine and arginine
residues and accounts for the presence of an ammonium ion (NH3+) at the N-terminus and
of a carboxylic acid (COOH) at the C-terminus.
Mass analysers separate peptide ions based on their mass-over-charge (m/z) ratios. Inside
the mass analyser, peptides form ionisation patterns (charge states) of different m/z ratios.
A minimum of two charge states is needed to identify the mass of a peptide. The charge z
of a single ion from the ionisation pattern, is calculated using the ion’s less intense isotopic
peaks given by the naturally-occuring isotope 13C. This isotope is present in all proteins at a
concentration of 1% and adds 1 Da per carbon to the peptide ion. The isotopic peaks have
m/z ratio of (m+1)/z. The difference between the 12C m/z and the isotopic 13C (m+1)/z
is used to calculate the charge z. The mass analyser collects m/z ratios from a minimum
of two consecutive charge states and uses this information to deconvolute the peptide mass m.
The peptide mass calculated in the first mass analyser is an important parameter, but it
is insufficient for identification of the amino acid sequence of the peptide [120]. Modern
mass spectrometers contain two (or even three) mass analysers connected in series. Between
the first and the second mass analyser, there is a fragmentation cell which uses high energy
to break peptide bonds [121]. The parental ion is fragmented into product ions which are
analysed in the second mass analyser. The product ion series (b and y ion series) is made
of smaller peptide ions which have lost amino acids from the N- and the C-termini of the
parental peptide (Figure 1.8). Using the parental peptide mass and several product ions
masses, a number of amino acids from the N- and the C-termini of the proteins can be as-
signed [120].
Peptides could in theory be ”sequenced” relying solely on the product ion masses. However,
in a complex mixture of peptide ions, a complete series of product ions is rarely observed in
the spectra collected from the second mass analyser. As such, the information provided by
the two mass analysers is complemented with the use of peptide databases that are prepared
in silico [122], [123], [124]. These databases provide a search space for peptide sequencing
algorithms which match the measured product ions with the synthetic peptide library. The
database includes the amino acid sequences of the proteins that are present in the analyte and
account for the use of proteases (most often trypsin), which are used to generate the peptides.
Several software packages were developed to extract the data obtained from the mass spec-
trometer using synthetic peptide databases as search spaces [122], [125].
1.5.2 The use of mass spectrometry in discovery proteomics
The high resolution capacity of modern mass spectrometers allows for the use of isotopic
tags (chemical tags, chemical labels and stable isotopes of amino acids) [126], [127], [128].
Mass analysers separate between proteins that were exposed to the isotopic tag and those
which were not based on the differences in the parental ion masses. As such, stable isotopes
of the amino acids lysine and arginine (which are present in all the peptides digested by
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trypsin) [129] can be used to label a cell’s entire proteome [128]. Stable isotope labeling of
amino acids in cell culture (SILAC) facilitates the identification of proteins that change their
abundance with respect to a particular treatment applied to cells [128]. The technique allows
also for the preparation of labeled cellular or subcellular extracts that can be used in affinity
purification experiments outside of the cellular environment [130]. SILAC nuclear extracts
were previously used in affinity purification experiments to address which nuclear interactors
bind modified histone tails [131]. The technique was also used in chromatin affinity purifica-
tion (ChAP) experiments, to compare the factors which bound modified nucleosomal arrays
to the interactors that were previously enriched with modified histone peptides [132]. Re-
cently, chromatin affinity purification coupled with mass spectrometry (ChAP-MS) has been
used to find the nuclear interactors that bind to ubiquitylated nucleosomal arrays [83], [74].
To distinguish between false positive and true positive identifications, chromatin affinity pu-
rification was designed to contain a forward and a reverse biochemical experiment (Figure
3.11A) [132]. In the forward experiment, the modified chromatin is incubated with SILAC-
labeled (heavy) nuclear extract and the unmodified chromatin is incubated with unlabeled
(light) nuclear extract. The eluates from the two purifications are mixed such that the
pooled forward eluate contains both light and heavy proteins. In the reverse experiment, the
modified chromatin is incubated with light nuclear extract and the unmodified chromatin
is incubated with heavy nuclear extract. The pooled reverse eluate contains both light and
heavy proteins. True positive identifications refers to the factors which are enriched in the
forward experiment and depleted in the reverse experiment.
The pooled eluate from the forward experiment is separated by SDS-PAGE to reduce sample
complexity and proteins are digested by trypsinisation (Figure 1.8). This step relies on the
assumption that both the light and the heavy proteins are digested to the same extent by
trypsin. Peptides originating from the forward or the reverse experiment are separated prior
to detection using high performance liquid chromatography (HPLC). HPLC separation of
corresponding heavy and light peptides is assumed not to be influenced by their mass dif-
ference. After elution from the HPLC column, peptides are ionised and analysed, assuming
that neither the ionisation ability, nor the detection in the two mass analysers is affected by
the peptide pair mass difference. Pairs of heavy and light parental ions are analysed in the
first mass spectrometer (Figure 1.8). The ratio between the intensity of the heavy parental
ion and the intensity of its corresponding light parental ion is referred to as the H/L ratio.
An H/L ratio higher than 1 suggests that the heavy protein was more abundant than the
light protein. An H/L ratio higher than 1 in the forward experiment indicates that the heavy
protein preferred the modified chromatin template over the unmodified control.
Assignment of enriched factors was previously done using a cutoff value that was chosen
based on the distribution of all H/L ratios [131], [132], [83], [74]. More recently, statistical
analysis was introduced to measure reproducibility of biological experiments and technical
measurements [133]. Mass spectrometry is thus coupled with affinity purification to discover
new proteins that are enriched by a particular modification.
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Figure 1.8: Identification of chromatin interactors by mass spectrometry. Enriched
proteins from the forward or reverse chromatin affinity purification experiments are separated
according to their molecular weight by polyacrylamide gel electrophoresis. The gel is sliced to
reduce sample complexity and proteins from each gel slice are digested with trypsin. Peptides
are eluted from the gel slices in an acidic environment and separated by high performance liquid
chromatography on a reverse phase C18 column according to their hydrophobicity index. Peptides
are injected into the mass spectrometer by electrospray ionisation and separated according to
their mass-over-charge (m/z) ratio using a quadrupole mass analyser. SILAC pairs (light and
heavy peptide ions) are resolved based on their different m/z values [128]. Most intense peptide
precursor ions are selected in data-dependent acquisition mode and fragmented by high-energy
collision dissociation to give rise to series of product ions. The product ions are measured in an
orbitrap which serves as the second mass analyser. De novo sequencing algorithms (MaxQuant
[125]) rely on species-specific databases of tryptic digests (Andromeda [124]) and use the m/z ratio
of the product ions to reconstruct peptide sequences. Reconstructed peptides are assembled into
protein groups and the corresponding summed heavy and light peptide intensities are scored to
obtain heavy-over-light (H/L) ratios. Statistical post-processing is performed on the reported H/L
ratios (Perseus [133]) to quantitatively assess modification-specific chromatin enrichment.
1.5.3 Crosslinking mass spectrometry
Crosslinking mass spectrometry is emerging as a technology that allows for the identification
of protein-protein interaction surfaces which can be used to assist the reconstruction of low
resolution structures [134], [135], [136], [137]. Crosslinkers form covalent bonds with target
amino acid residues. Bifunctional crosslinkers interact with two amino acids residues from
within the same protein or from two different proteins. Stable as well as flexible interac-
tions can be detected using crosslinkers with different arm lengths (distance between the
two functional groups). Bis(sulfosuccinimidyl)suberate BS3 is an amine-specific crosslinker
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that is used to stabilise medium range interactions. Its two homophilic functional groups
are separated by a spacer of 11.4 A˚ [138].
Mass spectrometry can be used to analyse crosslinked peptides in order to identify the
crosslinked residues [139]. Most challenging in the identification of crosslinked sites is the
generation of specific peptide databases. Standard peptide libraries used in de novo se-
queucing algorithms, are not useful because crosslinked peptides contain two separate and
non-adjacent amino acid sequences which are covalently attached. To sequence crosslinked
peptides, special databases and search algorithms are generated [140]. The identification of
crosslinked sites needs to account for the primary amino acid composition of the crosslinked
proteins, the enzyme used to prepapre the peptides, all crosslinkable sites (every lysine in
the case of BS3) and the mass of the crosslinker (572.43 Da). Special software packages are
dedicated to the analysis of crosslinked peptides [140].
1.6 Objectives of the PhD thesis
Histone ubiquitylation is a post-translational modification which introduces chemical and
physical changes to chromatin. Several histones residues are modified by ubiquitylation.
Distinct histone ubiquitylation marks are generally associated with unique biological func-
tions. We hypothesise that ubiquitylation of histones creates unique chromatin environments
which recruit specialised proteins and protein complexes that control different chromatin-
templated processes.
Our understanding of the mechanism through which histone ubiquitylation marks are recog-
nised by the nuclear proteome is limited presently by the availability of tools to study the
modification in a living organism or in an in vitro system. To understand how different
protein factors are recruited to ubiquitylated histones, these can be used directly in affinity
purification experiments. Since ubiquitylated histones cannot be expressed recombinantly,
the production of ubiquitylated histones relies on the development of in vitro enzymatic sys-
tems specific for every single modification. A more general strategy needs to be designed to
be able to produce ubiquitylate histones. Using ubiquitylated histones in affinity purification
experiments may increase the identification of novel direct histone ubiquitylation readers,
but would fall short in identifying interactors whose enrichment depends on additional fea-
tures present on the (modified) chromatin fibers. A standardised protocol which makes use
of chromatinised modified histones as affinity purification matrices needs to be developed.
Previously in our laboratory, native chemical ligation was employed to produce semi-synthetic
H2BK120ub which was then chromatinised and used to find the nuclear proteins that as-
sociate with this modification [132]. This study set up the systematic analysis of histone
ubiquitylation readers which will be described in this PhD thesis. The main objective of
the PhD thesis is to develop the tools to efficiently ubiquitylate histone residues and reli-
ably identify the nuclear proteins which recognise these modifications. To test the mapping
strategy, a subset of enriched interactors will be analysed recombinantly in the context of
the modified histone which was used for their identification.
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The first aim of the PhD thesis is to develop a general strategy to prepare ubiquitylated
histones and incorporate them into uniform nucleosomal arrays.
The second aim of the PhD thesis is to map the nuclear proteins which bind distinct ubiq-
uitylated histones and find what chromatin features are needed in the readout process.
The third aim of the PhD thesis is to focus onto the proteins enriched by the N-terminal
ubiquitylation of histone H3 marks and test the specificity of these interactors recombinantly.
We focused on the description of the interactions between DNMT1, Usp7, SCML2 and the
H3 ubiquitylated chromatin in order to understand the regulation of Usp7’s activity.
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Chapter 2
Materials and Methods
2.1 Instruments and Equipment
Table 2.1: List of common instruments and equipment
Instrument Company Addrees
AEKTA Explorer/Purifier GE Healthcare Buckinghamshire (UK)
Balances Sartorius Goettingen (DE)
Centrifuge Sorvall Evolution RC Thermo Scientific Braunschweig (DE)
Centrifuge 5415R/5810R Eppendorf Hamburg (DE)
Electrophoresis power supplies Bio-Rad Mnchen (DE)
Ultimate 3000 NanoLC Thermo Fisher Scientific Braunschweig (DE)
Qexactive HF Thermo Fischer Scientific Bremen (DE)
Mini-PROTEAN Tetra PAGE cell Bio-Rad Muenchen (DE)
Molecular Imager Gel Doc Bio-Rad Muenchen (DE)
NanoDrop ND-1000 Peqlab Erlangen (DE)
Peristaltic pump Ismatec Glattburgg (CH)
pH meter Metler-Toledo Giesen (DE)
Prominence HPLC Shimadzu Kyoto (JP)
Sonication bath SONOREX Super BANDELIN Electronic Berlin (DE)
Sorval SLC1500 rotor Thermo Scientific Braunschweig (DE)
SpeedVac Savant SPD121P Thermo Scientific Braunschweig (DE)
Sub-Cell agarose gel electrophoresis Bio-Rad Muenchen (DE)
Thermo F8-6x1000y rotor Thermo Scientific Braunschweig (DE)
Thermocycler epgradientS Eppendorf Hamburg (DE)
Thermomixer Comfort Eppendorf Hamburg (DE)
Turbo-Blot system Bio-Rad Muenchen (DE)
Water bath TW12 Julabo Selbach (DE)
XCell Sure Lock Mini NuPAGE cell Invitrogen Karlsruhe (DE)
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2.2 Chemicals and Reagents
Bacterial strains
Escherichia coli XL-1 Blue [159]
genotype: F’ proAB lacIqZ∆M15 Tn10 Tetr recA1 endA1 gyrA96 thi-1 hsdR17 supE44
resistance: tetracyclin
Escherichia coli DH10BacCre [160]
genotype: F mcrA (mrr-sdRMS-mcrBC) 80lacZ M15 lacX74 recA1 endA1 araD139 (ara,
leu)7697 galU galK rpsL nupG/bMON14272/pMON7124 pBADZ His-Cre
resistance: tetracyclin, kanamycin
Escherichia coli BL21 (DE3)-RIL [161]
genotype: F ompT hsdS (rB mB) dcm+ Tetr gal l (DE3) endA Hte [argU ileY leuW Camr]
resistance: chloramphenicol
Escherichia coli C2925 [162]
genotype: ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 hisG4 rfbD1
R(zgb210::Tn10) TetS endA1 rspL136 (StrR) dam13::Tn9 (CamR) xylA-5 mtl-1 mcrB1
resistance: streptomyicin, chloramphenicol
Genotype abbreviations: [163]
Insect cell lines
Spodoptera frugiperda Sf9 [164]
cell line: IPLB-Sf-21-AE, Thermo Fischer Scientific
insect cell medium: Sf900 II SFM medium, Thermo Fischer Scientific
Trichoplusia ni Hi5 [165]
cell line: BTI-TN-5B1-4, Expression Systems
insect cell medium: ESF 921 medium, Expression Systems
Human cell lines
HeLa clone S3: human cervical adenocarcinoma [166]
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Table 2.2: List of common chemicals
Product Ordering number Supplier
4-(2-Hydroxyethyl)-1-piperazineethanesulfonate 75277-39-3 VWR
Acetic acid 1000632511 Merck
Acetonitrile 1000292500 Merck
Agarose 9012-36-6 Serva
Boric acid 1001625000 Merck
Bovine serum albumin (BSA) 9048-46-8 Sigma-Aldrich
Bromophenol blue 34725-61-6 Serva
Bis(sulfosuccinimidyl)suberate (BS3) 21585 Thermo Scientific
Dithiothreitol (DTT) 3483-12-3 Merck
Deoxynucleotide-5’-phosphate mix L540.2 Roth
Ethanol 1009832511 Merck
Ethidium bromide 1239-45-8 Merck
Ethylendiamine tetraacetate (EDTA) 6381-92-6 Roth
Formic acid 64-18-6 VWR
Glycerol 1040922500 Merck
Guanidine hydrochloride G3272-1KG Sigma-Aldrich
Hydrochloric acid (37%) 1003172500 Merck
Iodacetamide I6125-100G Sigma-Aldrich
Magnesium chloride (MgCl2) M8266-1KG Sgima-Aldrich
Methanol 1060092511 Merck
Non-fat dry milk powder 70166-500G Sigma-Aldrich
Ortho-Phosphoric acid 1005731000 Merck
Polyethylene glycol 6000 (PEG 6000) 8074911000 Merck
Potassium chloride (KCl) 1049330500 Merck
Potassium dihydrogen phosphate (KH2PO4) 3904.1 Roth
Potassium hydrogen phosphate (K2HPO4) T875.2 Roth
S-(5-adenosyl)-L-methionine (SAM) A2408-25MG Sigma-Aldrich
S-(5-adenosyl)-L-homocysteine (SAH) A9384-10MG Sigma-Aldrich
Sodium acetate 6773.2 Roth
Sodium chloride (NaCl) 1064045000 Merck
Sodium dodecyl sulfate (SDS) 1.13760.1000 VWR
Sodium hydroxide (NaOH) 1064621000 Merck
Sodium mercaptoethanesulfonate (MESNA) M1511-25G Sigma-Aldrich
Trifluoroacetic acid (TFA) 91707-250ML-M Sigma-Aldrich
Tris(hydroxymethyl)amino ethane (Tris base) 4855.3 Roth
Triton X-100 1086431000 Merck
Tween-20 P1379-1L Sigma-Aldrich
Urea 1084875000 Merck
Ubiquitin-vinyl-sulfone U-212 Boston Biochem
Water 1153332500 Merck
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Table 2.3: List of plasmids
Plasmids Promoter Resistance Supplier
pET-22b H2A T7 ampicillin Prof. Wolfgang Fischle
pET-22b H2B T7 ampicillin Prof. Wolfgang Fischle
pET-22b H3 T7 ampicillin Prof. Wolfgang Fischle
pET-22b H4 T7 ampicillin Prof. Wolfgang Fischle
pET-22b H2A E61/64A T7 ampicillin cloned
pET-3a H3 T7 ampicillin Prof. Wolfgang Fischle
pET-3a H3∆1-24A25C T7 ampicillin cloned
pTXB1 Ub T7 ampicillin Dr. Shira Albeck
pTXB1 H2A∆113-129 T7 ampicillin cloned
pUC18 12x200x601 ampicillin Prof. Wolfgang Fischle
pUC18 52x187x601 ampicillin Prof. Wolfgang Fischle
pUC18 16x145x601 ampicillin Prof. Song Tab
pFB DNMT1 polyhedrin ampicillin, gentamycin Prof. Albert Jeltsch
pFB DNMT1∆RFTS polyhedrin ampicillin, gentamycin cloned
pFB DNMT1∆UIM polyhedrin ampicillin, gentamycin cloned
pFB Usp7 polyhedrin ampicillin, gentamycin Prof. Lori Frappier
pFB Usp7 C223A polyhedrin ampicillin, gentamycin cloned
pFB Usp7∆TRAF polyhedrin ampicillin, gentamycin cloned
pFB SCML2 polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆MBT polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆RBR polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆DUF polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆longSPM polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆preSPM polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆SPM polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆N polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆C polyhedrin ampicillin, gentamycin cloned
pFB SCML2∆RBR-DUF polyhedrin ampicillin, gentamycin cloned
pGEX SCML2 T7 ampicillin cloned
pGEX SCML2∆MBT T7 ampicillin cloned
pGEX SCML2∆RBR T7 ampicillin cloned
pGEX SCML2∆DUF T7 ampicillin cloned
pGEX SCML2∆longSPM T7 ampicillin cloned
pGEX SCML2∆preSPM T7 ampicillin cloned
pGEX SCML2∆SPM T7 ampicillin cloned
pGEX SCML2∆N T7 ampicillin cloned
pGEX SCML2∆C T7 ampicillin cloned
pGEX SCML2∆RBR-DUF T7 ampicillin cloned
pGEX RBR-DUF T7 ampicillin cloned
pGEX TRAF T7 ampicillin cloned
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Table 2.4: List of oligonucleotides
Oligonucleotide Sequence Supplier
EcoRI-btn-fwd 5’ - GGGGGGGGATCCGGGGGGG[phos] - 3’ Sigma-Aldrich
EcoRI-btn-rev 5’ - [phos]AATTCCCCCCCGGATCCCCCCCC[biotin] - 3’ Sigma-Aldrich
NotI-btn-fwd 5’ - GGCCGGGGGGATCCGGGGG[phos] - 3’ Sigma-Aldrich
NotI-btn-rev 5’ - [phos]CCCCCGGATCCCCCC[biotin] - 3’ Sigma-Aldrich
Table 2.5: List of antibodies
Antibody Dilution Ordering number Supplier
rabbit-anti-H2B 1:1000 ab1790 Abcam
rabbit-anti-H3 1:5000 ab1791 Abcam
rabbit-anti-PCNA 1:500 sc-56 (PC10) Santa Cruz
rabbit-anti-SCML2 1:500 Prof. Danny Reinberg
mouse-anti-SCML2 1:250 sc-271097 (F-7) Santa Cruz
mouse-anti-UHRF1 1:1000 sc-373750 (H-8) Santa Cruz
rabbit-anti-Usp7 1:1000 A300-033A-M Bethyl
rabbit-anti-DNMT1 1:500 A300-041A-M Bethyl
rabbit-anti-ACACA 1:250 C83B10 Cell Signalling Technology
swine-anti-rabbit 1:5000 P0399 Agilent
goat-anti-mouse 1:5000 P0447 Agilent
streptavidin-HRP 1:5000 P0397 Agilent
Table 2.6: Molecular biology enzymes
Enzyme Ordering number Supplier
AvaI R0152L New England Biolabs
BamHI R3136L New England Biolabs
BanI R0118S New England Biolabs
BfuCI R0636 New England Biolabs
DdeI R0175L New England Biolabs
DpnI R0176L New England Biolabs
EcoRI R3101L New England Biolabs
HaeII R0107L New England Biolabs
NotI R3189L New England Biolabs
NdeI R0111L New England Biolabs
Sau3 AI R0169L New England Biolabs
Antarctic phosphatase M0289L New England Biolabs
T4 DNA ligase M0202T New England Biolabs
M.SssI methyltransferase M0226L New England Biolabs
Pfu polymerase EP0501 Thermo Fischer Scientific
Ribonuclease A 9001-99-4 Sigma-Aldrich
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Table 2.7: Kits and other reagents
Product Ordering number Supplier
Infusion Cloning Kit 639648 Takara Bio company
Gel extraction kit 740609.250 Macherey Nagel
Plasmid Purification kit 740588.250 Macherey Nagel
Gigaprep kit 740593 Macherey Nagel
Chitin resin S6651L New England Biolabs
Magnesphere streptavidin beads Z5481 Promega
Glutathione agarose 16101 Thermo Fischer Scientific
GFP-trap resin gta-10 ChromoTek
Dynabeads sheep-anti-rabbit 11203D Thermo Fischer Scientific
Dynabeads goat-anti-mouse resin 11033 Thermo Fischer Scientific
TALON magnetic beads 635636 Takara Bio company
Anti-HA agarose 11815016001 Sigma-Aldrich
Q sepharose 17-5072-01 GE Healthcare
SP sepharose 17-5073-01 GE Healthcare
Superdex S200 10/300 GL 17-5175-01 GE Healthcare
HiTrap SP 17-1151-01 GE Healthcare
HiTrap Q 17-1153-01 GE Healthcare
Resource Q 17-1177-01 GE Healthcare
Reprosil-Pur120 C18 5µm resin r15-aq Dr. Maisch GmbH
Reverse phase C4 214TP54 Grace-Vydac
Amberlite 000020275 Sigma-Aldrich
NuPAGE gels NP0321BOX Thermo Fischer Scientific
NuPAGE loading dye NP0007 Thermo Fischer Scientific
NuPAGE reducing agent NP0004 Thermo Fischer Scientific
NuPAGE antioxidant NP0005 Thermo Fischer Scientific
SeeBlue Plus2 Protein Standard LC5925 Invitrogen
Isopropyl β-D-thiogalactoside I6758-10G Sigma-Aldrich
Silde-A-Lyser Mini 69552 Thermo Fischer Scientific
Spectrapor 3 Dialysis Membrane 132720 Spectrum Laboratories
X-Gal 15520034 Thermo Fischer Scientific
Ampicillin sodium salt A9518-25G Sigma-Aldrich
Gentamycin sulfate G1914-250MG Sigma-Aldrich
LB medium X965.3 Roth
2xYT medium X966.3 Roth
Ammonium bicarbonate 09830-1KG Simga-Aldrich
ECL plus RPN2132 Amersham GE Healthcare
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2.3 Preparation of nuclear extracts
HeLa S3 light and SILAC-labelled (Arg-6, Lys-4) nuclear extracts to be used in mass spec-
trometry experiments were prepared by Dr. Miroslav Nikolov and Dr. Nadin Zimmerman
using the Dignam protocol [167] and stored at 10 mg/mL concentration at -80 ◦C.
The Dignam protocol for preparation of fresh HeLa S3 nuclear extracts was modified to be
used in western blot analysis. 20 mL packed cells were swollen in 100 mL hypotonic buffer
(10 mM HEPES-NaOH pH 7.9, 10 mM NaCl) for 10 minutes on ice. Swollen cells were
transferred in a glass homogeniser and lysed by manual douncing over 20 strokes. Lysed
cells were centrifuged at 3000xg for 15 minutes at 4 ◦C to yield the cytosolic (supernatant)
and the nuclear (pellet) fractions. The nuclear pellet was resuspended in 40 mL high salt
buffer (25 mM HEPES-NaOH pH 7.9, 10% glycerol, 420 mM NaCl) and transfered to a
glass homogeniser. Nuclei were lysed by manual douncing over 20 strokes. Lysed nuclei
were incubated for 30 minutes at 4 ◦C at 200 rpm on a stirring plate. The nuclear extract
was obtained after centrifugation of the lysed nuclei at 13000xg for 30 minutes at 4 ◦C. The
nuclear extract was dialysed for 2 hours at 4 ◦C against storage buffer (25 mM HEPES-NaOH
pH 7.9, 10% glycerol, 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 0.1% Triton-X 100). The
dialysed nuclear extract was frozen in liquid nitrogen and stored at -80 ◦C.
2.4 Molecular cloning
Site-directed mutagenesis was performed in order to introduce amino acid mutations, insert
short tags (His- and HA-tags) and for deletion of domains in the SCML2 insect cell and
bacteria vectors. For site-directed mutagenesis, oligonucleotides were designed according to
the quick change protocol [168]. In addition, oligonucleotides with longer complementary
regions to the vector backbone were prepared for the mutants where the quick change pro-
tocol did not yield any clones. Mutants were obtained by polymerase chain reaction (PCR)
(Table 2.8; Table 2.9). 20 µL from the PCR reactions were digested with DpnI for 1 hour at
37 ◦C to remove the methylated parental plasmid. The digestion reaction was transformed
into the chemically competent XL-1 Blue Escherichia coli bacteria. Positive colonies were
screened by colony PCR and sequenced using primers against the vector backbone.
GST fusion constructs were prepared by infusion cloning according to the manufacturer pro-
tocol [169]. pGEX.6P1 plasmid was linearised with EcoRI and purified from an agarose gel
using a gel extraction kit. Inserts were amplified by PCR and contained 5’ and 3’ overhangs
complementary to the linearised plasmid (Table 2.10). After PCR, the insert was purified
from an agarose gel. In the infusion (homologous recombination) reaction, 50 ng linearised
plasmid was incubated with an equimolar amount of insert DNA in the presence of 1 µL
of infusion cloning mix for 15 minutes at 50 ◦C. The reaction was then placed on ice for 2
minutes and transformed into the chemically competent XL-1 Blue Escherichia coli strain.
Positive colonies were screened by colony PCR and further sequenced using primers against
the pGEX vector backbone.
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The H2A∆113-129-intein construct was prepared by fusion PCR. Synthesis of the insert
required three separate PCR steps. First, H2A∆113-129 was amplified from pET-3a H2A
plasmid with a 3’ end extension complementary to the 5’ region of the GyrA intein sequence.
Second, GyrA CBD was amplified from pTXB1 Ub plasmid with a 5’ extension end com-
plementary to the 3’ region of truncated H2A histone. Third, the forward primer of the first
PCR and the reverse primer of the second PCR where used to amplify a full-length construct
starting from an equimolar mix of the previous two PCR products. The final PCR product
was digested with NdeI and BamHI, purified by gel extraction and incubated in a three-
fold excess molar ratio with a pTXB1 linearised vector backbone. The mixture was ligated
with T4 DNA ligase for 1 hour at room temperature and transformed into the chemically
competent XL-1 Escherichia coli strain. Positive colonies were screened by colony PCR and
further sequenced using primers against the pTXB1 vector backbone.
Table 2.8: Pfu PCR reactions mix
Reagent Concentration Volume [µL]
Pfu buffer with MgCl2 10x 5
dNTPs mix 10 mM 1
primer mix 10 µM 1
DNA template x ng/µL x
Pfu Polymerase 2.5U/µL 1
H2O 42 - x
Total 50
Table 2.9: Site-directed mutagenesis thermomixer setup
Cycles Process Temperature [◦C] Time [sec]
1x denaturation 95 180
denaturation 95 30
35x annealing 60 30
elongation 72 480
1x elongation 72 600
Table 2.10: Pfu PCR thermomixer setup
Cycles Process Temperature [◦C] Time [sec]
1x denaturation 95 180
denaturation 95 30
35x annealing 55-65 30
elongation 72 60
1x elongation 72 600
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2.5 Preparation of recombinant proteins
2.5.1 Purification of human histones from bacteria
pET-3a plasmids containing Xenopus laevis histone expression constructs or pET-22b plas-
mids containing human histone expression constructs were transformed by heat shock in
BL21 (DE3)-RIL Escherichia coli. Single colonies were inoculated in 100 mL 2xYT medium
and grown overnight at 37 ◦C, at 140 revolutions per minute (rpm) shaking. The preculture
was diluted 1:100 in 2L 2xYT medium and grown at 37 ◦C until an OD600 value of 0.4 -
0.6. Protein synthesis was induced with 0.5 mM IPTG. Bacteria were harvested three hours
after the induction by centrifugation at 6000xg, for 12 minutes, at 4 ◦C. Bacteria were resus-
pended in lysis buffer (10 mL buffer/ 1L bacterial culture) (100 mM NaCl, 10 mM Tris-HCl
pH 7.5) and lysed by passing them three times through a French press at 1000-1500 psi. The
lysate was clarified by centrifugation at 25000xg for 30 minutes, at 4 ◦C. The presence of
the expressed protein in the lysate pellet (inclusion bodies) or in the lysate supernatant was
checked by SDS-PAGE.
Inclusion bodies were washed twice with wash buffer (20 mL buffer/ 1L culture) (100 mM
NaCL, 10 mM Tris-HCl pH 7.5, 1% Triton X-100) until complete resuspension of the pellet
and centrifuged at 25000xg for 30 minutes at 4 ◦C. The inclusion bodies were washed once
more with lysis buffer to remove the detergent, centrifuged and stored at -20 ◦C. The clean
inclusion bodies were solubilized in 1mL dimethylsulfoxide (DMSO). Proteins were extracted
from the solubilised inclusion bodies in 30 mL unfolding buffer (7 M guanidinium hydrochlo-
ride, 10 mM Tris-HCl pH 7.5, 10 mM DTT) for 1 hour under stirring at room temperature.
The extract was clarified by centrifugation at 25000xg for 30 minutes at 4 ◦C. An additional
10 mL unfolding buffer was added to the pellet to fully extract proteins from the inclusion
bodies. The pooled extract was dialysed three times against 2 L SAU 200 (7M urea, 200
mM NaCl, 20 mM NaAc pH 5.2, 2mM DTT, 1 mM EDTA), centrifuged and loaded onto a
combination of Q and SP sepharose anion-cation exchange columns.
Expressed histones which remained in the supernatant of the bacterial lysate were recovered
by acid extraction. Hydrochloric acid was added to a concentration of 0.5 M in the super-
natant, which was stirred for 30 min at room temperature and centrifuged at 25000xg for 30
min at 4 ◦C. The supernatant containing the expressed histones was collected and incubated
with 5 volumes of cold acetone overnight at -20 ◦C. The precipitated histones were collected
by centrifugation and washed to complete resuspension in 1 volume of acetone. The acetone
was removed by centrifugation and the protein pellet was air dried and stored at -20 ◦C.
The protein pellet was solubilised by incubation with 1 mL DMSO for 30 minutes at room
temperature. Histones were extracted from the solubilised pellet in an unfolding buffer (7
M guanidinium hydrochloride, 10 mM Tris-HCl pH 7.5, 10 mM DTT) under stirring, for 1
hour at room temperature. The histone extract was dialysed three times against 2 L SAU
200, centrifuged to remove aggregates and applied onto a combination of Q-Sepharose and
SP-Sepharose columns.
After loading of the histone extracts, the Q column was disconnected. Unbound proteins
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were removed by washing with 2 column volumes (CV) of SAU 200 buffer. Histones were
eluted with SAU 600 buffer (7M urea, 600 mM NaCl, 20 mM NaAc pH 5.2, 2mM DTT,
1 mM EDTA) (0.5 CV 30% SAU 600 followed by a 2 CV 30-100% SAU 200 - SAU 600
gradient). Peak fractions were collected, dialysed thrice against 2 L 2 mM DTT, lyophilsed
and stored at -80 ◦C. Protein purity was inspected using SDS-PAGE and ESI-MS. The urea
used in the buffers SAU 200 and SAU 600 was deionised by passing it three times through
a 3 L amberlite column.
2.5.2 Purification of C-terminal thioester constructs
Ubiquitin thioester
pTXB1.Ub plasmid was transformed into BL-21 chemically competent cells and single colonies
were inoculated overnight at 37 ◦C in 100 mL 2xYT medium. The preculture was diluted
1:100 in 2 L 2xYT, brought overday to OD600 0.6 - 0.8 at 37
◦C, induced with 0.5 mM IPTG
and cultured overnight at 18 ◦C and 140 rpm. The bacteria were pelleted by centrifugation
at 6000xg for 12 minutes at 4 ◦C. Bacterial cells were lysed by passing them three times
through the French press in lysis buffer (200 mM NaCl, 20 mM HEPES-NaOH pH 6.5, 1
mM EDTA). The lysate was pelleted by centrifugation at 25000xg for 45 minutes at 4 ◦C.
The supernatant was collected and filtered through 0.8 µm filters before incubating overnight
with pre-equilibrated (lysis buffer) chitin resin (10 mL beads slurry/2 L bacterial culture).
The bound fraction was washed four times with 30 mL lysis buffer/ 10 mL resin by rotating
the slurry for 30 minutes at 4 ◦C. Ubiquitin thioester was generated by incubating the chitin
resin with cleavage buffer (20 mL buffer/10 mL resin) (200 mM NaCl, 100 mM MES-Na, 20
mM HEPES-NaOH pH 6.5, 1 mM EDTA) on a rotating wheel for up to one week at room
temperature. Cleavage reactions were collected every 24 hours, centrifuged at 25000xg for
10 minutes and stored at 4 ◦C. The cleavage fractions were dialysed three times against 2
L deionized water and centrifuged to remove aggregates. The dialysed reaction soup was
centrifuged at 25000xg for 10 minutes, lyophilised and resuspended in 5% acetonitrile (ACN)
and 0.1% TFA. The concentrated ubiquitin thioester solution was purified by HPLC on a C4
column. The sample was applied onto the column with a 0.5 mL/min flow of 5% ACN and
0.1%TFA. Ubiquitin thioester was separated from the protein cleavage soup using a linear
90 minutes gradient of 5-95% ACN and 0.1% TFA. Pure fractions were dialysed three times
against 0.5 L deionized water, lyophilised and stored at -80 ◦C. Protein purity was inspected
by SDS-PAGE and ESI-MS.
H2A∆113-129 thioester
The histone construct was expressed using the protocol described above for the preparation
of the ubiquitin fusion construct. Bacteria were lysed by passing them three times through
the French press in lysis buffer (200 mM NaCl, 20 mM HEPES pH 6.5, 1 mM EDTA),
centrifuged and filtered. The filtered lysate was incubated with pre-equilibrated chitin resin
(10 mL beads slurry/ 2 L bacterial culture) overnight at 4 ◦C on a rotating wheel. The bound
fraction was washed four times with 30 mL lysis buffer/ 10 mL resin by rotating the slurry for
30 minutes at 4 ◦C. H2A thioester was obtained by incubating the chitin resin with cleavage
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buffer (20 mL buffer/ 10 mL resin)(200 mM NaCl, 100 mM MES-Na, 20 mM HEPES pH 6.5,
1 mM EDTA) over 48-64 hours. Cleavage fractions were collected every 24 hours, dialysed
three times against 2 L deionized water, centrifuged at 25000xg for 10 minutes to remove
aggregates, lyophilised and stored at -20 ◦C. Lyophilised proteins were resuspended in 0.5
mL DMSO and incubated at room temperature for 30 minutes. 30 mL unfolding buffer (7
M guanidinium hydrochloride, 10 mM Tris pH 7.5) per 10L histone culture were added to
unfold the proteins from the cleavage reaction. The unfolded polypeptides were dialysed
three times against 2 L SAU 200 buffer (7 M urea, 20 mM NaAc pH 5.2, 200 mM NaCl,
1 mM EDTA). Dialysed proteins were centrifuged and loaded onto anion-cation exchange
Q and SP sepharose columns. The proteins which bound to the SP-Sepharose column were
eluted with a gradient of SAU 200 - SAU 600 (7 M urea, 20 mM NaAc pH 5.2, 600 mM
NaCl, 1 mM EDTA) (0.5 column volumes with 30% SAU 600, then 2 column volumes with
a linear 30-100% SAU200 - SAU 600 gradient). Peak fractions were collected and dialysed
three times against 2 L deionized water, centrifuged at 25000xg for 10 minutes, lyophilised
and stored at -80 ◦C. Protein purity was inspected by SDS-PAGE and ESI-MS.
2.5.3 Purification of GST-tagged proteins
pGEX plasmids containing full-length or truncated human SCML2 expression constructs
were transformed by heat shock in BL21 (DE3)-RIL Escherichia coli. Single colonies were
inoculated in 100 mL 2xYT medium and grown at 37 ◦C overnight on 140 rpm shake. The
preculture was diluted 1:100 in 2 L 2xYT medium and grown at 37 ◦C until an OD600 value
of 0.6 - 0.8. Expontential growth was stopped by incubating the cultures for 10 min on an
ice bath. Protein synthesis was induced with 0.1 mM IPTG. Bacteria were grown overnight
at 18 ◦C and harvested by centrifugation at 6000xg, for 15 minutes, at 4 ◦C. Bacteria were
resuspended in lysis buffer (10 mL buffer/ 1 L bacterial culture) (300 mM NaCl, 50 mM
Tris-HCl pH 7.5, 10% glycerol, 2 mM DTT, 1 mM EDTA) and lysed by passing them three
times through a French press at 1000-1500 psi. The lysate was clarified by centrifugation
at 25000xg for 30 minutes, at 4 ◦C. The lysate supernatant was incubated overnight with
pre-equilibrated glutathione agarose (1 mL resin/ 1 L bacterial culture). Unbound proteins
were discarded and the beads were washed three times in wash buffer (750 mM NaCl, 50 mM
Tris-HCl pH 7.5, 10% glycerol, 2 mM DTT, 1 mM EDTA) (10 mL wash buffer/1 mL resin),
washed once more in lysis buffer and eluted with 10 mL elution buffer (300 mM NaCl, 50
mM Tris-HCl pH 7.5, 10% glycerol, 10 mM glutathione reduced, 2 mM DTT, 1 mM EDTA).
The eluted proteins were dialysed for 2 hours against dialysis buffer I (300 mM NaCl, 50 mM
Tris-HCl pH 7.5, 10% glycerol, 2 mM DTT, 1 mM EDTA) and overnight against dialysis
buffer II (300 mM NaCl, 50 mM Tris-HCl pH 7.5, 50% glycerol, 2 mM DTT, 1 mM EDTA).
Protein purity was inspected by SDS-PAGE. The recombinant proteins were aliquoted and
stored at -20 ◦C.
To further increase purity, the proteins were run over a 1 mL SP anion-cation exchange col-
umn. Protein aliquouts were dialysed against SP Buffer A (250 mM NaCl, 50 mM Tris-HCl
pH 7.5, 10% glycerol, 2 mM DTT, 1 mM EDTA), loaded onto the SP column and eluted
over 5 CV with a linear (0-100%) gradient with SP buffer B (750 mM NaCl, 50 mM Tris-HCl
pH 7.5, 10% glycerol, 2 mM DTT, 1 mM EDTA). Pure fractions were collected, dialysed
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overnight against dialysis buffer II and stored at -20 ◦C.
GST-tagged full-length SCML2 and GST-tagged SCML2 truncations, as well as GST-tagged
isolated domains were prepared according to this purification protocol.
2.5.4 Purification of His-tagged proteins from insect cells
Recombinant proteins were produced in insect cells using the Bac-to-Bac expression sys-
tem [170]. Coding sequences of the recombinant proteins were cloned in pFastBacHT donor
plasmids which were amplified in the electrocompetent DH10BacY Escherichia coli strain.
Transformation efficiency into the competent cells was controlled using the gentamycin re-
sistance on the donor plasmid. Transposition efficiency onto the baculovirus shuttle vector
was controlled using blue-white colony selection. Bacteria were transformed with 1 µg plas-
mid DNA by electroporation (1 pulse, 25F, 1.8kV) using 0.1 cm electroporation cuvettes.
After 1 minute incubation on ice, bacteria were resuspended in 1 mL LB medium and grown
overnight at 37 ◦C on shake. Screening was performed by plating several ten-fold dilutions of
the overgrown bacteria on LB-agar plates containing 20 µg/mL gentamycin, 150 µg/mL x-
Gal and 1 mM IPTG. White colonies were restreaked on fresh plates. Five mL single-colony
inoculates were grown overnight to obtain the recombinant bacmid, which was purified by
isopropanol precipitation of the neutralised bacterial lysate. The lysate was incubated with
70% isopropanol overnight at -20 ◦C and the precipitated bacmid was collected by centrifu-
gation at 13200xg at 4 ◦C for 30 minutes. The supernatant was removed and the bacmid
pellet was washed twice (without resuspension) with 500 µL 70% ethanol. The clean bacmid
was collected by centrifugation at 13200xg for 10 minutes at 4 ◦C and stored at -20 ◦C in 30
µL 70% ethanol.
The bacmid pellet was soaked for 15 minutes at room temperature in 20 µL deionised wa-
ter. The dissolved DNA was diluted in 200 µL Spodoptera frugiperda Sf9 insect cell culture
medium and incubated with 100 µL 1x transfection agent for 1 hour at room temperature.
Three mL 1 million Sf9 insect cells/ mL were infected with 150 µL transfection-ready bacmid
and incubated over 48 hours at 27 ◦C. Transfection efficiency was monitored using fluores-
cence microscopy which detected the expression of the YFP marker. The insect cell culture
medium was collected and stored at 4 ◦C as v0 virus. Twenty-five mL 0.7 million Sf9 insect
cells/ mL were infected with 500 µL vo virus and grown at 27 ◦C on 40 rpm shake in the dark.
Cell viability, mean cell diameter and cell count were checked every 24 hours to monitor the
progress of the viral infection. Cultures were diluted daily to 0.7 million cells/ mL until the
day after proliferation arrest (DPA) when the viability dropped bellow 80%. Insect cells were
pelleted 24 hours after the DPA at 300xg for 10 minutes at room temperature. Pellets were
inspected for expression and solubility of the recombinant proteins and the culture media
was collected and stored at 4 ◦C as v1 viruses. Two hundered mL 0.7 million Trichoplusia
ni Hi5 insect cells/ mL were infected with 500 µL v1 virus and grown at 40 rpm shake at
27 ◦C in the dark. Cell viability, mean cell diameter and cell count were checked every 24
hours to monitor the progress of the viral infection. Insect cells were pelleted 48 hours after
reaching the proliferation arrest. Insect cells were pelleted at 300xg for 20 minutes at 4 ◦C
and dry pellets were frozen in liquid nitrogen, then stored at -80 ◦C.
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Insect cell pellets were resuspended in lysis buffer (10 mL buffer/ 1 L insect cells culture)(300
mM NaCl, 50 mM Tris-HCl pH 7.5, 30 mM imidazole pH 7.5, 10% glycerol) and lysed by
sonication with 20% intensity in 0.5 seconds ON, 1.5 seconds OFF cycles for 3 minutes. The
lysate was clarified by centrifugation at 25000xg for 30 minutes, at 4 ◦C. The lysate super-
natant was incubated for 3 hours with pre-equilibrated Ni-NTA agarose beads (2 mL resin/
600 mL bacterial culture). Unbound proteins were discarded and the beads were washed
three times in wash buffer (750 mM NaCl, 50 mM Tris-HCl pH 7.5, 30 mM imidazole pH
7.5, 10% glycerol) (10 mL wash buffer/1 mL resin), one more time in lysis buffer and then
eluted with 10 mL elution buffer (300 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol,
300 mM imidazole pH 7.5). Eluted proteins were dialysed for 2 hours against dialysis buffer
I (300 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol, 2 mM DTT, 1 mM EDTA) and
overnight against dialysis buffer II (300 mM NaCl, 50 mM Tris-HCl pH 7.5, 50% glycerol,
2 mM DTT, 1 mM EDTA). Protein purity was inspected by SDS-PAGE. Proteins were
aliquoted and stored at -20 ◦C.
His-tagged full-length DNMT1, Usp7 and SCML2 as well as several His-tagged DNMT1,
Usp7 and SCML2 truncations were prepared according to this purification protocol.
2.6 Preparation of biotinylated DNA templates
Mononucleosomal DNA templates were prepared from plasmids containing repeats of the
601 positioning sequence: pUC18 16X145 and pUC18 52x187. Nucleosomal array templates
were prepared from a pUC18 12x200 vector. Plasmids were transformed by heat shock in
methylation deficient (dam-/dcm-) C2925 Escherichia coli, which were plated on 100 mg/mL
ampicillin resistance plates. Single colonies were inoculated in 100 mL LB medium and grown
overday at 37 ◦C. Precultures were diluted 1:100 into 2 L LB each and grown overnight at
37 ◦C under 140 rpm shake. Bacteria were centrifuged at 6000xg, for 12 minutes, at 4 ◦C
and plasmid DNA was purified from the pellet using a DNA GigaPrep extraction kit. DNA
was stored in 10 mM Tris-HCl pH 8.0 at -20 ◦C.
Mononucleosomal templates were obtained from the plasmid DNA by digesting the repeats
into monomeric units using the AvaI and NotI restriction enzymes. Nuclesomal array tem-
plates were obtained by digesting the plasmid backbone into short fragments (leaving the
inserts intact) using the EcoRI, DdeI, BfuCI and HaeII restriction enzyme mix. Generally,
1 mg plasmid DNA was incubated overnight with 300 units of each of the restriction en-
zymes. Complete digestions were checked by agarose gel electrophoresis. Separation of the
monomeric nucleosomal DNA from the intact backbone or of the long chromatin templates
from the plasmid backbone fragments was achieved by polyethyleneglycol (PEG) precipita-
tion [171].
Digestion reactions were stopped by heat-inactivation of the enzymes at 65 ◦C for 10 minutes.
The digest mixtures were centrifuged for 10 minutes at 13200xg, at 4 ◦C to remove protein
aggregates. Supernatants were transferred to new microreaction tubes, where the starting
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salt concentration of the precipitation mix was adjusted to 0.5 M NaCl. The precipitation
mix was pre-incubated at 37 ◦C for 30 minutes. PEG 6000 was added drop-wisely to the
reaction. The starting PEG concentration was 5% (weight/volume). The mix was incubated
for 15 minutes at room temperature and centrifuged for 10 minutes, at room temperature,
at 13200xg. The resulting supernatant was transferred to a new tube, where additional PEG
was added in consecutive steps to reach 6, 7 or 8 % PEG concentrations. The pellets of all
these fractions were cleaned with 70% ethanol by brief vortexing followed by a 5 minutes,
13200xg room temperature centrifugation step. The clean pellets were air-dried and then
resuspended in 10 mM Tris.HCl pH 8.0. The quality of the DNA preparation was assessed
by agarose gel electrophoresis.
DNA templates were dephosphorylated at their 5’ ends using 0.1 units/ µg DNA Antarc-
tic Phosphatase. The dephosphorylation reaction was stopped by heat-inactivation of the
enzyme at 65 ◦C for 10 minutes. Biotinylated oligos complementary to the EcoRI or NotI
digestion sites were ordered with phosphorylated 3’ ends. A ten-fold molar excess of the
biotinylated oligonucleotides was incubated with the dephosphorylated template DNA, in
the presence of T4 DNA ligase (10 units/ng DNA) in the appropriate buffer for 2 hours at
room temperature. The ligation reactions were supplemented with 1 mM ATP and incu-
bated for 1 hour more at room temperature. The reactions were stopped by heat-inactivaton
of the ligase at 65 ◦C for 10 minutes. The DNA templates were purified from the unligated
oligonucleotides by PEG precipitation. DNA was stored in 10 mM Tris-HCl pH 8.0 at -20
◦C. Biotinylation efficiency of nucleosome and chromatin DNA templates was checked by
agarose gel electrophoresis and by dot blot, using a Streptavidin-HRP conjugate probe.
2.7 Histone octamer assembly
Lyophilised histones were dissolved in 1-2 mL unfolding buffer (7 M guanidinium hydrochlo-
ride, 10 mM Tris-HCl pH 7.5, 10 mM DTT) for 1 hour on the rotating wheel at 4 ◦C. Histone
concentrations were calculated based on their theoretical molecular weights and extinction
coefficients. Histones H2A, H2B, H3 and H4 were mixed in equimolar amounts and diluted
to a 1 mg/mL with unfolding buffer. The histone octamer mixture was dialysed three times
against 2 L RB high buffer (2 M NaCl, 10 mM Tris-HCl pH 7.5, 2 mM DTT, 1 mM EDTA).
Histone octamers were collected from the dialysis bag and centrifuged for 10 minutes at
13200xg, at 4 ◦C to remove aggregates. The supernatant was loaded onto a Superdex 200
gel filtration column. Protein complexes of various molecular weights were eluted using 1 CV
of RB high buffer. Protein fractions were collected and checked by SDS-PAGE for equimolar
amounts of histones. Octamer-containing fractions were pooled and stored in 50% glycerol
at -20 ◦C or used directly for reconstitution of chromatin or mononucleosomes.
2.8 Mononucleosome and chromatin reconstitution
To assemble mononucleosomes and nucleosome arrays, histone octamers were mixed with the
positioning DNA templates at an optimal molar ratio. The ratio was determined in small
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scale reactions by titrating increasing histone octamer amounts to constant DNA amounts.
The reconstitution octamer:DNA ratios ranged between 0.7:1 and 1.5:1. The starting salt
concentration of the DNA fragments was adjusted to 2 M NaCl. Histone octamers were used
fresh (in 2M NaCl) or dialysed overnight at 4 ◦C from the 50 % glycerol stocks against 500
mL RB high (2 M NaCl, 10 mM Tris-HCl pH 7.5, 2 mM DTT, 1 mM EDTA). Dialysed
octamers were concentrated by ultrafiltration at 13200xg at 4 ◦C to reach a concentration
of 0.5 - 1 mg/mL. Reconstitution reactions were set up at 4 ◦C in 500 µL dialysis tubes
with 3500 Da molecular weight cutoff. The dialysis tubes were set on a floating disk in a
chamber filled with 500 mL RB high buffer. The salt concentration in the dialysis chamber
was decreased under continuous stirring over 36 hours by a peristaltic pump which exchanged
the 0.5 L RB high for 2 L RB low (20 mM NaCl, 10 mM Tris-HCl pH 7.5, 2 mM DTT, 1
mM EDTA). Reconstituted templates were collected from the dialysis buttons and stored at
4 ◦C. Reconstitution efficiency was checked by electrophoresis on 0.5% (chromatin) or 1%
(nucleosomes) agarose gels, which were run in 0.2x TB (0.178 M Tris, 0.178 M boric acid)
buffer at 4 ◦C, for 2 hours at 100 V. Gels were stained after the run with 1 µg/ mL ethidium
bromide (EtBr) for 15 minutes and destained in deionised water for further 15 minutes.
2.8.1 Quality control of reconstituted chromatin
To test nucleosomal positioning, 500 ng chromatin was incubated with 0.5 units restriction
enzymes (AvaI; NotI; BanI) and the appropriate buffer in 20 µL reactions. Digestion pro-
ceeded at 37 ◦C for 2 hours. The digested DNA products were loaded on a 1.5% native
agarose gel which preserved histone:DNA interactions. The gel was run at 120 V for 1 hour
and stained after the run in EtBr.
To test nucleosomal occupancy, 2.5 µg chromatin was incubated with 4 miliunits/µL mi-
crococcal nuclease in a 500 µL reaction. The reaction was performed in a reaction buffer
containing 10 mM Tris-HCl pH 7.5, 5 mM NaCl and 2 mM CaCl2 at room temperature.
One hundret µL aliquots were collected from the digestion reaction after 0, 10, 30 and 60
seconds. Full digestion to mononucleusomal product was achieved after 30 minutes. The
digestion reactions were stopped by mixing them with an equal volume of binding buffer
from a PCR cleanup kit. Digests were purified on spin columns and eluted in 20 µL water.
Digests were run on 1.5% native agarose gels at 120 V for 1 hour and stained after the run
in EtBr.
2.9 Interaction experiments
2.9.1 Histone affinity purification
Magnetic goat-anti-rabbit beads were used to capture a rabbit antibody which recongnises
the C-terminus of histone H3. In an affinity purification reaction 10 µL pre-equilibrated
beads were mixed with 1 µg antibody and 10 µg histone in the presence of 1 mg/mL BSA in
pull-down buffer (10 mM HEPES-NaOH pH 7.9, 150 mM NaCl, 5% glycerol, 1 mM DTT, 0.5
mM EDTA, 0.5 mM PMSF, 0.1% Triton X-100). Immobilisation was performed overnight
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at 4 ◦C on the rotating wheel. Unbound material was removed by washing with pull-down
buffer three times, over 5 minutes, on the rotating wheel. 75 pmol recombinant proteins or
2 mg HeLa nuclear extract was added to each pull-down reaction and allowed to incubate
for 1 hour. Unbound nuclear extract was removed by washing with pull-down buffer three
times, over 5 minutes, on the rotating wheel. The beads from each reaction were collected
by centrifugation at 3000xg for 3 min at 4 ◦C and resuspended in SDS-PAGE loading buffer.
Samples were incubated for 10 minutes at 70 ◦C and loaded on gradient 4-12% SDS-PAGE
gels. In the experiments using recombinant proteins, detection was achieved by Coomassie
staining of the gels. In the experiments where nuclear extracts were used, bound proteins
were transferred from the gels to PVDF membranes with constant 2.3 A for 8 minutes using
a semidry transfer system. The PVDF membrane was blocked for 1 hour in 5% milk in
PBST at room temperature and incubated overnight at 4 ◦C with the appropriate antibod-
ies. Unbound primary antibodies were removed with three 5 minutes washes of PBST. The
blots were incubated with appropriate secondary antibodies for 1 hour at room temperature.
Unbound secondary antibodies were removed with three 5 minutes washes of PBST. Proteins
recruited in the pull-downs were detected using the ECL chemiluminescent substrate.
Magnetic HisPur beads were used to capture the His.H2B and His.H2BK120ub constructs.
An adjusted pull-down buffer was used for this experiment (10 mM HEPES-NaOH pH 7.9,
150 mM NaCl, 5% glycerol, 0.5 mM PMSF, 0.1% Triton X-100).
Anti-HA affinity matrix was used for immobilization of the HA.H2B and HA.H2BK34ub
constructs. The experiment was performed with unchanged buffer conditions.
2.9.2 Chromatin affinity purification
Streptavidin paramagnetic beads were used for immobilisation of the biotinylated chromatin
and mononucleosome templates. Affinity purification reactions were performed with recom-
binant proteins or with HeLa nuclear extracts. Bound proteins were analysed by Coomassie
staining, by western blot or by mass spectrometry.
In the experiments where recombinant proteins were used, 20 µL pre-equilibrated strepta-
vidin beads were incubated with 1 µg chromatin and 75 pmol recombinant proteins and 1
mg/mL BSA in pull-down buffer (10 mM HEPES-NaOH pH 7.9, 150 mM NaCl, 5% glycerol,
1 mM DTT, 0.5 mM EDTA, 0.5 mM PMSF, 0.1% Triton X-100) for one hour at 4◦C on the
rotating wheel. The chromatin affinity purification protocol used the washing and elution
steps described above for the histone affinity purification protocol.
For western blot detection, 20 µL pre-equilbrated streptavidin beads were incubated with
2 µg chromatin and 1 mg/mL BSA in pull-down buffer overnight, at 4◦C, on the rotating
wheel. Unbound chromatin was removed by washing with pull-down buffer three times, over
5 minutes, on the rotating wheel. 2 mg HeLa nuclear extract was added to each pull-down
reaction and allowed to incubate for 1 hour. Washing and elution steps were performed
as described before for the histone affinity purification protocol. Proteins were transferred
onto PVDF membranes using semi-dry transfer. Western blot detection was performed as
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described before for the histone affinity purification protocol.
For mass spectrometry detection, 100 µL pre-equilibrated streptavidin beads were incubated
with 20 µg chromatin and 1 mg/mL BSA in pull-down buffer overnight, at 4 ◦C, on the
rotating wheel. Unbound chromatin was removed by washing with pull-down buffer three
times, over 5 minutes on the rotating wheel. Ten mg unlabeled or SILAC-labeled (Arg-6,
Lys-4) HeLa nuclear extracts were added to either the unmodified or the modified chromatin
samples in SILAC label-swap experiments [132]. Unbound nuclear extract was removed by
washing with pull-down buffer three times, over 5 minutes, on the rotating wheel. The beads
from each reaction were collected dry and resuspended in NuPAGE loading buffer. Samples
were incubated for 10 minutes at 70 ◦C and loaded on 4-12% gradient NuPAGE gels.
For detection of crosslinked peptides by mass spectrometry, 20 µL pre-equilibrated strep-
tavidin beads were incubated with 4 µg unmodified chromatin, 75 pmol recombinan full-
length His.Usp7 and GST.RBR-DUF and 1 mg/mL BSA in pull-down buffer for one hour,
at 4◦C, on the rotating wheel. Washing and elution steps were performed as described
before for the histone affinity purification protocol. Chromatin was digested to mononucle-
osomes with 100 units AvaI. Intra- and inter-molecular interactions were stabilised with 1
mM Bis(sulfosuccinimidyl)suberate S3 (dissolved in pull-down buffer) treatment. Crosslink-
ing reactions were performed in a thermomixer for 30 minutes at room temperature on 300
rpm shake and stopped by boiling for 10 minutes at 95 ◦C. The crosslinked products were
separated on 4-12% gradient NuPAGE gels.
2.9.3 GST and YFP affinity purification
Glutathione agarose resin was used to immoblise GST-tagged full-length or trunctated
SCML2 constructs in affinity purification (protein-protein interaction) experiments. GFP-
trap (agarose conjugated with an antibody raised against GFP) was used to immobilise
YFP-tagged FL or truncated DNMT1 constructs. 20 µL pre-equilibrated glutathione resin
or GFP-trap resin were incubated with 75 pmol recombinant proteins and 1 mg/mL BSA
in pull-down buffer (same as the one used in the chromatin pull-down experiments) for one
hour, at 4 ◦C, on the rotating wheel. Washing and elution steps were performed as de-
scribed before for the histone and chromatin pull-down experiments. The bound proteins
were eluted by incubation for 10 minutes at 70 ◦C, loaded on 4-12% gradient NuPAGE gels
and visualised by Coomassie staining of the gels.
2.9.4 Gel shift assays
To map the interaction between SCML2 and the nucleosome, 15 pmol unmodified nucleo-
somes (containing 147, 171 or 187 bp of template DNA) were incubated with full-length or
truncated SCML2 proteins. SCML2 was either kept stoichiometric to the nucleosomes or
was added in excess to the nucleosomes (three-fold titration series). SCML2 and the nucleo-
some were incubated in a thermomixer at 16 ◦C, at 300 rpm for 1 hour. SCML2-nucleosome
complexes were separated on 1% agarose gels at 120 V, for 1 hour and visualised by EtBr
staining of the gel after the run.
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2.9.5 Deubiquitylation experiments
Three hundret ng H3K18ub chromatin or mononucleosomes were incubated with 0.75 pmol
Usp7 and increasing concentrations of full-length or truncated SCML2 or DNMT1 constructs.
Titration series were performed in five-fold steps. For deubiquitylation of histones, 30 ng
H3K18ub histone were incubated with 0.08 pmol Usp7 in the presence of increasing amounts
of full length SCML2. 145 bp unmethylated or fully methylated DNA was added to the his-
tone deubiquitylation experiment in a equimolar ratio to the starting SCML2 concentration.
2.10 Mass spectrometry analysis
2.10.1 Peptide preparation
Peptides were prepared according to published protocols [172]. To reduce sample complexity
in the pull-down reactions, each lane was sliced into 2x13 bands which were chopped down
with a scalpel into 1x1 mm2 pieces. Unless otherwise stated, all incubation steps were
performed in a thermomixer at 800 rpm, for 15 minutes, at 26 ◦C. Gel pieces were washed
for 5 minutes in 300 µL deionised water and centrifuged at 3000 rpm for 1 minute. The
supernatant was removed and the gel pieces were dehydrated by incubating with 300 µL
acetonitrile. Acetonitrile was removed by pipetting and the gel pieces were completely dried
in a vacuum concentrator. To reduce disulfide bridges, the gel pieces were incubated with
200 µL 10 mM DTT for 50 minutes at 56 ◦C. The pieces were centrifuged and the reducing
solution was removed. Gel pieces were dehydrated further with 300 µL acetonitrile. The
acetonitrile was removed and the gel pieces were incubated for 20 minutes with 200 µL 55
mM iodacetamide to alkylate the reduced cysteines. Gel pieces were incubated for further 15
minutes with 300 µL 100 mM ammonium bicarbonate. The alkylating solution was removed
and the gel pieces were dehydrated twice in 300 µL acetonitrile. Gel pieces were completely
dried in a vacuum concentrator. The dried gel pieces were rehydrated in 200 µL digestion
buffer (42 mM ammonium bicarbonate, 4.2 mM CaCl2, 0.125 units/µL trypsin. The digestion
reaction was allowed to proceed overnight at 37 ◦C at 800 rpm. The digested peptides were
centrifuged at 3000xg for 1 minute and 100 µL deionised water were added on top to cover
the gel slices. 200 µL acetonitrile were added on top to shrink the gel pieces at 37 ◦C for 15
minutes at 800 rpm. The extract was collected into a new microreaction tube. 100 µL 5%
formic acid was added to the shrunk gel pieces and incubated for 15 minutes at 37 ◦C at 800
rpm. The gel pieces were shrunk with 100 µL more acetonitrile for 15 minutes. The mixture
was centrifuged at 300xg for 1 minute and added over the extract from the previous step.
The mixed peptide extract was dried to completion by vacuum centrifugation. Peptides
were stored dry at -20 ◦C. Before usage on the liquid chromatographer, the peptides were
resuspended in 20 µL 5% acetonitrile and 0.1% formic acid, sonicated for 3 minutes in a
water bath, centrifuged at 13200xg for 10 minutes and transferred to chromatography vials.
2.10.2 Liquid chromatography and mass spectrometry
The processed peptides were analyzed on a Q-Exactive Plus hybrid Quadrupole-Orbitrap
mass spectrometer coupled to a NanoLC pump. Samples were loaded with an autosampler
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and concentrated using a 10 µL/min flow of solvent A (5% acetonitrile, 0.1% formic acid)
on a reversed phase C18 precolumn (0.15mm ID x 20mm self-packed with Reprosil-Pur 120
C18-AQ 5µm). Peptides were separated at 60 ◦C on a reversed phase nanoflow C18 column
(0.075mm ID x 200mm self-packed with Reprosil-Pur 120 C18-AQ, 3µm). Peptides were
eluted from the column under a 0.3 µL/min flow using a 5 - 44% gradient of solvent A
solvent B (80% acetonitrile, 0.1% formic acid) over 90 minutes. Eluted peptides were ionised
by electron spray ionisation in the positive ion mode. Full scan MS1 spectra were acquired in
the 350 - 1600 m/z range at a resolution of 70000. The 20 most intense peaks from the survey
scan were selected for fragmentation with Higher-energy Collisional Dissociation (HCD, 15
of normalised collision energy). Product ions MS2 spectra were acquired in the 200 - 2000
m/z range at a resolution of 15000. Forward and reverse experiment samples were measured
in triplicates.
Raw files were imported into MaxQuant [173], [125], where they were grouped into forward
and reverse experiments. Ion intensity quantitation was performed from the MS1 spectra.
The ion multiplicity level was set to 2 and the heavy amino acid isotopes were indicated:
Arg-6, Lys-4. The digestion mode was set to specific and trypsin was indicated as the
chosen protease with two allowed missed cleavages per peptide. The minimum peptide
length was set to 7 amino acids and razor peptides were included into the search algorithm.
The peptide search database was generated from the reviewed human proteome [174]. The
decoy search database was generated by reversing each polypeptide sequence from the human
proteome database. Peptide sequencing was performed using the Andromeda-search engine
incoporated in MaxQuant [124]. The false discovery rate for both the peptide spectrum
match and the protein groups were set to 0.01. Carbamidomethylation of cysteine residues
was set as fixed modification for all peptides. Acetylation of protein N-termini and oxidation
of methionine residues were included in the search as variable modfiications.
2.10.3 Data analysis
MaxQuant output protein groups tables were imported as txt files into Perseus [175], [133].
Contaminant and hits from the decoy reverse database were manually removed from the
protein groups list. Entries with less than 4 valid values (from the 6 normalised heavy/light
abundance ratios) were excluded. Valid values were subjected either to one- or to two-sample
student’s t-tests. For the one sample test, the mean of all six measurements (combining the
foward and the reverse experiment) was compared to the zero mean of the entire protein
groups. For the two-sample t-test, the mean of the three forward experiment replicates was
compared to the mean of the three reverse experiment replicates. A Perseus build in permuta-
tion based algorithm was used to control the identifications of the two tests. The algorithm’s
false discovery rate was 0.01 and its backrgound correction value S0 = 2. Perseus output
tables were imported as csv files into R [176]. To obtain the interactome plots, heavy/light
enrichment ratios from the forward experiment were plotted against the inverse of the en-
richment ratios in the reverse experiment. Separately, to obtain volcano plots, the t-test
statistic was plotted against the t-test difference to display the statistical relevance of the
enriched interactors. Associations between the signifcantly enriched proteins within the dif-
ferent interactomes were displayed using an online protein-protein interaction platform [177].
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For analysis of the crosslinking mass spectrometry data, raw files were converted to mgf
format and imported into pLink [178], [140]. A database which contained the amino acid
sequences of all proteins used in the crosslinking experiment was manually prepared. BS3
was indicated as a conventional crosslinker. Trypsin was selected as the protease used for
digestion. The maximum number of missed cleavage sites was set to 3 sites and the peptide
length limits were set between 6 and 60 amino acids. Acetylation of protein N-termini
and oxidation of methionine residues were included in the search as variable modfiications.
The false discovery rate of the search algorithm was set to 0.05. Identified crosslinks were
accepted if they were present in a minimmum of two spectra. Inter- and intramolecular
crosslinks were displayed on the primary amino acid sequences of the proteins present in
the crosslinking experiment using xiNET [179], [180]. Crosslinkins were displayed on the
nucleosome and Usp7 cystal structures using PyMOL [181].
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Chapter 3
Results
3.1 Preparation of uniformly ubiquitylated nucleosomes
and nucleosomal arrays
3.1.1 Preparation of unmodified human histones
Histone ubiquitylation marks have been found in organisms throughout all kingdoms of life.
Considering the well-studied example of H2BK120ub, its functional relevance appears to be
conserved from yeast to human. To prepare nucleosomal arrays, we needed to decide to use
histones from a single organism. On one hand, the use of yeast as a model organism has
been valuable in the early years of histone ubiquitylation because of the ease with which
recombination techniques were used to manipulate the yeast genome. On the other hand,
frog histones have traditionally been used in the field of chromatin biochemistry due to their
convenient production in high amounts and purity. However, the most comprehensive anno-
tation of histone ubiquitylation marks has been curated from human cells and tissues. With
the advent of new genome editing technologies and the prospect of improved purification
strategies, it became desirable to switch from the yeast and frog histones towards the human
histones and use these as building blocks for the ubiquitylated nucleosomal arrays.
To prepare human histones two separate schemes were used. On one hand, the standard
protocol for purification of recombinant frog histones from bacterial overexpressions was
applied [182]. On the other hand, a protocol describing the extraction of histones from
cultured human cells was used [183]. For standardisation, the two protocols were combined
into a single scheme which takes advantage of the convenient overexpression of proteins in
bacteria (Figure 3.1A). After centrifugation of the bacterial lysate, presence of histones in
the lysate pellet or supernatant was inspected by SDS PAGE gel electrophoresis. Histones
present in the pellet (inclusion bodies) were purified with the frog histone protocol. Histones
found in the supernatant were purified with the acid (HCl) extraction protocol. Unmodified
human histones H2A and H2B were prepared using acid extraction (Figure 3.1B). Unmodified
human histones H3 and H4 were prepared from inclusion bodies. This scheme was applied
also for preparation of tagged HA.H2B and His.H2B or N-terminally truncated H3 and H2A
histones.
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Figure 3.1: Preparation of recombinant human histones. (A) Schematic protocols used to
purify recombinant human histones. Soluble proteins were purified by acid extraction, insoluble
protein were prepared from inclusion bodies as per the standard published protocol [182]. Histone-
intein fusion constructs were enriched on a chitin resin, making use of the C-terminal chitin binding
domain (B) Coomassie-stained SDS-PAGE gels of purified unmodified human histones.
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3.1.2 Preparation of ubiquitylated human histones
Expressed chemical ligation makes uses of the advantageous protein expression in bacterial
cultures and the specificity of the chemical reaction between thiols and thioesters. Since only
one human histone (H3.1) contains two cysteines - which have been mutated to serine and
alanine here - this strategy could efficiently be applied for ligation of ubiquitin to histones.
Ubiquitylation of histone H3
Semi-synthesis of ubiquitylated H3 histone required three components. Recombinant trun-
cated H3 histone and recombiannt ubiquitin thioester were prepared from bacteria. The
synthetic peptide was made in the laboratory of Prof. Ashraf Brik (Figure 3.4).
Purification of H3 ∆1-24 A25C was performed according to the standardised histone purifi-
cation protocol described above. Two protein peaks were recorded in the elution from the SP
Figure 3.2: Preparation of recombinant truncated H3. (A) Purification profile of the
truncated histone collected from the SP sepharose column. (B) Coomassie-stained SDS-PAGE gel of
fractions collected from the SP-sepharose column. (C) Electron-spray ionisation mass spectrometry
(ESI-MS) analysis of the first and second protein peaks (fractions collected at 300 and 330 mL,
respectively). M = molecular weight marker
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sepharose column (Figure 3.2A). SDS-PAGE gel electrophoresis indicated that both peaks
contained proteins of similar molecular weight (Figure 3.2B). For clarification of the iden-
tity of the proteins in the two peaks, aliquots from both fractions were measured by native
electron spray ionisation mass spectrometry (ESI-MS)(Figure 3.2C). The sample collected
at 300 mL contained a mixture of ions with molecular weight (MW) values between 12718
Da and 12877 Da. The sample collected at 330 mL contained a single ion with a MW of
12922 Da. The theoretical MW of the histone fragment with cysteine on the first position
was 12790 Da. The theoretical MW of the histone fragment including methionine on the
first position was 12922 Da. The protein collected from the first peak contained thus histone
suitable for native chemical ligation, whose N-terminal cysteine had however suffered modi-
fications during expression in the bacterial host. To activate the cysteine, the recombinant
histone collected from the peak eluting at 300 mL was treated with methoxylamine in the
laboratory of Prof. Ashraf Brik.
Preparation of ubiquitin thioester was adapted from a protocol obtained from the laboratory
of Shira Albeck from the Weizmann Institute of Science and Technology in Rehovot, Israel.
Figure 3.3: Preparation of recombinant ubiquitin thioester. (A) Purification profile of
ubiquitin from the GyrA intein cleavage reaction collected from a C4 high performance liquid
chromatography (HPLC) column. (B) Coomassie-stained SDS-PAGE gel of representative HPLC
fractions collected from the C4 column. (C) ESI-MS analysis of the fractions containing ubiq-
uitin (8563.6 Da) and ubiquitin thioester (8688.3 Da). CBD = chitin binding domain; MES =
mercaptoethanesulfonate. M = molecular weight marker
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Ubiquitin was expressed as a fusion construct containing an intein derived from the E. coli
DNA Gyrase A (GyrA) and a chitin binding domain (CBD) used as affinity tag. The fusion
construct was affinity purified using chitin beads and treated with sodium meracaptoethane-
sulfonate (MES-Na) to trigger a intein-catalysed cleavage reaction (Figure 1.7B; Figure 3.3).
The cleavage reaction was separated on a high performance liquid chromatography (HPLC)
column, which yielded several protein peaks at 214 nm (Figure 3.3A). Ubiquitin was purified
from the fractions eluting between 25 and 26.5 mL (Figure 3.3B). ESI-MS analysis indicated
that the 25 mL aliquout contained ubiquitin without the C-terminal MES thioester (8563
Da) (Figure 3.3C). The remaining fractions contained intact ubiquitin thioester (8688 Da)
and were used in native chemical ligation reactions in the laboratory of Prof. Ashraf Brik.
The synthetic peptide used in the native chemical ligation reaction containted on positions
K18, K23 or both on K18 and K23 protected thiollysines (Figure 3.4). Two separate ligation
reactions were performed to connect the three fragments. First, the truncated histone was
reacted with the synthetic peptide. Second, after thiollysine deprotection, the full-length
histone was reacted with the ubiquitin thioester. The cysteine inserted on position 25 to aid
the ligation reaction was converted to alanine. Ubiquitylated histones were purified from the
ligation reactions by HPLC. The masses of the pure constructs, as measured with ESI-MS,
were 23768, 23768 and 32314 Da for H3K18ub, H3K23ub and K3K18/23ub2, respectively.
Figure 3.4: Schematic representation of the synthesis of H3K23ub by native chemical
ligation. Synthetic H3 peptide and subsequent native chemical ligation reactions were performed
in the laboratory of Prof. Ashraf Brik at the Technion in Hiafa, Israel.
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Using this strategy, in collaboration with Prof Ashraf Brik’s laboratory, milligrams of ubiq-
uitylated histones with native isopeptide linkage were produced for the three H3ub analogs.
Ubiquitylation of histone H2A
In parallel to the production of ubiquitylated H3, truncations were made for other histone
constructs: the N-terminus of histone H2A (∆1-20), the C-terminus of histone H2A (∆113-
129) and the C-terminus of histone H4 (∆89-102). These were prepared in order to attach
ubiquitin to H2A at positions K13 or K15 and K119 as well as to H4 at position K91.
Histone H2A ∆1-20 A21C was extracted from the bacterial lysate according to the proto-
col used to prepare unmodified human H2A. The N-terminal truncation of H2A presented,
similarly to H3 ∆1-24 A25C (Figure 3.2A), two peaks in the eluate collected from the SP
sepharose column. The protein collected from the second peak contained the N-terminal
methionine (MW = 12099 Da). The protein collected from the first peak had a chemically
modified cysteine at the N-terminus, which needed subsequent activation for chemical liga-
tion.
Purification of the H2A and H4 C-terminal truncations was performed on a scheme combin-
ing elements from the protocols used to prepare ubiquitin thioester and unmodified human
Figure 3.5: Preparation of recombinant H2A and H4 thioesters. (A) Coomassie-stained
SDS-PAGE gel of representative aliquots illustrating the expression of the H2A-GyrA intein-CBD
fusion, the intein-catalysed cleavage reaction and the truncated H2A eluate collected from the
SP sepharose column. (B) Coomassie-stained SDS-PAGE gel of GyrA-intein catalysed cleavage
reactions of H2A-intein, H4-intein and ubiquitin-intein fusions in the presence of mercaptoethane-
sulfonate (MES). Both H2A (1-112) and H4 (1-88) constructs present C-terminal truncations.
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histones (Figure 3.1A, side loop). Both C-terminal truncations were found in the supernatant
after centrifugation of the bacterial lysate and were first purified as GyrA-CBD fusion con-
structs on chitin beads (Figure 3.5A). The truncated histones were released from the fusion
construct after addition of MES-Na (Figure 3.5B). HPLC purification of these truncations
was not as efficient as in the case of the ubiquitin thioester. To separate H2A ∆113-129
MES from the cleavage reaction, the protein was applied to a combination of Q and SP
sepharose anion-cation exchange columns. The pure truncated H2A harboring a thioester
at the C-terminus had a molecular weight of 12244 Da as measured by ESI-MS (theoretical
MW = 12243 Da).
Following the successful collaboration on the native chemical ligation of the H3 ubiquitylation
marks, semi-synthetic H2AK119ub was prepared from recombinant H2A ∆113-129 MES,
ubiquitin MES and a chemically synthesized peptide with cysteine on position 113 and
thiolysine on position 119. After all purification steps, the measured MW of the histone
analog was 22455 Da. One milligram of site-specifically ubiquitylated H2A with a native
isopeptide linkage was prepared in the laboratory of Prof. Ashraf Brik.
3.1.3 Assembly of ubiquitylated histone octamers
Ubiquitylated histones were incorporated into nucleosomes or nucleosomal arrays by mixing
them with unmodified histones into an equimolar 1:1:1:1 mixture. In this way, a H2BK120ub
histone octamer contained two copies of the ubiquitylated H2B and two copies each of the
unmodified human histones. Purification of the histone octamers from suboctameric assem-
blies was achieved by size exclusion chromatography (Figure 3.6A). Three separate peaks
were generally recorded on such a chromatograph. The first peak, eluting around 6-7 mL,
represented aggregated histones. The second peak, eluting around 10-12 mL, contained his-
tone octamers as indicated by the stoichiometric amounts of the individual histones on the
SDS-PAGE gel (Figure 3.6B). The third peak, eluting around 14 mL, contained dimers of
H2A and H2B.
Semi-synthetic histone His.H2BK120ub and the fully synthetic histone HA.H2BK34ub, which
had previously been produced in the laboratory of Ashraf Brik, both contained affinity pu-
rification tags (Kumar et al., 2009; Siman et al., 2013 [110]; [184]). Control His.H2B and
HA.H2B proteins were prepared using the standardised human histone purification proto-
col described above (Figure 3.1A). Tagged unmodified and ubiquitylated H2B octameric
assemblies were prepared for assembly into nucleosomal arrays (Figure 3.6C). Similarly, H3
ubiquitylated at lysines K18, K23 or K18 and K23 was also incorporated into octameric
assemblies. The unmodified control of these assemblies needed no additional tag on histone
H3 (Figure 3.6D).
3.1.4 Preparation of biotinylated DNA templates
Histone octamers were assembled on DNA templates to create nucleosomes and nucleosomal
arrays (also referred to as chromatin fibers). Templates of human, frog or viral origin may be
used in the process. Histone octamers assemble well onto these templates and reconstitute
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naturally occurring chromatin fibers. Such in vitro reconstitutions are succeptible however
to spontanous disruptions due to the low affinity of the underlying DNA sequence for the
histone octamer [185]. It is for this reason that synthetic DNA templates with high nucleoso-
mal positioning properties have artificially been evolved [186]. The 601 Widom positioning
sequence of 147 bp (or the shorter 145 bp) was used in this thesis either as such or with
additional linker DNA to create symmetric (187 bp) or asymmetric (171 bp) DNA templates.
For nucleosomal arrays, a construct containing twelve repeats of a 200 bp sequence embed-
ding the 147 bp Widom positioning sequence was used.
To be able to use the nucleosomes and nucleosomal arrays in affinity purification experiments
the DNA templates were prepared in house in high purity, after which they were biotinylated.
Production of the DNA templates required amplification using high copy number plasmids.
The inserts containing the nuclesomal positioning sequences were separated from the plasmid
backbone using restriction enzymes (Figure 3.7). Preparation of 171 bp DNA required
the use of AvaI and NotI which produced the short DNA template and an intact plasmid
Figure 3.6: Assembly of histone octamers. (A) Elution profile of H2BK120ub-containing his-
tone octamers from a Superdex S200 size exclusion column. (B) Coomassie-stained SDS-PAGE gel
of fractions collected from the elution profile. (C) Coomassie-stained SDS-PAGE gel of represen-
tative fractions of histone octamer assemblies containing His.H2B, HA.H2B, His.H2BK120ub and
HA.H2BK34ub histones. (D) Coomassie-stained SDS-PAGE gel of representative fractions of his-
tone octamer assemblies containing unmodified, H3K18ub, H3K23ub and H3K18/23ub2 histones.
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backbone (Figure 3.7A). Preparation of 12x200 DNA required the combined use of EcoRI,
HaeII, DdeI and BfuCI which digested the plasmid backbone into small fragments and
released an intact 2400 bp DNA template (Figure 3.7D). Both inserts were separated from
the corresponding digestion reactions by gradient PEG precipitation. To prepare the DNA
templates for biotinlylation, these were first dephosphorylated at their 5’ ends using Antarctic
Phosphatase. This was performed to prevent self-ligation during the subsequent ligation
reaction (Figure 3.7B). Biotinylation was performed with biotinylated oligos (phosphorylated
at their 3’ ends), specific for the 171 and for the 12x200 templates, in the presence of T4
DNA ligase (Figure 3.7B, Figure 3.7D). The incorporation of the biotin tag into the 187
and 12x200 DNA templates was verified by dot blot with a streptavidin-HRP probe (Figure
3.7C, Figure 3.7E).
3.1.5 Reconstitution of mononucleosomes and nucleosomal arrays
Unmodified or ubiquitylated histone octamers were assembled onto the biotinylated bio-187
or bio-12x200 synthetic DNA templates using salt gradient dialysis. Generally, titration se-
ries with histone octamer:template DNA ratios of 0.9:1 - 1.5:1 were performed prior to large
scale reconstitutions. Most mononucleosome reconstitution reactions required octamer:DNA
ratios of 1.3:1 and 1.5:1 to obtain fully saturated constructs, devoid of hemisomes (subnu-
cleosome assemblies) or of free unbound template DNA. Most chromatin reconstitutions
required octamer:DNA ratios of 1.1:1 and 1.3:1 to obtain full saturation, which was exam-
ined by micrococcal nuclease and restriction enzyme digestions.
Using biotinylated 187 bp DNA and octameric assemblies containing His.H2BK120ub and
HA.H2BK34ub, uniformly ubiquitylated mononucleosomes were prepared for identification
of novel nuclear interactors in affinity purification experiments (Figure 3.8B). In parallel,
control biotinylated mononucleosomes were prepared from the corresponding His.H2B and
HA.H2B octameric aseemblies.
Using biotinylated 12x200 bp DNA and octameric assemblies containing unmodified, H3K18ub,
H3K23ub and H3K18/23ub2 or His.H2B, HA.H2B, His.H2BK120ub and HA.H2BK34ub uni-
formly ubiquitylated nucleosomal arrays were reconstituted for identification of novel nuclear
interactors in chromatin affinity puritication experiments (Figure 3.8C, Figure 3.8E). Addi-
tional chromatin templates containing a mutated H2A histone (H2A E61A E64A, H2Amt)
were prepared later to better understand the readout of H3 ubiquitylated histone by a group
of proteins identified during the chromatin affinity purification experiments (Figure 3.8D).
3.1.6 Quality control of reconstituted nucleosomes and nucleoso-
mal arrays
To obtain reproducible ubiquitylated nucleosome and chromatin templates, these were recon-
stituted to full saturation of the DNA template with histone octamers. Mononucleosomes
saturation was examined by native agarose gel electrophoresis. The presence of unbound
template DNA or the unwanted assembly of subnucleosome complexes was resolved by over-
titration of histone octamers into the reconstitution reaction. Fully saturated mononucle-
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Figure 3.7: Preparation of DNA templates for mononucleosome and chromatin re-
constitution. (A) Ethidium bromide (EtBr)-stained agarose gel of a pUC18-52x187 plasmid
digested with AvaI and NotI restriction ezymes and gradient PEG 6000 purification of the result-
ing 171 bp DNA insert away from the intact plasmid backbone. (B) EtBr-stained agarose gel of
dephosporylation (Antarctic phosphatase) and biotinylation (T4 DNA ligase) reactions on the 171
bp DNA. (C) Dot blot using Streptavidin-HRP conjugate to detect biotinylated DNA templates.
(D) EtBr-stained agarose gel of a pUC18-12x200 plasmid digested with EcorI, HaeII, DdeI and
BfuCI restriction ezymes and gradient PEG 6000 purification of the resulting 12x200 insert from
the digested plasmid backbone. (E) EtBr-stained agarose gel of the biotinylation reaction of the
12x200 template. (F) Dot blot using Streptavidin-HRP conjugate to detect biotinylated DNA tem-
plates. NC = negative control. After biotinitylation, the mononucleosomal DNA template was 187
bp long. M = DNA ladder marker [bp]
osomes appear on an agarose gel as a single band that is shifted from 187 bp to 400-500
bp (Figure 3.8C). Since octamer composition may change the surface properties of the nu-
cleosomes (charge, folding), different mononucleosomes travel slightly differently through a
native gel.
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Figure 3.8: Reconstitution of mononucleosomes and nucleosomal arrays. (A) EtBr-
stained gel of the pure DNA templates used in the reconstitution reactions. (B) EtBr-stained
gel of biotinylated mononucleosomes, including the His.H2B, HA.H2B, His.H2BK120ub and
HA.H2BK34ub reconstitutions used in affinity purification experiments for mass spectrometry
analysis. (C) EtBr-stained gel of biotinylated nucleosomal arrays, including unmodified, H3K18ub,
H3K23ub and H3K18/23ub2 reconstitutions used in affinity purification experiments for mass spec-
trometry analysis. (D) EtBr-stained gel of biotinylated nucleosomal arrays, including unmodified,
H2Amt, H3K18ub, H3K23ub, H3K23ub H2Amt and H3K18/23ub2 reconstitutions used in affin-
ity purification experiments with recombinant proteins. (E) EtBr-stained gel of biotinylated nu-
cleosomal arrays, including unmodified, His.H2B, HA.H2B, His.H2BK120ub and HA.H2BK34ub
reconstitutions used in affinity purification experiments for mass spectrometry analysis.
Reconstitution of nucleosomal arrays was investigated with respect to two different parame-
ters. The first parameter, nucleosome positioning, refers to the ability of the DNA sequence
to prevent deviation (sliding or unwrapping) of a nucleosome from a set point (dyad axis)
along the DNA sequence. If nucleosomes were misplaced, the desired uniform distribution
conferred by the core positioning sequences would be skewed, which would result in the for-
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Figure 3.9: Nucleosomal positioning control on reconstituted nucleosomal arrays. (A)
Schematic annotation of cleavage sites for AvaI, BanI I and NotI restriction enzymes with respect
to two consecutive nucleosomal positioning sequences. (B) EtBr-stained gel of enzymatic digests of
nucleosomal arrays including His.H2B, HA.H2B, His.H2BK120ub and HA.H2BK34ub-containing
templates.
mation of unequal nucleosome spacing across the array. The second parameter, nucleosome
occupancy, refers to the local density of nucleosomes within a given chromatin template. The
nucleosome arrays used in this thesis contained twelve positioning sequences and were thus
able to position strongly twelve nucleosomes. An undersaturated nucleosome array would
contain less than twelve assembled nucleosomes.
Nucleosome positioning was addressed by restriction enzyme digestion, using enzymes that
cleave unprotected DNA (Figure 3.9A). Restriction enzyme AvaI cleaves the 12x200 DNA
template 34 bp upstream of the start of the core positioning sequence (108 bp away from
the dyad axis). Restriction enzyme NotI cleaves the DNA template 7 bp upstream of the
core positioning sequence (81 bp from the dyad axis). Restriction enzyme BanI cleaves the
DNA template 13 bp downstream of the core positioning sequence (61 bp from the dyad axis).
Upon treatment with AvaI, the unmodified and ubiquitylated H2B chromatin arrays were
fully digested to products which run to a front corresponding of 400 - 500 bp (Figure 3.9B).
This indicated that the linker DNA was available for digestion along the entire length of
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Figure 3.10: Nucleosomal occupancy control on reconstituted nucleosomal arrays.
(A) Schematic representation of the micrococcal nuclease (MNase) sensitive region between two
consecutive nucleosomal positioning sequences. (B) EtBr-stained gel of time-course MNase digests
of nucleosomal arrays containing His.H2B and His.H2BK120ub. (C) EtBr-stained gel of time-course
MNase digests of nucleosomal arrays containing HA.H2B and HA.H2BK34ub. (D) EtBr-stained
gel of time-course MNase digests of nucleosomal arrays containing unmodified and H3H23ub.
the nucleosome array. Upon treatment with NotI, the unmodified and ubiquitylated H2B
chromatin arrays were fully digested to products which run to a front corresponding of 400
- 500 bp. This suggested that nucleosomes were not placed outside of the core positioning
sequences. Together, the digestion reactions indicate that the nucleosomes were properly
positioned after reconstitution.
Upon treatment with BanI, the His.H2B, HA.H2B and His.H2BK120ub chromatin fibers
show protection against enzymatic digestion. In the case of HA.H2BK34ub, this protection
is lost and several digestion products (mono-, di-, trinucleosomes) are observerd on the na-
tive agarose gel. This is not an effect of nucleosomal positioning, but rather a consequence
of spontaneous nucleosomal breathing [187]. H2BK34ub lowers the energy needed to brake
the histone-DNA contacts at the two extremeties of the nucleosomal positioning sequence.
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Nucleosome occupancy was addressed experimentally by digestion with micrococcal nuclease
(MNase). In a MNase digestion experiment, unmodified chromatin is processed in parallel
with ubiquitylated chromatin. Unprotected DNA (linker DNA or unbound nucleosomal po-
sitioning sequence) is sensitive to MNase digestion (Figure 3.10A). All chromatin templates
assayed produced twelve distinct cleavage bands in the first time-point of the digestion reac-
tion (Figure 3.8B, Figure 3.10C, Figure 3.10D). Second, upon treatment with either AvaI,
NotI or BanI, there was no evidence of unbound positioning sequences, which would appear
as 200 bp DNA fragments on the native agarose gel (Figure 3.10B, Figure 3.10C). Together
with the observation that MNase digests produced twelve cleavage products, this indicated
that all nucleosome arrays that were produced for the chromatin affinity purification exper-
iments were fully saturated.
The micrococcal nuclease digestion rate was slightly faster in the case of ubiquitylated nu-
cleosomal arrays (Figure 3.10B, Figure 3.10C, Figure 3.10D). This was not an effect of
nucleosome occupancy since the 147 bp or 200 bp digestion end products accumulate to
the same extent in both unmodified and ubiquitylated arrays. This observation may have
resulted from a higher order folding of ubiquitylated chromatin fibers that differed from that
of the unmodified controls. Ubiquitylation of histones likely opened chromatin fibers locally,
making the linker DNA more sensitive to MNase treatment.
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3.2 Mapping of nuclear proteins recognising ubiquity-
lated histones
3.2.1 Chromatin affinity purification - mass spectrometry
To isolate protein complexes that bind modified histones, an affinity purification approach
was previously developed in our laboratory [132]. This technique uses biotinylated nucleoso-
mal arrays as an affinity tag for nuclear proteins. After purification, the proteins which are
recruited to chromatin are identified by mass spectrometry. Chromatin affinity purification
- mass spectrometry (ChAP-MS) enriches for proteins from nuclear extracts (Figure 3.11B).
To separate false-positives from true-positive interactors, ChAP-MS is combined with stable
isotope labeling of amino acids in cell culture (SILAC) and uses extracts that have been pre-
pared from human cells grown in media that have been supplemented with heavy arginine
(+6 Da, 13C) and lysine (+4 Da, 2H) isotopes.
A regular ChAP-MS scheme contains a forward and a reverse experiment (Figure 3.11A). In
the forward experiment, unmodified chromatin is incubated with light nuclear extract and
modified chromatin is incubated with heavy nuclear extract. In the reverse experiments, la-
bels are swapped such that the unmodified chromatin is incubated with heavy nuclear extract
and the modified chromatin is incubated with light nuclear extract. Pooled eluates from the
forward experiment are analysed by mass spectrometry. Peptide intensities from proteins
enriched from the heavy or the light extract are measured and the resulting ratios between
heavy and light protein groups (H/L) are sorted on a logarithmic scale (Figure 3.11C). In
parallel, the eluates from the reverse experiment are also analysed by mass spectrometry.
The H/L ratios are inverted and sorted as in the forward experiment (Figure3.11D). The
distributions of H/L ratios identified in the two experiments follow closely a normal distri-
bution of 0 mean and 1 standard deviation (Figure 3.11C, Figure3.11D). If most measured
protein groups fall within the boundaries of the normal distribution, several proteins are
found on either side of the distribution mean. Enriched outliers have a positive H/L ratio.
Excluded outliers have a negative H/L ratio.
To separate false-positive from true-positive outliers the two H/L distributions were plotted
against each other (Figure 3.11E). Such an interactome plot separates all measured protein
groups into four quadrants. The top left quadrant included ubiquitin, histones and pro-
teins that bind strongly to chromatin with no regard for the modification. The bottom left
quadrant included proteins that are reproducibly excluded from modified chromatin. The
bottom right quadrant identified interactors that have been enriched during the preparation
of the heavy extract and bind chromatin with no regard for the modification. The top right
quadrant included protein groups that have been reproducibly enriched on the modified
chromatin.
Until recently, true-positive and true-negative outliers were selected from the top right and
bottom left quadrants based on an arbitrary threshold or cutoff value which was applied
to both the forward H/L and the reverse L/H ratio distributions (Figure 3.11F). Since the
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Figure 3.11: Chromatin affinity purification - mass spectrometry. (A) Schematic represen-
tation of experiments performed for isolation of nuclear proteins that recognise modified chromatin.
(B) Input nuclear extract and eluted proteins from forward (fwd) and reverse (rev) biochemical
experiments. (C) Histogram of heavy/light (H/L) ratios for proteins identified in the forward exper-
iment, with normal distribution plotted on top. (D) Histogram of L/H ratios for proteins indetified
in the reverse experiment. (E) Intersection of the H/L distributions from the forward and reverse
experiments. (F) Highlighted enriched (cyan) and excluded (light green) proteins in the two H/L
distributions and their intersection.
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Figure 3.12: Statistical analysis of ChAP-MS datasets. (A) One-sample student’s t-test
analysis of the grouped H/L ratios from the forward and reverse experiemnts. The dashed parabolas
deliniate the test’s significance threshold (B) Two-sample student’s t-test analysis of the separate
mean H/L ratios from the forward and reverse experiments. The dashed parabolas represent the
significance treshold. (C) Representation of the one-sample t-test significant outliers on the interac-
tome plot. (D) Representation of the two-sample t-test significant outliers on the interactome plot.
(E) Representation of significant reproducible outliers on an interactome plot. (F) Representation
of significant reproducible outliers on a volcano plot. Enriched outliers are highlighted in cyan,
excluded outliers are highlighter in light green.
affinity purification experiments are measured thrice in the mass spectrometer, the repro-
ducibility of the measurements can be statistically quantified [133]. In order to identify
significant outliers the triplicate measurements from the forward and the reverse experi-
ments were subjected to student’s t-test analysis. Two types of analyses can be performed.
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A one-sample t-test statistical analysis pools the information from the forward and the re-
verse experiments in one dataset. The test calculates the overall mean of the three H/L ratios
from the forward distribution and the three inverse L/H ratios from the reverse distribution
and compares it to the zero mean of the entire dataset. The one-sample t-test calculates if
the pooled mean is significantly different from the zero mean and plots the difference values
against the corresponding p values (Figure 3.12A). The one-sample t-test is an indicator of
measurement reproducibility across the forward and the reverse datasets.
A two-sample student’s t-test calculates if the difference between the mean of the three H/L
ratios of a protein identified in the forward experiment is significantly different from the
mean H/L ratios of the same protein identified in the reverse experiment. The difference
between the mean H/L ratios of each protein group measured in the two experiments is
plotted against the corresponding t-test p value (Figure 3.12B). The two-sample t-test is an
indicator of experimental difference between the forward and the reverse datasets.
The p values in the two t-test analyses were calculated using a permutation based algorithm
whose false discovery rate (FDR) value was set to 0.01. Additionally, a S0 = 2 constant was
added to increase pooled sample variance (decrease background noise) during calculations of
both the t-test statistics. These parameters specified the significance threshold of the two
analyses.
The significant outliers identified by the statistical analyses did not all agree with the previ-
ously set H/L cutoff values. Both t-test analyses were more permissive in the identifiaction
of enriched factors than the set H/L cutoff. In the one-sample t-test analysis, many inter-
actors which defied the null hypothesis had low H/L enrichment or depletion ratios (Figure
3.12C). This selection, included all enriched or depleted factors, which were selected based
on the H/L cutoff, but had a relatively high identification background. In the two-sample
t-test, the comparison between the measurements in the forward and reverse experiments,
improved the identification confidence (Figure 3.12D). This being said, some significantly
enriched interactors were still only enriched in one of the H/L ratio distributions and some
significantly excluded interactors were only excluded from one of the H/L ratio distributions.
This happened because the two-sample t-test evaluated if the difference between the mean
H/L ratios from the forward and the reverse experiments was statistically significant. The
two-sample t-test did not check for strict reproducibility of the two experiments, that is if
the inverse of the reverse experiment matched the forward experiment, which was controlled
by the one-sample t-test. The two-sample t-test was superior in its identification confidence
to the one-sample t-test, but had some limitations with regard to the reproducibility of the
forward and reverse biochemical experiments.
The t-test analysis was complemented by the previously set H/L cutoff values (Figure 3.12E,
Figure 3.12F). The intersection of the two-sample t-test with the H/L distribution thresholds
was chosen to insure that biochemically reproducible enriched or excluded outliers were also
statistically significant. Throughout the thesis, the thresholds were set to a log2 (H/L) value
of 1.75 in the forward experiment, a log2 (L/H) value of 1.75 in the reverse experiment and a
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two-sample t-test FDR value of 0.01 and S0 value of 2. Two parameters were thus arbitrary
set for confident identification of statiscally enriched interactors: the H/L cutoff and the S0
constant. The final interactome (H/L ratio distributions) and volcano (t-test statistics) plots
presented in the thesis contained all measured protein groups and highlighted the significantly
enriched outliers. To this end, the interactome plots focused on the representation of the
top right quadrant and the volcano plots display only the positive t-test significance area.
3.2.2 Histone ubiquitylation interactome mapping
The interactome of H2BK120ub
Previously in our laboratory, using chromatin affinity purification coupled with quantitative
mass spectrometry, the interactome of H2BK120ub was presented [83]. In that study, ubiq-
uitylation recruited to chromatin the RNA polymerase, proteins that control transcription
elongation, the small nuclear RNA-processing integrator complex and the switch/sucrose
nonfermentable chromatin remodeling complex.
To understand the molecular requirements for histone ubiquitylation readout in general and
for H2BK120ub readout in particular, we repeated the affinity purification scheme mentioned
above with the addition of ubiquitylated H2BK120ub histone and ubiquitylated H2BK120ub
mononucleosomes as modified templates (Figure 3.11A, Figure 3.13). The two additional
affinity matrices were selected to provide information with regard to the requirement of
inter- and trans-nucleosomal contacts as well as additional interaction surfaces (DNA gyres,
linker DNA and unmodified histones) for readout of the ubiquitylation mark.
In the histone affinity purification experiment, four proteins were reproducibly enriched (Fig-
ure 3.13A, Figure 3.13B). Nuclesomal assembly protein 1-like 1 and 4 (NAP1L1, NAP1L4),
nucleolar (upstream) transcription factor (UBTF) and the Treacher-Collins ribosome biogen-
esis factor 1 (TCOF1) discriminated ubiquitylated H2B histone from the unmodified control.
In the mononucleosome affinity purification experiment, a group of fourteen proteins were
reproducibly enriched (Figure 3.13C, Figure 3.13D). Four subunits of the integrator complex
(INTS 1, INTS3, INTS6 and INTS12) and the RNA polymerase II subunit A (POLR2A)
were identified as strong readers. Zinc-finger containing proteins ZMYNDB, ZNF687, struc-
tural maintenance of chromosomes 1A and 3 (SMC1A, SMC3) and the E3 protein ligase
ring finger 169 (RNF169) also prefered the ubiquitylated mononucleosome matrix to the
unmodified control.
In the chromatin affinity purification experiment, thirty-five proteins were reproducibly en-
riched (Figure 3.13E, Figure 3.13F). In agreement with the published H2BK120ub chromatin
interactome [83], eleven subunits of the integrator complex (INTS1-INTS10, INTS12) were
recruited to the modified chromatin. Three subunits of the RNA polymerase machinery
(POLR2B, POLR2C, POLR2E) and several subunits controlling transcription elongation
(NELFB, NELFC/D, SUPT5H) were also enriched. DNA excision repair proteins 1 and 4
(ERCC1 and ERCC4) as well as the Zn-finger proteins ZMYNDB, ZNF609 and ZNF687
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Figure 3.13: ChaP-MS analysis of H2BK120ub. (A) Representation of enriched interac-
tors on an interactome plot from a histone affinity purification experiment. (B) Representation of
enriched interactors on a volcano plot from a histone affinity purification experiment. (C) Represen-
tation of enriched interactors on an interactome plot from a mononucleosome affinity purification
experiment. (D) Representation of enriched interactors on a volcano plot from a mononucleosome
affinity purification experiment. (E) Representation of enriched interactors on an interactome plot
from a chromatin affinity purification experiment. (F) Representation of enriched interactors on a
volcano plot from a chromatin affinity purification experiment.
and the E3 ligase RNF169 preferred the ubiquitylated chromatin array over the unmodified
control.
There was no overlap between the factors that were enriched using histone affinity purifi-
cation and the factors that bound the mononucleosome or the chromatin templates. None
61
of the proteins enriched with the histone matrix werre present in the mononucleosome or
the chromatin sets. None of the proteins enriched on the mononucleosome or the chromatin
matrices were found within the histone set.
There was overlap between the mononucleosome and chromatin affinity purification experi-
ments. Several subunits of the integrator complex, the RNA polymerase and several Zn-finger
proteins were found in both experiments. The momonucleosome matrix recruited however
only a fraction of the factors enriched on the chromatina arrays.
The nucleosomal arrays provide thus a more complex and larger interaction surface, which
translates during the affinity purification into more binding events. The biotiniylated nucle-
osomal arrays create efficient affinity matrices, where the nuclear interactors’ need for inter-
and trans-nucleosomal contacts is statisfied and where the presence of ubiquitin is readily
discriminated.
The interactome of H2BK34ub
Histone and chromatin affinity purification experiments were also used to identify proteins
that recognise H2BK34ub.
Using a ubiquitylated histone matrix, the H2BK34ub modification enriched for a number
of proteins with seemingly unrelated functions: the phospholipase A2 activating protein
(PLAA), the transcriptional regular SUB1, the solute carrier family member 4A1 (SLC4A1),
the ADP ribosylation factor like 6 (ARL6), and the Zn-finger RNA binding protein 2
(ZRANB2) (Figure 3.14A, Figure 3.14B).
Using a ubiquitylated chromatin matrix, the H2BK34ub mark reproducibly enriched for six
proteins, including the DNA Polymerase E3 (POLE3), the chromatin accessibility complex
1 (CHRAC1), a subunit of the INO80 chromatin remodeling complex and the actin related
protein 5 (ACTR5) (Figure 3.14C, Figure 3.14D).
Similarly as for the H2BK120ub modification, there was no overlap between the histone and
the chromatin affinity purification datasets collected for H2BK34ub.
None of the interactors enriched on the H2BK120ub histone, mononucleosome or chromatin
matrices was identified within the H2BK34ub-specific datasets.
The interactome of H3K18ub and H3K23ub
The chromatin affinity purification mass spectrometry technique was also used to identify
the proteins which recognise the H3K18ub, H3K23ub and H3K18/23ub2 modifications.
The proteins purified on the H3K18ub template were more widely distributed than the other
two H3 ubiquitylated templates (Figure 3.15A, Figure 3.15B). After applying the statistical
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Figure 3.14: ChaP-MS analysis of H2BK34ub. (A) Representation of enriched interactors on
an interactome plot from a histone affinity purification experiment. (B) Representation of enriched
interactors on a volcano plot from a histone affinity purification experiment. (C) Representation
of enriched interactors on an interactome plot from a chromatin affinity purification experiment.
(D) Representation of enriched interactors on a volcano plot from a chromatin affinity purification
experiment.
analysis and the enrichment threshold, twenty-eight proteins were found reproducibly en-
riched. These included as strongest interactors the DNA methyltransferase 1 (DNMT1), the
ubiquitin specific protease 7 (Usp7), the Sex comb on midleg-like 2 (SCML2), the acetyl-coA
carboxylase alpha (ACACA) and the ubiquitin specific protease 3 (Usp3). Other enriched
interactors included Zn-finger proteins ZBTB1, ZBTB14 and ZBTB44, histone deacetylase
components SIN3A and associated subunits SAP30 and SAP 130, transcription regulators
Forkhead Box 1 and 2 (FOXK1, FOXK2) as well as MAX dimerization protein MLX and
interacting proteins MLXIP and MLXIPL with transcription factor properties.
Using the H3K23ub nucleosomal array, six proteins were enriched by affinity purification
(Figure 3.15C, Figure 3.15D). Similarly to the H3K18ub template, DNMT1, Usp7, SCML2
and ACACA were among the enriched factors. In addition, the DNA sensor 5-hydroxymethyl-
cytosine binding embryonic stem cell specific (HMCES) and the G2/M phase specific E3
ubiquitin ligase G2E3 also preferred the ubiquitylated template to the unmodified control.
Using the double-modified H3K18/23ub2 nucleosomal array, six proteins were enriched by
affinity purification (Figure 3.15E, Figure 3.15F). As in the H3K18ub and the H3K23ub ex-
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Figure 3.15: ChaP-MS analysis of H3 ubiquitylaion. (A) Representation of enriched in-
teractors on an interactome plot from a H3K18ub chromatin affinity purification experiment. (B)
Representation of enriched interactors on a volcano plot from a H3K18ub chromatin affinity pu-
rification experiment. (C) Representation of enriched interactors on an interactome plot from a
H3K23ub chromatin affinity purification experiment. (D) Representation of enriched interactors
on a volcano plot from a H3K23ub chromatin affinity purification experiment. (E) Representation
of enriched interactors on an interactome plot from a H3K18/23ub2 chromatin affinity purification
experiment. (F) Representation of enriched interactors on a volcano plot from a H3K18/23ub2
chromatin affinity purification experiment.
periments, this purification enriched for DNMT1, Usp7, SCML2 and ACACA. In addition,
it recruited MLX1PL and FOXK2, which were also found on the H3K18ub affinity matrix.
There was overlap between the three H3 ubiquitylated affinity matrices. DNMT1, Usp7,
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SCML2 and ACACA were the highest enriched factors in all datasets. There was no over-
lap between these three interactomes and the interactomes collected for the H2BK120ub or
H2BK34ub chromatin templates.
Complete lists of enriched factors are presented in Table 3.1, Table 3.2 and Table 3.3. For
each interactome, the tables list three separate identifications: the two-sample t-test analysis,
the application of the H/L enrichment cutoff and the combined use of the H/L enrichment
cutoff with the t-test statistical analysis which has been presented in the thesis.
3.2.3 Network analysis of the histone ubiquitylation interactome
maps
Some proteins identified in the histone, mononucleosome and chromatin affinity purifica-
tion experiments are part of large annotated complexes which perform known biochemical
functions. This is the case of the RNA polymerase machinery and the integrator complex
found in the H2BK120ub interactome. Other proteins form smaller complexes involved in
processes such as DNA repair (ERCC1, ERCC4, SLX4), transcription elongation control
(NELFB, NELFCD, SUPT5H) or maintenance DNA methylation (DNMT1 and Usp7).
There are however many factors which are not part of any of these two types of complexes.
Such proteins may still form weaker interactions with the defined core protein complexes,
they may form interactions with other isolated proteins or they may contact the ubiquity-
lated chromatin templates directly. To connect proteins from within individual interactomes,
STRING analysis was performed (Figure 3.16) [177]. An online STRING analysis curates
information about a given set of proteins (one interactome) from several publically available
databases and links proteins that share common features. STRING analysis collects exper-
imental evidence (biochemical interaction, coexpression analysis), genetic evidence (fusion
events, neighboring genes) and evidence derived from text-mining from publically available
abstracts.
The STRING analysis indicated that in the H2BK120ub mononucleosome list of enriched
factors, the negative receptor corepressor 1 (NCOR1) connected transducing beta like1 X-
linked receptor 1 (TBL1XR1) to the RNA polymerase A subunit (Figure 3.16B). Similarly,
in the H2BK34ub chromatin interactome, the STRING analysis pointed out that the weak
association between INO80C and CHRAC1 connected ACTR5 and POLE3 in a process
that may involve actin polymerisation and DNA replication (Figure 3.16E). Using STRING
analysis, the protein core formed by the integrator complex in the H2BK120ub chromatin
interactome accommodated also additional factors such as the cleavage and polyadenylation
specific factor 3L (CPSF3L), the human asunder homolog (ASUN), the von Willebrand fac-
tor A9 (VWA9), and the nucleic acid binding protein 2 (NABP2) (Figure 3.16C). Further
text-mining revealed that CPS3FL, ASUN and VWA9 were in fact subunits of the integrator
complex: INTS11, INTS13 and INTS14. The STRING analysis facilitated the identification
of all 14 subunits of the integrator complex within the enriched proteins purified from the
H2BK120ub chromatin affinity matrix.
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Figure 3.16: STRING analysis of significantly enriched interactors. (A) Interaction
network of the H2BK120ub histone affinity purification dataset. (B) Interaction network of
the H2BK120ub mononucleosome affinity purification dataset. (C) Interaction network of the
H2BK120ub chromatin affinity purification dataset. (D) Interaction network of the H2BK34ub his-
tone affinity purification dataset. (E) Interaction network of the H2BK34ub chromatin affinity pu-
rification dataset. (F) Interaction network of the H3K18ub chromatin affinity purification dataset.
(G) Interaction network of the H3K23ub chromatin affinity purification dataset. (H) Interaction
network of the H3K18/23ub2 chromatin affinity purification dataset. The DNMT1-Usp7-SCML2
association in the three H3 ubiquitylation interactomes is highlighted in cyan.
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With regard to the H3 ubiquitylation datasets, the STRING analysis connected DNMT1
and Usp7 with SCML2 in all three interactomes (Figure 3.16F, Figure 3.16G, Figure 3.16H).
The strength of the association was stronger between DNMT1 and Usp7 and weaker between
Usp7 and SCML2. DNMT1 was placed at the centre of the STRING association network
in the H3K18ub dataset, implying that it may serve to recognise the H3 ubiquitylated chro-
matin and recruit subsequently additional proteins and protein complexes.
There was no direct linkage between ACACA and any of the other strongly enriched in-
teractors (Figure 3.16G, Figure 3.16H). ACACA could however indirectly be connected to
DNMT1 through MLXIPL (and SIN3A) or through the transcription factor E2F3 which
accumulates in the cell at the end of S phase (Figure 3.16F). In the H3K23ub dataset, no
known association between SCML2, Usp7 or DNMT1 with the hydroxymethylation sensor
HMCES or the ubiquitin ligase G2E3 could be assigned (Figure 3.16G).
The STRING analysis also facilitated the identification of two additional complexes recruited
on the H3K18ub chromatin template (Figure 3.16F). First, a histone deacetylation complex
formed and included SIN3A, SUDS3, SAP30 (BRMS1) and SAP130 with possible assoacia-
tion of FOXK1 and FOXK2. Second, a heterochromatinisation complex was revealed includ-
ing subunits of the dimerisation partner, RB-like, E2F and multivalval class B (DREAM)
complex: LIN9 and LIN54 as components of the muvB complex, E2F3, transcription factor
dimerisation protein 1 (TFDP1) and retinoblastoma 1 (RB1).
The Zn-finger containing Usp3 did not connect with any other enriched factor from the
H3K18ub interactome list, which might suggest that it could contact the ubiquitylated chro-
matin directly (Figure 3.16F).
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Table 3.1: Enriched proteins across all affinity purification experiments. T-test significance.
H2B H2B H2B H2B H2B H3 H3 H3
K120ub K120ub K120ub K34ub K34ub K18ub K23ub K18/23ub2
histone mono chromatin histone chromatin chromatin chromatin chromatin
UBTF INTS3 INTS3 SLC4A1 POLE3 DNMT1 PHF14 DNMT1
NAP1L1 INTS6 INTS4 SUB1 TGIF1 USP3 RPL7 USP7
TCOF1 RNF169 INTS2 ZRANB2 PGK1 USP7 DNMT1 SCML2
NAP1L4 POLR2A CPSF3L LUC7L2 FSCN1 MAX RPL12 ACACA
LEO1 INTS1 INTS10 ARL6IP4 PPA1 SCML2 RPL4 ARID4B
RPL24 PPP1R10 INTS5 SRRM2 HMGB1 MYC RPL7A MLXIPL
PAF1 INTS12 RNF169 PLAA NME2 ZBTB14 RPL6 SIN3A
CDC73 RBM15 BP2 DDX46 INO80C MNT ACACA MNT
RPS3A TBL1XR1 INIP SF3B1 CHRAC1 WDR43 G2E3 FOXK1
GNL2 KIAA1429 INTS1 PHF5A TPI1 HES1 PELP1 FOXK2
CSNK2A1 NCOR1 POLR2C PUF60 ACTR5 FOXK1 USP7 SAP130
WDR61 ZC3H13 INTS6 UBTF PRDX6 NFRKB HMCES ZBTB14
RPL13 TOX4 ASUN U2AF1 FUBP1 SIN3A ANKRD32 ZBTB21
CWC22 BCOR DCAF7 U2AF2 SET FOXK2 WDR18 ARID4A
DIEXF SMC1A DYRK1A PCMT1 PPIA HMBOX1 RAD18 TONSL
ABCF1 ZMYND8 INTS12 BCAR1 PSAT1 ACTR5 TEX10 SAP30
RPL18 SMC3 ZMYND8 TK1 KMT2B GTF2IRD1 SCML2 LM
RPL17 NOP2 INTS7 CHCHD2 ZFP64 SAP130 SMC1A
TCEB3 G3BP1 POLR2B ACTA1 BAZ1A E2F3 SMC3
RPL35 DDX21 INTS8 ANXA2 RTN4 RB1 KMT2B
ZFR RAD18 ZNF687 EEF1D L3MBTL2
RPL32 ZNF687 POLR2E EIF4A1 H2AFV/Z
BRD2 MYBBP1A C7orf26 CFL1 EP400
RPL13A KDM2B PPP2R1A PSMA5 SUDS3
RPL4 RSL1D1 INTS9 EIF5A ACACA
RPL7 T10 TBL1XR1 AHK SAP30
RPL23A CPSF1 SLX4 TFAP4 MYBL2
NPM1 HNRNPU ZNF609 INO80B MLXIPL
RPL18A UBTF ERCC1 HSP90AA1 ACTR8
RPL29 GNL2 PPP2CA EIF3A LIN54
RPL35A PABPC1 VWA9 MLXIP MLX
RPL26 NIPBL SUPT5H PSMD11 TFDP1
NCL NCL RAD18 ASS1 KIAA1958
RPL5 SRRT RECQL5 POLR1C ZBTB44
RPL27 CDC5L ERCC4 STRAP TRRAP
CSNK2A2 DDX23 NELFB CLTC KLF5
CSNK2B DDX5 POLR2A POLR2H RAD18
EIF3B MATR3 ANKRD32 ASH2L KMT2B
RPL10A GCN1L1 POLR2G HSP90AB1 INO80
RPL7A EFTUD2 BCOR MEN1 BEND3
RPL8 ABCF1 KP1 CBX3 MLXIP
RPL6 PRPF6 PCGF1 PSMC2 ARNTL
RPL3 THOC5 TOX4 BAG6 LIN9
RPS14 RRP12 USP7 LDHB BCOR
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Table 3.2: Enriched proteins across all affinity purification experiments. H/L cutoff selection.
H2B H2B H2B H2B H2B H3 H3 H3
K120ub K120ub K120ub K34ub K34ub K18ub K23ub K18/23ub2
histone mono chromatin histone chromatin chromatin chromatin chromatin
UBTF INTS3 PKP2 SLC4A1 POLE3 DNMT1 DNMT1 DNMT1
NAP1L1 INTS6 INTS3 SUB1 TGIF1 USP3 ACACA USP7
TCOF1 RNF169 INTS4 ZRANB2 HMGB1 USP7 G2E3 SCML2
NAP1L4 INTS10 INTS2 LUC7L2 INO80C SCML2 USP7 ACACA
POLR2A CPSF3L ARL6IP4 CHRAC1 ZBTB14 HMCES MLXIPL
INTS1 INTS10 CTR9 ACTR5 MNT SCML2 FOXK2
POLR2C INTS5 PLAA HES1
POLR2B RNF169 FOXK1
PPP1R10 NABP2 SIN3A
INTS12 INIP FOXK2
TBL1XR1 INTS1 SAP130
ZNF592 POLR2C E2F3
NCOR1 ZNF592 RB1
PDS5B INTS6 SUDS3
TOX4 ASUN ACACA
SMC1A DCAF7 SAP30
ZMYND8 DYRK1A BRMS1
SMC3 INTS12 MYBL2
ZNF687 ZMYND8 PARD3
INTS7 ARID4A
POLR2B MLXIPL
INTS8 LIN54
ZNF687 MLX
POLR2E TFDP1
C7orf26 KIAA1958
PPP2R1A ZBTB44
INTS9 MLXIP
TBL1XR1 DDHD1
SLX4 LIN9
ZNF609 RFX5
ERCC1 YWHAE
PPP2CA ZBTB1
VWA9 TLE3
SUPT5H
PPP2R1B
NELFCD
RECQL5
ERCC4
NELFB
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Table 3.3: Enriched proteins across all affinity purification experiments. Intersection.
H2B H2B H2B H2B H2B H3 H3 H3
K120ub K120ub K120ub K34ub K34ub K18ub K23ub K18/23ub2
histone mono chromatin histone chromatin chromatin chromatin chromatin
UBTF INTS3 INTS3 SLC4A1A POLE3 DNMT1 DNMT1 DNMT1
NAP1L1 INTS6 INTS4 SUB1 TGIF1 USP3 ACACA USP7
TCOF1 RNF169 INTS2 ZRANB2 HMGB1 ACACA G2E3 SCML2
NAP1L4 POLR2A CPSF3L LUC7L2 INO80C DDHD1 USP7 ACACA
INTS1 INTS10 ARL6IP4 CHRAC1 SCML2 HMCES MLXIPL
PPP1R10 INTS5 CTR9 ACTR5 RFX5 SCML2 FOXK2
INTS12 RNF169 PLAA USP7
TBL1XR1 BP2 ZBTB14
NCOR1 INIP ZBTB44
TOX4 INTS1 E2F3
SMC1A POLR2C ZBTB1
ZMYND8 INTS6 FOXK2
SMC3 ASUN MNT
ZNF687 DCAF7 MYBL2
DYRK1A MLXIPL
INTS12 RB1
ZMYND8 FOXK1
INTS7 LIN54
POLR2B PARD3
INTS8 TFDP1
ZNF687 MLX
POLR2E SIN3A
C7orf26 SUDS3
PPP2R1A HES1
INTS9 KIAA1958
TBL1XR1 SAP130
SLX4 BRMS1
ZNF609 LIN9
ERCC1
PPP2CA
VWA9
SUPT5H
RECQL5
ERCC4
NELFB
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3.3 DNMT1, Usp7 and SCML2 cross-talk on the H3
ubiquitylated chromatin
3.3.1 DNMT1 recruits Usp7 and SCML2 ex vivo to H3 ubiquity-
lated chromatin
Chromatin affinity purification coupled with mass spectrometry indicated that DNMT1,
Usp7, SCML2 and ACACA bind the three different H3 ubiquitylated templates (Figure 3.15).
STRING analysis pointed out that DNMT1 may be found at the center of the H3K18ub inter-
actome, which may help to recruit additional proteins and protein complexes to the modified
chromatin. DNMT1 was shown to have a strong association with Usp7, which in turn was
found to associate weakly with SCML2 (Figure 3.16). No direct association was evident
between ACACA and any of DNMT1, Usp7 or SCML2, but a couple of possible indirect
paths from ACACA towards DNMT1 were suggested during the STRING analysis.
To validate the mass spectrometry identifications and the statistical enrichment analysis
upon which the STRING maps were drawn, fresh HeLa nuclear extracts were prepared and
a series of western blot (WB) analyses was performed (Figure 3.17).
WB analysis was performed with antibodies against H3 histone, proliferating cell nuclear
antigen (PCNA), SCML2, ubiquitin-like containing plant homeodomain and really interest-
ing new gene finger 1 (UHRF1), Usp7, DNMT1 and ACACA to validate both antibody
specificity and preparation of the nuclear extract (Figure 3.17A). PCNA and UHRF1 were
also investigated even though they were not enriched in any of the interactomes. Previ-
ous biochemical evidence linked PCNA loading at the replication fork and UHRF1’s abil-
ity to catalyse the ubiquitylation of the H3 N-terminal histone tail with DNMT1 recruit-
ment [188], [189], [35], [36].
Ubiquitylated histone affinity matrices were created by immobilising unmodified or ubiqui-
tylated histones with the help of a C-terminal specific anti-H3 antibody to a magnetic resin
(Figure 3.17B). The fresh nuclear extract was incubated with the histone matrices and the
eluates were subjected to western blot analysis. The analysis indicated that during incu-
bation with the nuclear extract, DNMT1 was enriched on the H3K18ub and H3K18/23ub2
and, to a lower extent, to the H3K23ub histone templates. Both Usp7 and UHRF1 bound
unspecifically to the mock control, making it difficult to argue whether their binding to the
affinity matrices was ubiquitylation-specific. SCML2 did not bind any of the matrices.
Six different chromatin templates were used in affinity purification experiments (Figure
3.17C). Next to the control unmodified chromatin and an acidic patch H2A mutant (H2Amt)
chromatin, four ubiquitylated templates were prepared. Besides the three templates used
in the mass spectrometry identification experiments, a H3K23ub H2Amt template was also
prepared. The two H2A mutant chromatin templates were added to understand if the nu-
cleosome acidic patch were a putative interaction surface for any of the factors enriched on
the H3 ubiquitylated chromatin.
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Figure 3.17: Western blot validation of the H3ub interactors identified by mass spec-
troemtry (A) Preparation of fresh HeLa nuclear extracts and validation of primary antibodies
used for detection of H3ub interactors. (B) Histone affinity purification from HeLa nuclear extract
using unmodified H3, H3K18ub, H3K23ub, and H3K18/23ub2 histones. Western blots analysis of
the elution fractions from the different affinity purification experiments was performed for Usp7,
SCML2 and H3. (C) Chromatin affinity purification from HeLa nuclear extract using biotinylated
chromatin containing unmodified, H2Amt, K18ub, K23ub, K23ub H2Amt and K18/23ub2 histones.
Western blots analysis of the elution fractions from the different affinity purification experiments
was performed for ACACA, DNMT1, Usp7, UHRF1, SCML2, PCNA, H3 and H2B.
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There was noticeable deubiquitylation of the chromatin arrays during the incubation with
the nuclear extract. This was indicated in the WB analysis by the accumulation of free H3
histone in the H3K18ub, H3K23ub and H3K23ubH2Amt samples and by the conversion of
the H3ub2 mark to H3ub1 and free H3 histone in the H3K18/23ub2 sample. There was no
evidence for binding of PCNA to any of the chromatin affinity purification matrices. Both
the short and the long isoform of SCML2 were enriched on the ubiquitylated chromatin
arrays, with preference towards H3K18/23ub2 and H3K18ub. SCML2 was not recovered on
the H3K23ubH2Amt array. UHRF1 bound preferentially to the chromatin templates con-
taining H3K23ub. Usp7 was enriched strongest on the double-modified H3K18/23ub2, and
the H3K18ub arrays. Usp7 recruitment, like that of SCML2 was lost in the H3K23ub H2Amt
sample. DNMT1 bound strongest to H3K18/23ub2 and to H3K18ub, and associated weakly
with H3K23ub and H3K23ubH2Amt. ACACA bound all chromatin templates, forming a
weaker association with the H3K18ub chromatin array.
The western blot analyses validated the mass spectrometric findings that SCML2, Usp7 and
DNMT1 were specific for the ubiquitylated chromatin matrices. ACACA’s binding to the
mock control makes it difficult to argue if the protein prefers ubiquitylated over unmodi-
fied chromatin. The western blot analyses also suggested that PCNA is not involved in the
events occurring on the H3ub chromatin and that UHRF1 bound ubiquitylated chromatin,
specifically H3K23ub and doubly modified H3K18/23ub2 chromatin, which was not observed
during the mass spectrometry analysis. The use of the K23ubH2Amt arrays showed that the
chromatin targeting of both Usp7 and SCML2 was sensitive to the mutation of the nucleo-
some acidic patch.
Using histones as affinity tags, only DNMT1 was specifcally enriched by H3 ubiquitin. Using
chromatin arrays as affinity tags, SCML2, UHRF1, Usp7 and DNMT1 were all preferentially
recruited to the ubiquitulated templates. This suggested that SCML2, UHRF1 and Usp7
needed additional surfaces on the nucleosome which were not present on H3 ubiquitin to be
able to interact with the modified histone.
Inhibition of DNA methylation and histone deubiquitylation
To better understand the order of recruitment of H3ub interactors to chromatin, nuclear ex-
tracts were treated with inhibitors to separate the two main events occuring on this template
(Figure 1.6; Figure 3.18). First, DNA methylation was blocked with S-adenosyl homocys-
teine (SAH) treatment [190]. Second, deubiquitylation was slowed using ubiquitin vinyl
sulfone (UVS) treatment [93].
Treatments were performed in parallel to untreated controls to minimise experimental vari-
ations in terms of recruitment reproducibility. The western blot analysis performed on the
eluates of the SAH-treated samples showed that the deubiquitylation of histone H3 was un-
affected by the DNA methylation block (Figure 3.17C, Figure 3.18A). SCML2 recruitment
to ubiquitylated chromatin was lower in the treated samples than in the untreated controls.
Both isoforms were affected equally by the SAH treatment, an observation which held on all
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Figure 3.18: Inhibition of DNA methylation and H3 deubiquitylation in the HeLa nu-
clear extract affects recruitment of several factors to H3ub chromatin. Chromatin affinity
purification from HeLa nuclear extract using biotinylated nucleosomal arrays containing unmodi-
fied, K18ub, K23ub and K18/23ub2 histones. Western blots analysis of the elution fractions from
the different affinity purification experiments was performed for DNMT1, Usp7, UHRF1, SCML2,
H3 and H2B. (A) Inhibition of DNA methylation was achieved with 100 µM S-adensoyl Homocys-
teine (SAM) treatment. (B) Inhibition of global deubiquitylation was performed by treatment of
the nuclear extract with 10 µg/mL recombinant ubiquitin vinyl sulfone (UVS) treatment.
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Figure 3.19: Degradation of RNA from nuclear extract results in decreased binding
of several interactors to chromatin. Chromatin affinity purification from HeLa nuclear ex-
tract using biotinylated nucleosomal arrays containing unmodified, K18ub, K23ub and K18/23ub2
histones. Western blots analysis of the elution fractions from the different affinity purification
experiments was performed for DNMT1, Usp7, UHRF1, SCML2, H3 and H2B. Degradation of
RNA was performed by treating the nuclear extract with 50 µg/mL recombinant heat-inactivated
ribonuclease A (RNase A).
ubiquitylated chromatin templates. UHRF1 recruitment to H3K23ub and H3K18/23ub2 was
not affected by the SAH treatment. Similarly, DNMT1 and Usp7 did not show differences
in recruitment after the treatment to inhibit DNA methylation.
To inhibit Usp7 activity, exracts were treated with UVS prior and during incubation with
the chromatin templates (Figure 3.18B). As shown in the western blot analysis, H3 deubiq-
uitylation remained largely unaffected after UVS treatment. Similarly, SCML2 and DNMT1
recruitment to all three ubiquitylated templates did not change. Interestingly, UHRF1 re-
cruitment from the treated extracts suffered some modifications. UHRF1 bound unmodified
chromatin and was recruited less to the H3K18/23ub2 template. Usp7 was recruited in
higher amounts to the H3K23ub and the H3K18/23ub2 templates. Neither the SAH nor the
UVS treatment of the nuclear extracts resulted in clear inhibition of H3 deubiquitylation.
SCML2 and UHRF1 are sensitive to the removal of nuclear RNA
SCML2 has previously been shown to have the ability to bind RNA, a property which was
thought to play an essential role in its chromatin targeting [100]. To address if SCML2
recruitment to chromatin may be mediated by RNA, the nuclear extract was treated with
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ribonucleas A (RNase A) prior to the chromatin affinity purification (Figure 3.19). While
SCML2 recruitment decreased after RNase treatment, so did the recruitment of DNMT1
and to a lesser extent that of Usp7. Interestingly, UHRF1 revocery on the H3K23ub and
H3K18/23ub2 chromatin templates was also affected by the RNase treatment. Deubiquity-
lation proceeded slower in the H3K18ub and H3K18/23ub2 samples in comparison to the
untreated controls. This observation correlated with the decreased recruitment of DNMT1,
Usp7 and SCML2 onto these templates.
The treatments applied to the nuclear extract did not provide clear answers with respect to
the order of recruitment of the different factors. However, the recovery of SCML2 in the
SAH treatment experiment and the recovery of SCML2 and UHRF1 in the RNase treatment
experiment were affected by the induced perturbations. This suggests that their recruitment
and the release to and from the modified chromatin may be also regulated by mechanisms
other than hierarchical protein-protein interactions.
3.3.2 Preparation of recombinant SCML2 truncations
To tackle the order of events on the H3 ubiquitylated chromatin from a different angle,
DNMT1, Usp7 and SCML2 were produced recombinantly. While the interaction between
DNMT1 and Ups7 is very well documented in the literature [92], the interaction between
Usp7 and SCML2, as suggested by the STRING association (Figure 3.16) needed further
biochemical characterisation [98].
Recombinant Usp7 was produced in insect cells and purified by affinity chromatography
using an N-terminal His-tag (Figure 3.20D). Recombinant SCML2 was produced in bacteria
or insect cells and purified by affinity chromatography using N-terminal GST- or His-tags
(Figure 3.20B, (Figure 3.20C)). Several SCML2 truncations were presented throughout the
thesis. To map the interaction between SCML2 and Usp7, several truncations were made
in SCML2 which included SCML2’s previously annotated domains: malignant brain tumor
domains (MBT), RNA-binding region (RBR), domain of unknown function (DUF) and sex
comb on midleg and polyhomeotic (SPM) (Figure 3.20A). With the exception of the bacterial
DUF domain deletion, recombinant proteins were prepared in high amounts and purity both
from the bacterial and the insect cell expression systems.
3.3.3 SCML2 recruits Usp7 to ubiquitylated chromatin arrays
RBR-DUF region connects SCML2 with Usp7
It has previously been shown that SCML2 interacts with Usp7 in vitro [98]. There the region
between the MBT and DUF domains of SCML2 was shown to bind to the tumor necrosis
facor receptor associated factor (TRAF) domain of Usp7. To better define the regions in
SCML2 responsible for its interaction with Usp7, GST-tagged full-length (FL) SCML2 or
SCML2 truncations were immobilised on a glutathione resin and FL His.Usp7 was added
to each mixture (Figure 3.21). Usp7 did not bind the affinity matrix by itself (Figure
3.21A). Usp7 did not bind the matrix when incubated with GST recombinant protein (Fig-
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ure 3.21C). FL SCML2 recovered Usp7 on the beads in 1:1 stoichiometry. None of the three
initial SCML2 truncations tested could lose Usp7 recovery on the GST beads (Figure 3.21A).
A similar experiment was performed using His-tagged SCML2 constructs which were ex-
pressed in insect cells. Instead of the glutathione affinity resin, an antibody specific for
SCML2’s C-terminus was used to co-immunoprecipitate SCML2 and Usp7 (Figure 3.21B).
The co-immunoprecipitation experiment suggested that the deletion of the DUF domain
resulted in a substoichiometric recovery of Usp7. The DUF domain was thus found to be
important, but insufficient for the full interaction between SCML2 and Usp7. Additional
interaction surfaces in SCML2 were responsible for its binding to Usp7.
Two additional SCML2 truncations were made, which separated the protein in two halves.
The first half contained the MBT domains and the RBR region (∆C) and the second half
contained the DUF and the SPM domains (∆N). GST affinity purification experiments
showed that both the ∆N and the ∆C truncations recruited substoichiometric amounts of
Figure 3.20: Purification of recombinant Usp7 and SCML2 proteins. (A) Schematic anno-
tation of the domains and regions present in Sex-comb on midleg-like 2 (SCML2). (B) Coomassie-
stained SDS-PAGE gel of affinity-purified full-length (FL) and truncated GST-SCML2 proteins
from bacterial overexpressions. (C) Coomassie-stained SDS-PAGE gel of affinity-purified FL and
truncated His-SCML2 proteins from insect cells infections. (D) Coomassie-stained SDS-PAGE gel
of affinity-purified FL His.Usp7 protein from insect cells infections. MBT = malignant brain tumor;
RBR = RNA-binding region; DUF = domain of unknown function; SPM = sex-comb on midleg
and polyhomeotic.
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Figure 3.21: Mapping of SCML2 interaction surface responsible for Usp7 binding. (A)
Coomassie-stained SDS-PAGE gel of GST affinity purifications of GST-tagged FL or truncated
SCML2 proteins with FL Usp7. (B) Coomassie-stained SDS-PAGE gel of co-immunoprecipitation
experiment using a commercial antibody against the C-terminus of SCML2 (sc271097) with FL
or truncated His.SCML2 proteins and FL Usp7. (C) Coomassie-stained SDS-PAGE gel of GST
affinity purification of free GST and GST-tagged FL SCML2 with FL Usp7. (D) GST-pull-downs
of additional SCML2 truncations with FL Usp7. (E) Coomassie-stained SDS-PAGE gel of GST
pull-downs of FL SCML2, SCML2 ∆RBR-DUF and GST.RBR-DUF constructs with FL Usp7.
Usp7 to the beads, indicating that there were interaction surfaces in both halves of the pro-
tein (Figure 3.21D). Knowing that the DUF domain was one of the contact points between
SCML2 and Usp7, the two domains connecting the two SCML2 halves, namely the RBR
region and the DUF domain, were truncated together. GST-SCML2 ∆RBR-DUF could not
bind Usp7, suggesting that SCML2 required both domains for a stable interaction with Usp7.
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Figure 3.22: Interaction of SCML2 with Usp7 and DNMT1. (A) Coomassie-stained
SDS-PAGE gel of GST affinity purifications of FL GST.SCML2 with FL His.Usp7 and/or FL
His.YFP.DNMT1. (B) Coomassie-stained SDS-PAGE gel of YFP affinity purifications of FL
His.YFP.DNMT1 with His Usp7 and or GST.SCML2.
To test if the RBR-DUF region was sufficient for the interaction between SCML2 and Usp7,
the fragment was produced recombinantly with a N-terminal GST tag. Using the previ-
ously described affinity purification strategy, FL SCML2 recovered stoichiometric amounts
of Usp7, His.SCML2 ∆RBR-DUF lost the interaction with Usp7 and GST.RBR-DUF recov-
ered the lost interaction fully (Figure 3.21E).
The STRING analysis of the three H3 ubiquitylated chromatin arrays pointed out that
SCML2 may be connected to DNMT1 through its association with Usp7. Two affinity
purification schemes were used to test this hypothesis (Figure 3.22). First, FL GST.SCML2
was incubated with FL Usp7, FL DNMT1 or both Usp7 and DNMT1 on the glutathione
resin. While SCML2 could not recruit DNMT1 when the two were incubated together, it
did so, even though in a substoichiometric manner, in the presence of Usp7 (Figure 3.22A).
In the reverse experiment, YFP-DNMT1 was incubated with FL SCML2, FL Usp7 or both
SCML2 and Usp7 on a GFP-trap affinity matrix. While DNMT1 could not recruit SCML2
on its own, it did so in the presence of Usp7 (Figure 3.22B). SCML2, Usp7 and DNMT1
could be recovered together on beads but in substoichiometric amounts.
RBR region links SCML2 to mononucleosomes
The RBR domain of SCML2 was shown to bind RNA, a mononucleosome and a ternary
complex containing both RNA and mononucleosome [100]. In parallel, the DUF domain of
SCML2 was also shown to bind dsDNA, irrespective of its methylation status [101].
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Figure 3.23: The RBR region links SCML2 to nucleosomes. (A) EtBr-stained native
agarose gel documenting the interaction between an undersaturated 200 bp nucleosome and FL as
well truncated His-tagged SCML2 constructs. FL Usp7 was added in alternate reactions. (B) EtBr-
stained native agarose gel of a 145 bp DNA construct incubated with FL or truncated His.SCML2.
To understand which of the two domains was important for SCML2 chromatin targeting,
we used the His.SCML2 truncations produced for the Usp7 interaction experiments in na-
tive gel shift assays (Figure 3.23A). Unsaturated 200 bp mononucleosomes were incubated
with different SCML2 constructs in the presence or absence of Usp7. All SCML2 constructs
bound the mononucleosome as indicated by their corresponding shifts in the native agarose
gel, with the exception of SCML2∆RBR. The addition of Usp7 did not produce noticeable
supershifts, although the resolution of the native agarose might not have been optimal to
separate that interaction.
Since SCML2 has the ability to bind not only mononucleosomes, but also dsDNA, the differ-
ent SCML2 truncations were incubated in increasing concentration to DNA of 145 bp (Figure
3.23B). All SCML2 constructs, with the exception of SCML2∆RBR, bound the DNA and
shifted it. This pointed out that the SCML2 interaction with the nucleosomes might have
been mediated by the linker DNA or by the DNA wrapped around the histone octamer core.
If the FL SCML2 and SCML2∆MBT and SCML2∆DUF constructs bound the DNA in reg-
ular steps (the equivalent of 150 bp), the SCML2 construct lacking SPM bound the DNA
at twice that interval. Likely, several SCML2 molecules bound the same DNA template.
However it might be possible that one SCML2 protein bound two DNA molecules at once.
SCML2 binds nucleosomal DNA. To test if SCML2 prefers mononucleosomes with linker
over linker-less nucleosome core particles, unmodified nucleosomes were reconstituted on 145
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Figure 3.24: SCML2 binding to mononucleosomes is affected by linker DNA. (A) EtBr-
stained native agarose gel of nucleosomes assembled on DNA templates of 145, 171 and 187 bp
which were incubated with increasing amounts of FL SCML2. (B) EtBr-stained native agarose gel
of unmodified or H2A mutant (H2A E61A/E64A) nucleosomes incubated with FL SCML2.
bp, 171 bp and 187 bp DNA templates. The 171 bp DNA is an asymmetric template, with
16 bp of linker DNA present downstream of the core positioning sequence. The 187 bp
DNA is a symmetric template, with linker DNA present on both sides of the nucleosome.
Increasing amounts of SCML2 were incubated with the unmodified nucleosome templates to
obtain full saturation (Figure 3.24A). SCML2 bound all nucleosome templates, with a slight
preference for the asymmetric 171 bp construct. Interestingly, while SCML2 bound to the
nucleosome with linker DNA in the equivalent of 300 bp steps, the 145 bp nucleosome was
shifted to twice that distance in the presence of SCML2. Bearing in mind the observation
that SCML2∆SPM bound free DNA at intervals twice as large as the FL protein, it could
be that the linker DNA might be needed for the SPM domain to induce a conformational
change in the full-length protein that allowed two interaction surfaces from within the RBR
domain to contact the nucleosome core.
SCML2 binds nucleosomes in the absence of linker DNA. To test if SCML2 binds on the
nucleosome core, two mutations were prepared in the nucleosome acidic patch. 145 bp
nucleosome core particles were reconstituted with unmodified or H2A mutant octamers which
were previously shown to deter binding of proteins to the nucleosome [72]. SCML2 was able
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to bind a 145 bp nucleosome core particle with a mutated acidic patch (Figure 3.24B), .
Both the unmodified and the mutant nucleosome core particles were shifted at twice the
distance observed with the 171 bp and 187 bp constructs.
SCML2 and DNMT1 recruit Usp7 to unmodified chromatin
Whilst FL SCML2 has the ability to bind nucleosomes, Usp7 does not (Figure 3.23A).
SCML2 interacts in 1:1 stoichiometry with Usp7 and may be able through this interaction to
recruit Usp7 to nucleosomes or to nucleosomal arrays. Chromatin affinity purification assays
were performed on unmodified chromatin using recombinant FL Usp7 and FL SCML2 as well
as all previously described truncations used to map the interaction between the two proteins
(Figure 3.25A). By itself, Usp7 could not bind nucleosomal arrays. FL SCML2 could recover
Usp7 to chromatin in 1:1 stoichiometry. Deletion of the MBT, preSPM or the SPM domains
had no effect on the equimolar recovery of SCML2 and Usp7 to chromatin. SCML2∆RBR
was shown not to be able to bind free DNA or interact with nucleosomes (Figure 3.23A,
Figure 3.23B). In consequence, removal of the RBR domain resulted in the loss of SCML2
and Usp7 binding to nucleosomal arrays. Additionally, SCML2∆C and SCML2∆RBR-DUF,
which lacked the RBR domain, could not bind to the nucleosomal arrays and were not able
to recruit Usp7 to chromatin. Interestingly, the SCML2∆C truncation, which bound nucleo-
somal arrays, showed a severe loss of Usp7-mediated recruitment, pointing out the necessity
of a continuous RBR-DUF surface for stable interaction between SCML2 and Usp7. To
verify if the RBR-DUF region was sufficient for SCML2-mediated Usp7 chromatin target-
ing, FL SCML2, SCML2∆RBR-DUF and GST.RBR-DUF constructs were used in similar
chromatin pull-down experiments with FL Usp7 (Figure 3.25B). GST.RBR-DUF rescued
the Usp7 recruitment lost with the SCML2∆RBR-DUF truncation.
SCML2 interacts with Usp7 in 1:1 stoichiometry and can recruit it to chromatin. DNMT1
has the ability to bind both nucleic acid and interact with Usp7 (Figure 3.22B). To test
if DNMT1 can target Usp7 to chromatin, chromatin pull-downs were performed as before
with FL recombinant SCML2 and Usp7 or FL DNMT1 and FL Usp7 (Figure 3.26A). Usp7
could not by itself bind the nucleosomal arrays, but when incubated with either SCML2 or
DNMT1 it was recruited in 1:1 stoichiometry to chromatin. Interestingly, when incubated
with both SCML2 and DNMT1, Usp7 mananged to stabilise an equimolar trimeric complex
on the unmodified chromatin, which was not the case when the recombinant proteins were
mixed in the absence of chromatin (Figure 3.22). To test if the observed complex was a stable
trimeric interaction or a mixture of two distinct complexes, where Usp7 is recruited to chro-
matin separately by SCML2 or DNMT1, increasing amounts of SCML2 were titrated into
a 1:1 Usp7:DNMT1 complex on unmodified chromatin (Figure 3.26B). Addition of SCML2
recovered more Usp7 on the chromatin, but the effect was not controlled by the SCML2
concentration, but rather by the availability of DNMT1. Excess SCML2 bound chromatin
separate of Usp7 and DNMT1 with formation of SCML2 homodimers. The reverse experi-
ment, in which increasing amounts of DNMT1 were titrated into an equimolar SCML2:Usp7
complex on unmodified chromatin, pointed out that excess DNMT1 also bound chromatin
separate of the other two recombinant factors (Figure 3.26C). We deduced that SCML2,
Usp7 and DNMT1 formed a stable trimeric complex on unmodified nucleosomal arrays.
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Figure 3.25: SCML2 recruits Usp7 to chromatin (A) Coomassie-stained SDS-PAGE gel of
chromatin affinity purifications using biotinylated unmodified nucleosome arrays with GST.SCML2,
His.Usp7 and complete series of His.SCML2 truncations. (B) Coomassie-stained SDS-PAge of
chromatin affinity purifications using biotinylated unmodified nucleosome arrays with GST.SCML2,
His.Usp7 and FL or ∆RBR-DUF or GST.RBR-DUF constructs.
SCML2 and DNMT1 recruit Usp7 to H3 ubiquitylated chromatin
Recombinant SCML2, Usp7 and DNMT1 form a stable complex on unmodified chromatin
(Figure 3.26). The initial chromatin affinity enrichment protocols indicated however that
SCML2, Usp7 and DNMT1 were enriched on H3 ubiquitylated over unmodified chromatin
arrays in both the mass spectrometry and the western blot analyses (Figure 3.15; Figure
3.17C).
To address if SCML2, DNMT1 and Usp7 are recruited specifically to ubiquitylated chro-
matin, the recombinant proteins were incubated alone or in various combinations with six
different types of chromatin arrays. These included unmofidied, H2Amt, ubiquitylated
H3K18ub, H3K23ub and H3K18/23ub2 as well as H3K23ub H2Amt chromatin templates
(Figure 3.27). SCML2 bound all six chromatin templates, with decreased recovery on the
two H2A mutant matrices (Figure 3.27A). Usp7 was not able to form stable interactions with
any chromatin templates and was not recruited by any of the templates. Usp7 may have
transiently bound the modified chromatin templates as these underwent partial deubiqui-
tylation during incubation with the protease (Figure 3.27B). DNMT1 bound all chromatin
templates, with decreased recovery on the H2A mutant, but strong enrichment on all ubiq-
uitylated templates. DNMT1 was enriched strongest on the doubly modified H3K18/23ub2
chromatin, then on the H3K18ub and then on the H3K23ub templates (Figure 3.27C). When
incubated together with SCML2, Usp7 was recovered on all chromatin templates. There was
no preference for the Usp7:SCML2 complex for one or the other matrix. In the presence of
SCML2, Usp7 deubiquitylated all modified chromatin arrays to completion (Figure 3.27D).
In the presence of DNMT1, Usp7 was recovered on all chromatin arrays. Both recombinant
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Figure 3.26: SCML2 and DNMT1 recruit Usp7 to chromatin. (A) Coomassie-stained
SDS-PAGE gel of chromatin affinity purifications using biotinylated unmodified nucleosome ar-
rays and GST.SCML2, His.Usp7 and His.YFP.DNMT1. (B) Coomassie-stained SDS-PAGE gel of
chromatin affinity purifications using unmodified nucleosome arrays with stoichiometric His.Usp7
and His.YFP.DNMT1 and increasing concentraitons of His.SCML2. (C) Coomassie-stained SDS-
PAGE gel of chromatin affinity purifications using unmodified nucleosome arrays with stoichiomet-
ric His.Usp7 and His.SCML2, but increasing concentraitons of His.YFP.DNMT1.
proteins show decreased recruitment to the H2A mutant template and increased binding
to the H3K18/23ub2 matrix. DNMT1 did not influence Usp7’s deubiquitylation activity
(Figure 3.27E). When incubated together, DNMT1, Usp7 and SCML2 were all recovered on
the six chromatin arrays. There was no clear preference for ubiquitylated versus unmodified
chromatin templates, though all recombinant proteins were recruited less to the acidic patch
mutant. Within the given experimental conditions, in the presence of DNMT1, SCML2
could not stimulate Usp7’s deubiquitylation function (Figure 3.27F).
SCML2’s interaction with Usp7 proved important in targeting Usp7 to H3 ubiquitylated
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chromatin. Interestingly, SCML2 stimulated Usp7’s deubiquitylation function and this ef-
fect was lost when DNMT1 was also present in the reaction mixture. To better understand
how the SCML2 activation was brought about, several SCML2 truncations were incubated
with FL Usp7 on ubiquitylated chromatin in affinity purification experiments (Figure 3.28).
Removal of the RBR domain was shown before to lose SCM2 binding to DNA, mononucleo-
some and unmodified chromatin arrays (Figure 3.23, Figure 3.25). SCML2 ∆RBR could not
bind any ubiquitylated template and could not target Usp7 to chromatin. All ubiquitylated
arrays remained unchanged after incubation with the Usp7 protease (Figure 3.28A). Removal
of the DUF domain was shown to be important for contacting Usp7 and for targeting it to
unmodified nucleosomal arrays (Figure 3.23, Figure 3.25). SCML2 ∆DUF targeted Usp7 to
ubiquitylated chromatin arrays in substoichiometric amounts, but this targeting was suffi-
cient to activate the enzyme which deubiquitylated all of the H3K18ub and H3K18/23ub2
and parts of the H3K23ub templates. This suggested that the removal of the H3K18ub mark
may have been more prone than that of H3K23ub (Figure 3.28B).
Deletion of the entire RBR-DUF region was previously shown to lose both the interaction
between SCML2 and Usp7 and SCML2’s chromatin binding completely (Figure 3.21E, Fig-
ure 3.25A). During incubation of SCML2∆RBR-DUF with Usp7 on the ubiquitylated chro-
matin arrays, no stable interaction could be preserved and none of the two proteins could
be recovered from the beads (Figure 3.28C). Also, the modified nuclesomal arrays suffered
marginal deubiquitylation. Upon incubation with GST.RBR-DUF chromatin targeting to
the modified nucleosomal arrays of Usp7 was restored. All modified templates were com-
pletely deubiquitylated. Recovery of GST.RBR-DUF and Usp7 was considerably lower on
the H2A mt chromatin arrays, suggesting that additional domains in SCML2 may have been
important for SCML2 stabilisation on a mutated nucleosomal surface (Figure 3.28D).
It has previously been reported that SCML2 binds to the TRAF domain of Usp7. To test
if this interaction is also relevant in the context of H3 deubiquitylation, chromatin affinity
purification experiments were performed with FL SCML2 and Usp7∆TRAF. Deletion of the
TRAF domain resulted in the loss of SCML2-mediated recruitment of Usp7 to any of the
six chromatin arrays. As a result, the enzyme was unable to catalyse the deubiquitylation
reactions (Figure 3.28E).
Together, the chromatin affinity pull-down experiments performed with recombinant proteins
showed that SCML2 stimulated Usp7 deubiquitylation by interacting with the enzyme and
targeting it to chromatin.
3.3.4 SCML2 stimulates Usp7 on H3 ubiquitylated chromatin
To better understand the mechanism of SCML2-induced activation of Usp7 function, the
chromatin pull-down experiments presented above were complememnted with a series of
deubiquitylation experimetns performed on various substrates ranging from free histones to
assembled chromatin arrays.
To test the degree of SCML2-induced Usp7 stimulation, several substrates, including H3K18ub
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Figure 3.27: SCML2 and DNMT1 recruit Usp7 to H3 ubiquitylated chromatin
templates. Coomassie-stained SDS-PAGE gels of chromatin affinity purifications document-
ing the interaction of SCML2, Usp7 and DNMT1 with ubiquitylated chromatin arrays. Bi-
otinylated nucleosomal arrays containing unmodified, H2Amt, H3K18ub, H3K23ub, H3K23ub
H2Amt and H3K18/23ub2 histones were incubated with recombinant His.SCML2 (A), His.Usp7
(B), His.YFP.DNMT1 (C), His.Usp7 and His.SCML2 (D), His.Usp7 and His.DNMT1 (E) and
His.SCML2 and His.Usp7 and His.DNMT1 (F).
histone, mononucleosomes and chromatin arrays were incubated with constant amounts of
Usp7 and increasing amounts of SCML2 (Figure 3.29A). Usp7 stimulation was observed in
the case of the mononucleosome assembled on the symmetric 187 bp DNA template and in
the case of the nucleosomal array. Interestingly, SCML2 could not stimulate Usp7 function
when H3K18ub histone was used as a substrate.
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Figure 3.28: SCML2 stimulates Usp7 by targeting it to chromatin. Coomassie-stained
SDS-PAGE gels of chromatin affinity purifications documenting SCML’2 stimulation of Usp7 deu-
biquitylation activity. Biotinylated nucleosomal arrays containing unmodified, H2Amt, H3K18ub,
H3K23ub, H3K23ub H2Amt and H3K18/23ub2 histones and FL His.Usp7 were incubated with
recombinant His.SCML2 ∆RBR (A), His.SCML2 ∆DUF (B), His.SCML2 ∆RBR-DUF (C), FL
His.Usp7 with GST.RBR-DUF (D) and His.Usp7 ∆TRAF with FL His.SCML2 (E).
SCML2 may activate Usp7 by inducing a conformational change in the enzyme upon binding
to its TRAF domain. Since direct stimulation on the histone substrate was not achieved by
SCML2, linker DNA, as a constituent of nucleosomes but not of free histones was added to
the deubiquitylation reaction. Free DNA (unmodified and fully methylated at CpG dinu-
cleotide sites) was used to induce a conformational change in SCML2, which in turn might
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Figure 3.29: SCML2 requires a nucleosome containing linker DNA for stimulation of
Usp7. Coomassie-stained SDS-PAGE gels documenting deubiquitylation reactions. (A) Constant
Usp7 and increasing amounts of FL His.SCML2 were used to deubiquitylate H3K18ub histone, 187
bp mononucleosome or chromatin substrates. (B) H3K18ub histone deubiquitylation reaction in
the presence of constant Usp7 with stoichiometric unmethylated or methylated DNA and increasing
amounts of FL His.SCML2. Deubiquitylation experiments performed with constant FL Usp7 and
increasing amounts of SCML2 on H3K18ub 147 bp mononucleosome (C), 187 bp mononucleosome
(D) and chromatin (E) substrates.
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Figure 3.30: DNMT1 inhibits SCML2’s stimulation of Usp7 deubiquitylation function.
Coomassie-stained SDS-PAGE gels documenting chromatin deubiquitylation reactions. Constant
Usp7 and increasing amounts of FL His.SCML2 (A), His.SCML2 RBR-DUF (B), GST.RBR-DUF
(C) and FL DNMT1 were used to convert H3K18ub chromatin to H3 and free ubiquitin (D).
(E) Chromatin deubiquitylation reactions with constant Usp7 and overstoichioemtric DNMT1 in
the presence of increasing amounts of FL His.SCML2. (E) Chromatin deubiquitylation reactions
with constant Usp7 and constant understoichiometric FL His.SCML2 in the presence of increasing
amounts of FL DNMT1.
have activated Usp7 (Figure 3.29A). Surprisingly, addition of DNA to the deubiquitylation
reaction did not stimulate Usp7 function, but completely blocked the enzyme’s activity. Even
at high SCML2 molar excess (which should have buffered the DNA), the enzyme remained
largely inactive. Arguably, DNA directly inhibited Usp7 enzyme.
Free DNA was able to inhibit Usp7 function. This set the posibility that unprotected linker
DNA within a chromatin array may also inhibit Usp7. To address this, linker-less 147 bp
nucleosome, symmetric linker 187 bp nucleosomes and chromatin arrays were subjected to
deubiquitylation reactions in the presence of increasing SCML2 concentrations. Even though
SCML2 bound all templates, it could only stimulate Usp7 activity on the nucleosome with
linker DNA and on the chromatin array (Figure 3.29D, Figure 3.29E). It could be that
SCML2 needed to bind the linker DNA to activate Usp7’s function. By doing so, SCML2
89
Figure 3.31: DNMT1 does not hinder Usp7 function by binding the ubiquitylation
mark Coomassie-stained SDS-PAGE gels documenting chromatin deubiquitylation reactions. (A)
Constant Usp7 and DNMT1 (A) or GST.RFTS (B) were added to the deubiquitylation reaction
in the presence of increasing amounts of FL His.SCML2.. Chromatin deubiquitylation reactions
with constant Usp7 and increasing amounts of DNMT1∆UIM (C) and DNMT1∆RFTS (D). UIM
= ubiquitin interaction motif; RFTS = replication foci targeting sequence.
might have performed two tasks: it underwent an activating conformational change and
buffered the free DNA from inhibiting the Usp7 enzyme.
Deletion of the RBR-DUF region was shown to be essential for Usp7 binding and its recruit-
ment to ubiquitylated chromatin. SCML2 could not stimulate Usp7 activity when missing
the RBR-DUF region (Figure 3.30B). Incubation of Usp7 with recombinant RBR-DUF res-
cued this function, showing that the two domains contained all the necessary information
for stimulation of the deubiquitylating enzyme in chromatin context (Figure 3.30C).
DNMT1 binds Usp7 and recruits it to chromatin, but it does not stimulate its deubiquityla-
tion function. When incubated with Usp7 and SCML2, DNMT1 inhibited the stimulatory ef-
fect of SCML2 (Figure 3.27). On experiments performed on unmodified chromatin, DNMT1
and SCML2 formed a stable trimeric complex with Usp7 (Figure 3.26). The trimeric complex
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could be static in that all proteins are locked in immobile conformations, but also dynamic
where Usp7 might be able to transition from a DNMT1-bound to a SCML2-bound conforma-
tion. In the later case, an increased local concentration of either DNMT1 or SCML2 would
shift the Usp7 conformational equilibrium. To test that hypothesis, Usp7 was incubated with
overstoichiometric DNMT1 concentrations on H3K18ub chromatin arrays and SCML2 was
titrated over a wide range of concentrations. While at low SCML2 concentrations, DNMT1
prevented SCML2’s stimulatory effect of Usp7 function (Figure 3.30A), at higher SCML2
concentrations, there was an increased deubiquitylation activity. In the reverse experiment,
SCML2 was kept at understoichiometric amounts with respect to Usp7 and DNMT1 was
added in increasing amounts to the deubiquitylation reaction. Less deubiquitylation was ob-
served as increasing amounts of DNMT1 were being titrated in the reaction. Likely, DNMT1
inhibits the SCML2 stimulation of Usp7’s deubiquiylation activity.
Whilst the observed inhibition of SCML2 by DNMT1 may be explained by Usp7’s promis-
cuous behaviour, it could also be that DNMT1, which directly binds H3K18ub [37], protects
the mark from deubiquitylation. To test this hypothesis, FL DNMT1 or the replication foci
targeting sequence (RFTS) domain, responsible for H3ub binding, were titrated into deu-
biquitylation reactions in the presence of SCML2 (Figure 3.31A, Figure 3.31B). While there
was some inhibition of SCML2 stimulation in the reactions where the recombinant RFTS
domain was added, the effect was not as pronounced as in the reaction where FL DNMT1
was added. To test this hypothesis further, the RFTS domain and the ubiquitin interaction
motif (UIM) within RFTS were removed from DNMT1. The deletion constructs were used
in deubiquitylation reactions (Figure 3.30C, Figure 3.30D). Neither the RFTS nor the UIM
deletions could stimulate Usp7 activity on H3K18ub nucleosomal arrays, suggesting that
blocking or protection of the H3ub mark was not the mechanism by which DNMT1 failed to
activate Usp7 or inhibit the SCML2 stimulatory effect.
3.3.5 SCML2 positions Usp7 at the N-terminus of histone H3
To better understand how SCML2 activates Usp7 on chromatin, crosslinking mass spec-
trometry analysis was performed (Figure 3.32). Recombinant FL His.Usp7 and recombinant
GST.RBR-DUF were incubated with unmodified chromatin on streptavidin beads. Excess
His.Usp7 and RBR-DUF were removed during the chromatin pull-down. The GST.RBR-
DUF construct was prefered over FL SCML2 to avoid SPM-mediated multimerisation of
SCML2 during protein-protein crosslinking (Figure 3.26B) [106]. GST.RBR-DUF was shown
to be necessary and sufficient for SCML2’s interaction with Usp7, for SCML2 and Usp7 chro-
matin targeting and for SCML2 stimulation of Usp7 deubiquitylation activity (Figure 3.21E,
Figure 3.30C, Figure 3.28D). Stable as well as transient interactions between GST.RBR-
DUF, FL His.Usp7 and the histones making up the unmodified chromatin were covalently
linked at the end of the affinity purification experiment. The crosslinker used was BS3, a
homobyfunctional crosslinker with a spacer of 11.4 A˚ that links lysine residues found in close
proximity to each other.
Besides the known interaction with the TRAF domain of Usp7 (Figure 3.28F) [98], RBR-
DUF formed several crosslinks with the ubiquitin like domains UBL1, UBL2, UBL3, UBL4
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and UBL5 (Figure 3.32A). Most crosslinks originated from the RBR region and contacted
the UBL2-3 domains. The RBR region also contacted the nucleosome at the N-termini of
histones H2B, H3 and H4. The Usp7 catalytic domain contacted the nucleosome on the
N-terminal tail of histone H3 (residues K15 and K37) and the C-terminal tail of histone
H4. Additional contacts were detected between UBL4-5 domains and the N-terminus of
histone H2B. The extreme C-terminus of Usp7 formed intramolecular crosslinks with Usp7’s
catalytic domain and the UBL1 domain, in what was previously shown to constitute an ac-
tivating conformational change [70]. GST.RBR-DUF recruited Usp7 to the nucleosome and
positioned it in the right orientation to mount a subsequent deubiquitylation attack onto the
N-terminal tail of histone H3 (Figure 3.32B).
Previously, it was shown that ubiquitin specific protease adaptors bind the nucleosome at its
acidic patch [72]. In the crosslinking mass spectrometry experiment, GST.RBR-DUF bound
the nucleosome around the DNA gyres proximal to the N-terminus of histone H3. Only two
crosslinking sites (H2BK112; H3K56) were found proximal to the nucleosomal acidic patch.
As suggested before, SCML2 may bind the nucleosome on two distinct surfaces. (Figure
3.17, Figure 3.24A, Figure 3.27A, Figure 3.28D).
The known interation between SCML2 and the TRAF domain of Usp7 was only indicated by
two crosslinks (Figure 3.32A), one to the RBR domain, one to the DUF domain. Arguably,
this was a consequence of the tight interaction between RBR-DUF and TRAF, which created
a solvent-inaccesible interface. GST.RBR-DUF’s crosslinking sites on Usp7 mapped primar-
ily to the UBL1-5 domains (Figure 3.32C). Surprisingly, the crosslinking sites coincided with
known interaction surfaces between Usp7 and the polybasic region (PBR) of UHRF1 and
between Usp7 and the bromo-adjacent homology (BAH) domains of DNMT1 (Figure 3.32D,
Figure 3.32E) [91], [92].
The crosslinking mass spectrometry experiments suggested the formation of a cross-talk or
competition between DNMT1, SCML2 (and UHRF1) for interaction with the UBL1-2-3 do-
mains of Usp7. Previously, we showed that DNMT1 inhibits SCML2 stimulation of Usp7
(Figure 3.30, Figure 3.31). During the deubiquitylation experiment, Usp7 likely switched
between the DNMT1-bound state and the SCML2-bound state which caused conformational
changes with functional implications in the enzyme. SCML2 may be needed on the H3ub
chromatin to lower the activation energy for the Usp7-catalysed deubiquitylation reaction,
to foster the recycling of the H3ub-bound DNMT1. To test this hypothesis, di-ubiquitylated
chromatin arrays were preincubated to saturation with recombinant DNMT1 and then sub-
jected to deubiquitylation in the presence or absence of GST.RBR-DUF over a time course
of four hours (Figure 3.33). After chromatin afinity purification, Usp7 partially converted
the H3ub2 mark to H3ub1 and decreased marginally the DNMT1 concentration on the
chromatin array. In the presence of excess GST.RBR-DUF, more Usp7 was recruited to
chromatin which resulted in more conversion of H3ub2 to H3ub1 and free H3 and less recov-
ery of DNMT1 on the biotinylated arrays. This finding is in agreement with the hypothesis
that SCML2 is needed for recycling of DNMT1 by facilitating the removal of the H3ub mark
from chromatin arrays.
92
93
Figure 3.32 (preceding page): SCML2 adapts Usp7 to H3ub chromatin. (A) Crosslinking
mass spectrometry analysis of Usp7 and GST.RBR-DUF on unmodified chromatin arrays. Inter-
molecular crosslinks are depicted with straight lines. Intramolecular crosslinks are depicted as
curves. SCML2 crosslinks to the nuclesome or to Usp7 are colored in cyan. Usp7 crosslinks to the
nucleosome are colored in green. (B) Representation of the observed crosslinks on the nucleosome
and Usp7 crystal structures. SCML2 crosslinked sites on Usp7 and on the nucleosome are high-
lighted as cyan spheres. The SCML2 crosslinks on the nuclesome are displayed for each of the two
copies of H2B, H3 and H4. Usp7 crosslinks on the nucleosome and nucleosome crosslinks on Usp7
are highlighted as green spheres. The interaction between the catalytic domain and the H3 tail
is represented by straight green lines. Usp7 catalytic centre is depicted in yellow. (C) Represen-
tation of SCML2 crosslinks on the UBL1-2-3-4-5 crystal structure. (D) SCML2 crosslinks on the
UBL1-2-3 domains coincide with the interaction surface occupied by the UHRF1’s PBR peptide.
(E) SCML2 crosslinks on the UBL1-2-3-4-5 coincide with both of DNMT1’s binding surfaces onto
Usp7. Structural information was obtained from crystal structures with PDB accession numbers
1KX5 (mononucleosome), 5FWI (Usp7 CD and UBL1-2-3), 5C6D (Usp7 UBL1-2-3 with UHRF1
PBR) and 4YOC (Usp7 UBL1-2-3-4-5 with DNMT1) [191], [192], [91], [92].
Figure 3.33: SCML2 controls DNMT1 residence time on H3 ubiquitylated chromatin.
Coomassie-stained SDS-PAGE gel of a time-course chromatin pull-down experiment with pre-
incubated FL DNMT1 in the presence of equimolar FL Usp7 or equimolar FL Usp7 and over-
stoichiometric GST.RBR-DUF. Samples were collected 1, 2 and 4 h after addition of Usp7 or Usp7
and GST.RBR-DUF.
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Chapter 4
Discussion
4.1 Histone ubiquitylation confers chromatin unique
properties
We hypothesised that ubiquitylation of histones creates distinct chromatin environments
which differ from unmodified environments in the nuclear proteins and protein complexes
which are attracted to them. To address this hypothesis, site-specifically ubiquitylated hi-
stones were incorporated in chromatin arrays which were used in affinity purification ex-
periments to map the nuclear interactomes associated with them. The interactomes of all
modified chromatin templates differered from the control chromatin and the interactomes of
all modified chromatin templates differed between themselves. This suggests that ubiquityla-
tion of histones confers different properties to the underlying conjugation sites which specify
these for unique downstream processes. We propose that the readout of the different histone
ubiquitylation marks coroborates with parallel chemical and physical changes on chromatin
and on the associated interactors to create unique signalling hierarchies which translate into
specific biological functions.
4.1.1 ChAP-MS highlights the requirements for histone ubiquity-
lation readout
Recognition of ubiquitin conjugation to target proteins occurs through dedicated reader
proteins, which contain specialised ubiquitin binding domains (UBDs). Based on their ar-
chitectural features, UBDs are divided into two main groups [64]. The first group of domains
consists of alpha-helices and includes the elongated single helix of the ubiquitin interaction
motif (UIM), the three-helix bundle of ubiquitin associated domain (UBA), coupling of ubiq-
uitin to ER degradation (CUE) and GGA and TOM1 (GAT) as well as the eight-helix fold
of Vps, HRF and STAM (VHS). The second group of ubiquitin binding domains consists of
folded beta-strands and includes the four-stranded antiparallel beta-sheet of Npl4 Zn Finger
(NZF) and the beta-propeller of tryptophan aspartate 40 (WD40). We suggest that, for
correct recognition of ubiquitylated histones, the reader must contain a dedicated ubiqui-
tin binding domain which contacts ubiquitin, but also several distinguishing features of the
nucleosome core particle.
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The chromatin affinity purification experiments presented in this thesis found a large num-
ber of proteins which associated with the different histone ubiquitylation marks (Table 3.3).
To date, only a limited number of these proteins have been structurally described to the
extent that their respective ubiquitin binding domains are well annotated. This is the case
of Rad18, Rnf169 and DNMT1, where recognition is achieved by specialised UIMs [68], [37].
An intersection of all UBDs known to date with a database containing all annotated protein
domains within the identified interactors yielded a few additional proteins which may have
the ability to bind ubiquitin. This is the case of PLAA, DCAF7 and TBL1XR1, which
contain WD40 domains, and the case of Usp3, ZMYNDB, Znf592, ZnF609, ZnF687, which
contain Zn fingers.
We have shown that ubiquitin is interpreted differently by the nuclear proteome when it is
incorporated on a histone protein than when it is part of a mononucleosome or chromatin
array. Neither the RNA polymerase nor the integrator complex could be recruited on the
H2BK120ub histone, but they were both enriched on ubiquitylated mononucleosomes or ubiq-
uitylated chromatin arrays (Figure 3.13). None of the proteins enriched on the H2BK34ub
chromatin array were previously found on the H2BK34ub histone template (Figure 3.14).
Neither Usp7 nor SCML2 was recruited to any of the H3 ubiquitylated histones, but they
were both enriched onto all of the H3 ubiquitylated chromatin arrays (Figure 3.17B, Figure
3.17C, Figure 3.14). The additional features present on the more complex templates allows
for the formation of more specific and more stable interaction surfaces where both dedicated
UIMs and adaptor proteins are likely to play a role.
We found that each histone ubiquitylation mark generally recruited a distinct set of pro-
teins (Table 3.3). When confronting the literature, there were some notable exceptions to
this observation. We showed that DNMT1 was enriched on three H3 ubiquitylation tem-
plates (Figure 3.17C, Figure 3.15). In the literature, DNMT1 also appeared enriched on
H2AK119ub mononucleosomes [74]. We showed that Rad18 and RNF169 were enriched on
the H2BK120ub mononucleosome and chromatin templates (Figure 3.13C, Figure 3.13E).
In the literature, both Rad18 and RNF169 have been associated with the DNA-damage re-
sponse H2AK13/15ub mark [68]. We reported that Usp7 was found enriched on the H3ub
chromatin arrays. In the literature Usp7 was previously shown to control the ubiquitylation
levels of both H2BK120ub and H2AK119ub [96], [98], [193]. We reported that Usp7 can also
deubiquitylate H3K18/23ub chromatin (Figure 3.29).
DNMT1, Rad18 and RNF169 have specialised ubiquitin interaction motifs (Figure 1.3) [68],
[37]. This allows them to directly recognise ubiquitin embedded in a nucleosomal context.
Binding of DNMT1 to both H2AK119ub and H3K14/18/23ub may be a consequence of the
topological proximity of the flexible H3 and H2A N- and C-terminal tails at the nucleosomal
dyad axis. Similarly, both Rad18 and RNF 169 exchanged H2AK13/15ub for H2BK120ub
arguably because of their spatial proximity at the DNA gyres with superhelical location SHL
+4 and SHL -5. Finally, for Usp7 to discriminate between H2AK119ub, H2BK120ub and
H3K14/18/23ub, its targeting depends largely on ubiquitin readers (DNMT1) or adaptor
proteins: GMPS for H2BK120ub and SCML2 for H3K18/23ub (Figure 3.25, Figure 3.32)
[96], [95].
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4.1.2 The histone ubiquitylation interactomes reveal complex sig-
nalling events
Only a small number of the proteins that were found in the different mass spectrometry
analyses contain ubiquitin binding domains or ubiquitin interaction motifs. Similarly, few
interactors are involved directly in the metabolism of the histone ubiquitylation marks. We
argue that several intermolecular interactions, biochemical reactions and structural changes
occur in parallel to the histone ubiquitylation readout process and that these may account
for the enrichment of the remaining interacting proteins.
First, most proteins identified in the mass spectrometry analysis are part of annotated pro-
tein complexes. As such, readout of the ubiquitylated histone is expected to occur through
one dedicated subunit which recruits the remaining complex to the marked site. By ex-
tension, some proteins and protein complexes are only recruited to the modified chromatin
as part of secondary binding events. The interaction between the RNA polymerase II and
the NELF and DSIF complexes, which are involved in transcription elongation, as well
as the association of the polymerase with ERCC1/ERCC4/SLX4, which are part of the nu-
cleotide excision repair machinery, are well documented in the literature (Figure 3.13, Figure
3.16C) [194], [195]. Recruitment of the transcription elongation factors or of the DNA repair
machinery may not have been observed in the absence of the RNA Polymerase II.
Second, since the nuclear extract contains not only proteins and nucleic acid molecules,
but also a limited yet complete set of small soluble cofactors, several biochemical reactions
may occur on the ubiquitylated chromatin templates during incubation with the nuclear
extract. These reactions may affect the chemistry of the histone proteins, of the underly-
ing DNA template or of the proteins that are recruited to the modified chromatin arrays.
DNMT1 has previously been shown to have increased methylation activity in the presence
of ubiquitylated H3 [37]. It is possible that the ubiquitylated chromatin arrays also undergo
DNA methylation during incubation with the extract, which would explain the enrichemnt
of a heterochromatin formation complex on the H3K18ub template. Acetylation of DNMT1
has been shown before to control its stability [92], [93]. Deletion or mutation of DNMT1’s
lysine residues in its KG linker resulted in the loss of the interaction between Usp7 and
DNMT1 [92], [93]. This suggested that acetylation of DNMT1’s KG linker hinders its in-
teraction with Usp7. The Sin3a-SAP130-SUDS3 co-repressor deacetylation complex was
enriched in the H3K18ub affinity purification experiment (Figure 3.15, Figure 3.16F) and
opens the possibility that DNMT1 may be deacetylated in the course of the nuclear ex-
tract incubation reaction. This may affect DNMT1’s surface chemistry in such a way that
DNMT1-mediated Usp7 recruitment to the H3 ubiquitylated chromatin is favored. These
observations indicate that the H3ub chromatin and the associated interactors do not form a
static environment, but a dynamic stage where several reactions take place.
Third, the presence of twenty-four ubiquitin molecules per chromatin array may have affected
the array’s folding properties. Ubiquitylated chromatin templates may be more accessible
than unmodified fibers to proteins which bind the linker DNA or the surface of the nucleo-
some core. Histone ubiquitylation in general and the H2BK120ub modification in particular
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have been shown in vitro to induce changes in the way chromatin folds [22], [196]. These
differences were not attributed to the position of ubiquitin, but to the presence of an acidic
patch on the surface of ubiquitin [23]. This implies that all histone ubiquitylation marks
may have the ability to induce conformational changes to the marked chromatin fibers. We
showed that Zn finger containing proteins as well as Swi3, Ada2, N-Cor, and TFIIIB (SANT)
domain containing proteins, which probe the nucleic acid and the surface of the histone oc-
tamers, were recovered in the histone ubiquitylation datasets. Their recovery may have re-
sulted from the larger accessibility to the chromatin array induced by histone ubiquitylation.
Fourth, it is likely that a number of interactors contain yet to be annotated ubiquitin in-
teraction motifs. Rad18, RNF168 and RNF169 are E3 ligases which associate with DNA
repair and were found to target H2A’s N-terminal K13 and K15 residues [59], [197]. Recent
structural investigation of the ubiquitylation mechanism pointed out the presence of UIMs
in Rad18 and RNF169 [68]. Along the same lines, following the observation that JARID2
acts as a reader which recruits the PRC2 complex to H2AK119 ubiquitylated chromatin,
the presence of a UIM at the JARID2’s N-terminus was mapped [74], [75], [145]. Similarly,
after observing that DNMT1 recognises H3K18 and H3K23 ubiquitylation, the UIM within
its RFTS was also identified [35], [36]. Further biochemical experiments will be needed to
define which subunits of the multiprotein complexes described in this thesis are responsible
for direct recognition of the various ubiquitin marks.
4.2 SCML2 fine-tunes H3 deubiquitylation during main-
tenance DNA methylation
In addition to the readout process, each ubiquitylation reaction requires dedicated protein
complexes for proper setup and removal of the modification. As such, with the exception
of the ubiquitylation sites found in close proximity to each other (as it is the case with
H2AK13 and H2AK15, or with H2AK118 and H2AK119 or with H3K14 and H3K18 and
H3K23), each modification is deposited by a dedicated set of E2 and E3 conjugating and
ligating enzymes (Table 1.1). Along the same lines, different enzymes catalyse the removal
of distinct ubiquitylation marks and increased specificity for these proteases is achieved with
the help of adaptor proteins. For deubiquitylation of H2BK120ub, Ubp8 requires the adaptor
Sgf11 [154], [198], [72] and Usp7 requires the adaptor GMPS [96]. For deubiquitylation of
H2A residues K13 and K15, Usp16 requires the adaptor Herc2 [142]. Similarly, for deubiq-
uitylation of H2AK119ub, BRCA-1 associated protein 1 (BAP1/Calypso) protease requires
the adaptor protein additional sex combs (ASX) [148]. Our results indicate that SCML2
has a similar regulatory role in the context of H3 ubiquitylation. We propose that SCML2
regulates the timing of events on the H3 ubiquitylated chromatin by inducing an activat-
ing conformational change in Usp7, which removes the H3 ubiquitylation mark to promote
recycling of DNMT1 from fully-methylated CpG sites.
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4.2.1 SCML2 activates Usp7 for deubiquitylation of histone H3
Previously, SCML2 has been shown to mediate the interaction between Usp7 and PCGF4.
This interaction was shown to be important in vivo for Usp7 driven deubiquitylation of
the E3 ubiquitin ligase RING1B [98]. In the same article, recombinant SCML2 was in-
cubated with Usp7, but no direct stimulation of Usp7’s deubiquitylation activity could be
recorded using a minimal deubiquitylation substrate [98]. The authors argued in that study
that no stimulation was observed, because the substrate used in their experiments was not
”physiologically relevant”. We prepared ubiquitylated H3 histone with a native isopeptide
linkage and provided evidence that the interaction between SCML2 and Usp7 is important
for Usp7’s deubiquitylation activity. We propose that the observed activation is mediated
by an allosteric effect caused by SCML2 on Usp7 directly on the H3 ubiquitylated chromatin.
We have shown that Usp7 can by itself deubiquitylate H3 histones, mononucleosomes and
chromatin arrays (Figure 3.29). This was achieved because the protease recognises ubiq-
uitin through a dedicated ubiquitin binding domain, which is part of its larger catalytic
domain [69]. We reported that Usp7 deubiquitylated free histones more readily than chro-
matin arrays (Figure 3.29A). The difference in activation energy was lowered on chromatin
and mononucleosomes containing linker DNA by Usp7’s interaction with SCML2 (Figure
3.29D; Figure 3.29E). As suggested before, SCML2 stimulated Usp7 function in the presence
of a physiologically relevant substrate [98].
We showed that SCML2 could not stimulate Usp7 when ubiuitylated linker-less nucleosomes
or free histones were used as substrates (Figure 3.29A, Figure 3.29C). The observation that
SCML2 cannot stimulate Usp7 on a linker-less nucleosome may be explained by the fact
that only one of the two SCML2 nucleosome binding surfaces within the RBR domain was
available to bind the nucleosome in the absence of linker DNA (Figure 3.23, Figure 3.24).
SCML2’s inability to stimulate Usp7 on a free histone may be explained by the fact that
SCML2 does not bind either unmodified or ubiquitylated H3 histone (Figure 3.17B) to in-
crease Usp7’s local concentration onto these substrates. We argue that SCML2 binding to
Usp7 is insufficient for activation of the protease. Likely, allostery alone is insufficient for
Usp7 activation by SCML2.
We found that SCML2 recruited Usp7 to chromatin arrays and stimulated its deubiquityla-
tion activity on both H3K18ub, H3K23ub and H3K18/23ub2 (Figure 3.27D). Deletion of the
RBR-DUF domain, which was essential to recover a complete interaction between SCML2
and Usp7 resulted in the loss of chromatin recruitment and the inability to deubiquitylate
any of the chromatin templates (Figure 3.28C). Deletion of the RBR domain, which we found
to be essential for SCML2 targeting to chromatin, showed the same effects (Figure 3.28A).
These experiments suggest that SCML2 binding to chromatin is essential for stimulation of
Usp7’s deubiquitylation activity.
We found that a SCML2 mutant which lacks the DUF domain, whose interaction with Usp7
is decreased but is still able to bind chromatin, exhibited an Usp7 stimulatory effect compa-
rable to that of the FL protein, even though it recovered substoichiometric amounts of the
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protease to the chromatin templates (Figure 3.28B). This observation suggests that SCML2
activates Usp7 through a mechanism more complex than simple recruitment to the substrate.
We presented that DNMT1 can also target Usp7 to chromatin, but that this association
does not result in stimulation of deubiquitylation activity (Figure 3.30D, Figure 3.27E). Re-
moval of the RFTS domain of DNMT1 or of the UIM within the RFTS domain, which was
previously shown to bind ubiquitylated H3 with nanomolar affinity [37], could not stimulate
Usp7 activity (Figure 3.31C, Figure 3.31D). We argue that Usp7 targeting to chromatin is
insufficient for stimulation of its deubiquitylation activity.
We found that the N-terminal tail of histone H3 crosslinks to residues proximal to the active
centre of Usp7 when the protease is incubated with unmodified chromatin in the presence of
SCML2 (Figure 3.32). This suggests that SCML2 positions Usp7’s catalytic domain close to
the isopeptide linkages of ubiquitin to the H3 histone tail. We propose that Usp7’s activity
on the H3 ubiquitylated chromatin templates is stimulated by SCML2 through a mechanism
which combines chromatin targeting with allosteric activation.
4.2.2 SCML2 mediates the cross-talk between DNMT1, UHRF1
and Usp7
Shortly after DNA replication, UHRF1 recognises hemi-methylated CpG marks [33], [34].
Upon this recognition, UHRF1 ubiquitylates the N-terminal tail of histone H3 which recruits
DNMT1 that pastes the methylation pattern from the parental DNA strand onto the daugh-
ter strand [35]. The timing and the mechanism of Usp7 and SCML2 recruitment to the H3
ubiquitylated chromain is not yet clear. We propose that DNMT1 recruits Usp7 and SCML2
(through its interaction with Usp7) to the modified chromatin.
Using western blot analysis of chromatin affinity purification experiments from nuclear ex-
tracts, we have shown that, differently than the recombinant proteins, neither SCML2 nor
DNMT1 could bind unmodified chromatin (Figure 3.17C). In addition to that, the three
H3 ubiquitylated chromatin arrays showed different recruitment patterns for DNMT1, Usp7,
UHRF1 and SCML2. On one hand, DNMT1, Usp7 and SCML2 reproducibly preferred the
H3K18ub and H3K18/23ub2 over the H3K23ub chromatin arrays (Figure 3.17C, Figure 3.18,
Figure 3.19). On the other hand, UHRF1 bound better to the H3K23ub and H3K18/23ub2
arrays (Figure 3.17C, Figure 3.18, Figure 3.19).
In agreement with the previously described binding constants calculated for the RFTS do-
main in the presence of ubiquitylated H3 histone peptides, DNMT1 prefered the H3K18ub
and H3K18/K23ub2 over the H3K23ub modification (Figure 3.17C) [37]. In that study, the
affinity of the RFTS domain for H3K18ub was twenty fold higher than that for H3K23ub.
The affinity of the RFTS domain for H3K18/23ub2 was forty fold higher than that for
H3K23ub. We observed similar differences in enrichment in the affinity purification experi-
ments performed with nuclear extracts (Figure 3.17C).
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Figure 4.1: Cross-talk between the H3ub-specific interactors. UHRF1 recognition of hemi-
methylated CpG sites (open and full circles) results in deposition of ubiquitin (orange triangle) on
the N-terminal tail of histone H3 at lysine residues K14, K18 and K23. DNMT1 recognition of H3
ubiquitin (large open circle) stimulates methylation of the hemimethylated CpG sites. Recruitment
of Usp7 to chromatin relies on its interaction with SCML2, DNMT1 or UHRF1. SCML2 stimulates
Usp7 to deubiquitylate the N-terminal tail of H3 histone. Catalytic activities are represented with
thick arrows. Recognition events on the nucleosome are depicted with dashed lines that end in
open circles. Inter and intra molecular interactions between the H3ub interactors are depicted with
dashed lines. Stimulatory interactions end with arrowheads.
The high recruitment of DNMT1 in the case of the H3K18/23ub2 arrays was correlated with
the high enrichment of Usp7 and SCML2. Similarly, lower recruitment of DNMT1 in the
case of the H3K23ub arrays was correlated with lower enrichment of Usp7 and SCML2. It
is unlikely that SCML2 recognised the ubiquitylated chromatin separately of DNMT1, since
SCML2 did not show enrichment levels of equal intensity on all three ubiquitylated arrays
(Figure 3.17C). More than that, SCML2 could not be recovered on ubiquitylated histones
from nuclear extracts (Figure 3.17B) and recombinant SCML2 did not show any preference
for ubiquitylated chromatin over the unmodified control templates (Figure 3.27A). We pro-
pose that SCML2 is recruited to the the modified chromatin through its interaction with
Usp7 which binds DNMT1.
Differently than Usp7 and SCML2, UHRF1’s enrichment on chromatin arrays did not depend
on that of DNMT1. UHRF1’s PBR region contacts DNMT1 at the RFTS domain (Figure
4.1) [90]. It is possible that, when bound by the ubiquitylated H3, the RFTS domain of
DNMT1 was inaccessible for PBR binding, which resulted in the loss of the interaction be-
tween DNMT1 and UHRF1 (Figure 4.1). Since UHRF1 does not contain a known ubiquitin
binding motif and was not enriched in the mass spectrometry analysis, it remains unexplained
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how it bound specifically onto the H3K23ub-containing arrays. Of note, the chromatin ar-
rays used throughout this thesis are prepared to be devoid of CpG or H3K9 methylation at
the beginning of each experiment, which could have been recognised by UHRF1’s SRA and
TTD domains.
UHRF1’s binding to the H3K23ub arrays suggested however two probable scenarios. First,
it may be that the E3 ligase is stimulated by this modification to further ubiquitylate
other neighbouring lysine residues on the N-terminal tail of histone H3. In this case, the
H3K23ub-containing chromatin would, like the better studied examples of H2BK120ub and
H2AK119ub, experience ubiquitylation/deubiquitylation cycles [65], [66]. These cycles would
insure a stepwise, rather than a linear removal of ubiquitin (Figure 4.2). Second, if UHRF1
contacts Usp7 on the H3K23ub-containing arrays, it may also be possible that in addition to
its activity on the H3 histone tail, UHRF1 ubiquitylates Usp7, controlling thus the protease’s
activity. The opposite, namely that Usp7 controls UHRF1’s autoubiquitylation activity, thus
the protein’s stability, has already been shown [91].
When bound by H3 ubiquitin, the RFTS domain of DNMT1 cannot interact with UHRF1
(Figure 4.1). UHRF1-mediated-targeting of DNMT1 to new CpG sites is prevented. When
DNMT1 binds ubiquitylated nucleosomes, its KG linker interacts with the UBL1-5 domains
of Usp7 and recruit the protease to the marked nucleosomes. This interaction limits the avail-
ability of Usp7 for UHRF1 regulation. Presently, additional information is needed to resolve
the problem of DNMT1 recycling which would liberate Usp7 from the marked nucleosomes
to control UHRF1 activity in order to drive the maintenance methylation process forward.
Acetylation of the KG linker of DNMT1 may regulate Usp7 removal from the marked nucleo-
somes [92]. DNMT1 acetylation would need to be coordinated with two additional chemicmal
modifications: methylation of the marked CpG sites and full deubiquitylation of histone H3.
We propose that removal of histone H3 is the trigger that initiates the recycling process and
that SCML2, through its interaction with Usp7 mediates the cross-talk between UHRF1,
Usp7 and DNMT1.
The PBR region of UHRF1 contacts the UBL1-2-3 domains of Usp7 [91]. The three UBL do-
mains form also the largest interaction surface between Usp7 and DNMT1 [92]. Crosslinking
mass spectrometry analysis of Usp7 and SCML2 in the presence of unmodified chromatin
(Figure 3.32), suggests that SCML2 also contacts Usp7 at its UBL1-2-3 domains, separate
of the known interaction with the TRAF domain (Figure 3.28E) [98]. Usp7 constitutes
the central interaction node of the H3 ubiquitylated chromatin network. SCML2, UHRF1
and DNMT1 compete for UBL1-2-3 binding. The deubiquitylation experiments suggested
that SCML2 stimulates Usp7 (Figure 4.1). Crosslinking analysis of Usp7 in complex with
SCML2 and chromatin indicates that SCML2 stabilises Usp7’s active conformation (Figure
3.32). First, in the presence of SCML2, the C-terminal tail of Usp7 flips onto the back of
the catalytic domain of the enzyme to activate it (Figure 3.32A) [70]. Second, the catalytic
center of Usp7 is positioned by SCML2 in the right orientation and close to the N-terminal
tail of histone H3, which protrudes outside of the nucleosome (Figure 3.32B). We propose
that, through its ability to stimulate H3 deubiquitylation, SCML2 resolves the cross-talk
between UHRF1, Usp7 and DNMT1 in order to accelerate their recycling from chromatin.
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Figure 4.2: Adaptation of DNMT1 to a distributive methylation mechanism. Ubiquity-
lation of histone H3 (orange triangle) marks hemi-methylated CpG sites (open circles) for DNMT1
recognition. The enzyme methylates the CpG sites (full circles) proximal to the tagged nucleosome
and is recycled from chromatin by Usp7-mediated removal of H3 ubiquitin. In a distributive methy-
lation mechanism, a new group of hemimethylated CpG sites from within the same CG-rich region
needs to be specified by the addition of a new H3 ubiquitylation mark. In a processive methylation
mechanism, after removal of the initial H3 ubiquitylation mark, the methyltransferase moves along
the substrate to methylate also the distal CpG sites from within the same CG-rich region without
the need of another H3 ubiquitylation mark.
4.2.3 SCML2 controls DNMT1 residence time on H3 ubiquity-
lated chromatin
The diploid human genome contains approximately 56 million CG/CpG dinucleotides [199].
An estimated 80% of the CpG sites are methylated or undergo oxidation reactions down-
stream of cytosine methylation [13], [14]. Each HeLa cell contains an average of 25000
DNMT1 protein copy numbers [200]. After DNA replication, the methylation status of each
CpG dinucleotide needs to be correctly inherited by the daughter strand. Sequencing analy-
sis of nascent DNA strands suggests that the vast majority (70%) of all CpG sites across the
genome are being processed by DNMT1 within the first hour after replication [201], [202].
DNMT1 needs thus to be recycled in an efficient manner to be able to scan in such a short
time most of the genome.
On average, each nucleosome from human cells contains two CpG sites. Recruitment of all
25000 DNMT1 molecules by H3 ubiquitylation would cover in the absence of a recycling
mechanism only the first 50000 methylation sites. CpG dinucleotides are however not nor-
mally distributed across the genome, but often found close to each other in regions that span
several hundreds of base pairs. Such areas include methylation free CpG islands in promoter
regions and repetitive, highly methylated regions, like transposons (viral DNA elements) and
centromeric or satellite DNA sequences [15]. The fact that methylated CpG dinucleotides
are not normally distributed throughout the genome, but compacted together in CpG righ
regions facilitates DNMT1 recycling.
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H3 ubiquitylation recruits DNMT1 to hemi-methylated CpG sites and stimulates DNMT1’s
methylation activity [35], [37]. Recycling of DNMT1 is thought to occur through Usp7-
mediated removal of the H3 ubiquitylation marks [93]. It may seem surprising that Usp7,
which removes the ubiquitylation mark, is recruited to the H3ub chromatin primarily in a
DNMT1-dependent manner (Figure 3.17C, Figure 3.18, Figure 3.19). We propose that Usp7
(and SCML2) are needed for DNMT1 recycling from H3 ubiquitylated chromatin.
First, the tight binding of the RFTS domain of DNMT1 with the H3 ubiquitylation marks
makes it difficult for the recycling process to rely solely on DNMT1’s association and disso-
ciation kinetics [37], [93].
Second, the spatial proximity of (SCML2) and Usp7 to DNMT1 and UHRF1 streamlines the
genome-wide maintenance DNA methylation process by removing the ubiquitylation mark
right after DNA methylation. We reported that irrespective of the levels of Usp7 recruitment,
the extent of H3 deubiquitylation was similar on the H3K18ub, H3K23ub and H3K18/23ub2
chromatin arrays (Figure 3.17C, Figure 3.18, Figure 3.19). Along the same lines, the differ-
ent enrichment levels of DNMT1 or those of SCML2 or UHRF1 did not correlate with the
extent of deubiquitylation on the three modified chromatin arrays. We showed that SCML2,
Usp7 and DNMT1 form a stoichiometric complex when incubated on unmodified chromatin
in vitro (Figure 3.26B, Figure 3.26C). Likely, the H3ub interactors do not function inde-
pendently of each other, but they act in synchrony for efficient maintenance methylation.
Recognition of hemi-methylated CpG sites is followed by ubiquitylation of histone H3. This
is succeded by methylation of the CpG sites, which is then followed by deubiquitylation of
H3 ubiquitin (Figure 4.2, top panel).
Third, DNMT1’s recycling by Usp7 could also be seen as an adaptation of the methyl-
trasnferase to a processive behavior, where the enzyme methylates consecutive CpG sites in
CpG-rich sequences without dissociation from the substrate (Figure 4.2, bottom panel). A
processive methylation mechanism would be more efficient than a distributive mechanism,
where DNMT1 would need to be recycled after each molecular encounter [203], [204]. In the
scenario where DNMT1 assumes a processive behavior, the enzyme would make use of its two
domains which have the ability to bind DNA (the CXXC domain and the target recognition
domain) and move along the substrate according to a ”random walk model” [204]. In vitro,
methylation experiments performed on linear DNA templates show that DNMT1 does not
exchange strands or skip target CpG sites during the methylation process [205], [203], [206].
Sequencing of nascent DNA strands suggests the formation of homogeneous methylation
landscapes as opossed to accumulation of locally hypermethylated areas [201]. In vivo,
processive methylation may be facilitated by chromatin remodeler activities which ”melt”
nucleosomal histone-DNA contacts that may obstruct the movement of the methyltransferase
along the substrate [207]. Finally, possible premature removal of the ubiquitylation mark by
Usp7, that is before DNMT1 finishes methylating the daughter strand, may be dealt with
by UHRF1 which proofreads if hemi-methylated CpG sites are left unprocessed behind.
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4.2.4 SCML2 integrates complementing queues from surrounding
chromatin
Previously, it was shown that SCML2 integrates a large number of biochemical queues includ-
ing post-translational modifications of histones, the presence of RNA molecules, accessibility
to DNA and the protein’s readiness for multimerisation [104], [102], [103], [100], [101]. We
propose that SCML2 chromatin targeting relies primarily on the interaction of the RBR do-
main with the nucleosome. First, we have shown that the RBR domain of SCML2 is essential
for binding to free DNA, mononucleosomes and chromatin arrays (Figure 3.23). Targeting of
SCML2 to chromatin in vitro does not require RNA, as previously suggested [100]. Second,
we have observed that removal of the DUF domain does not abrogate SCML2’s binding to
DNA or to a nucleosome core particle (Figure 3.23). If the DUF domain is required for
DNA binding, as previously suggested in the literature [101], then such binding events are
secondary to the main RBR-directed interaction. Third, we have shown that in vitro, the
RBR-DUF region of SCML2 is sufficient to bind Usp7, recruit it to chromatin and stimulate
its deubiquitylation function.
While the work presented in this thesis suggests that the RBR-DUF region suffices to fine-
tune Usp7’s activity and streamline the maintenance DNA methylation process, it is not
excluded that SCML2 may need to integrate additional queues from the surrounding chro-
matin environment during DNA replication for proper stimulation of Usp7. In vivo, mutation
of key residues in the second MBT domain of the Drosophila Scm results in embryonic lethal-
ity [102]. Removal of the SPM domain of Scm prevents heterochromatin spreading [104]. It
was previously suggested that this effect was caused by SCML2’s SPM-mediated interaction
with the polyhomeotic-like protein 1 (PHC1), for incorporation into the PRC1 complex [106].
We have shown that SCML2 may have the ability to form homotypic multimers (Figure 3.26).
While the SPM-mediated association with the polycomb complex is not excluded by our ob-
servation, one needs to account for the fact that the SPM domain may be unavailable when
involved in homotypic interactions.
We showed that UHRF1 and SCML2 chromatin targeting is sensitive to the degradation of
nuclear RNA (Figure 3.19). Both UHRF1 and SCML2 have been proposed to bind RNA be-
fore [100], [208]. No connection has to date been documented between SCML2 and UHRF1.
It is thus possible that SCML2 and UHRF1 bound the same RNA or two separate RNA
molecules.
The long noncoding RNA UHRF1 protein-associated transcript (UPAT) was shown to sta-
bilise UHRF1 by limiting its auto-ubiquiytlation activity [208]. UHRF1 was found enriched
on the H3K23ub-containing chromatin (Figure 3.17C, Figure 3.18, Figure 3.19) which sug-
gested that its ubiquitylation activity may still play an important role after setup of this
mark. We hypothesise that RNA stabilization of UHRF1 on the H3K23ub chromatin is
important to maintain the appropriate balance between ubiquitylation and deubiuquityla-
tion of the H3 tail on the freshly replicated chromatin to drive the maintenance methylation
process forward in an error-free manner (Figure 4.3).
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Figure 4.3: Updated order of events on the H3ub chromatin. The recruitment of nuclear
proteins to the H3ub chromatin is controlled by the cross-talk between DNA methylation and
histone ubiquitylation. Hemi-methylated DNA is converted to fully methylated DNA, in a linear
irreversible process. Differently than methylation, ubiquitin is first deposited, after which it is
erased. As such, three ubiquitylation/deubiquitylation patterns may form: a gradual pattern,
which follows closely the concentration of UHRF1 and DNMT1; a cyclic pattern, where Usp7
and UHRF1 coordinate to establish an optimal amount of H3 ubiquitylation; a sporadic pattern,
where a high local density of CpG sites signals to SCML2, Usp7 and UHRF1 to adapt DNMT1 for
processive methylation. Timing and efficiency of the recycling of H3ub interactors may constitute
the driving force of all the events occurring on the H3ub chromatin fiber and as such a combination
of the suggested ubiquitylation/deubiquitylation patterns may form. RNA may be involved in
the regulation of UHRF1 stability and SCML2-mediated recruitment of complexes dedicated to
heterochromatin formation.
The long noncoding HOX transcript antisense RNA (HOTAIR) was proposed to recruit
SCML2 to PRC1-targetted chromatin [100]. We have shown that the RBR-DUF region of
SCML2 is sufficient in vitro for SCML2 stimulation of Usp7 function on chromatin (Figure
3.28). Previously, the isolated RBR domain of SCML2 was found to be able to simultaneously
bind a nucleosome and a short fragment of the HOTAIR transcript [100]. We argue that RNA
is not needed for the direct binding of SCML2 to the H3 ubiquitylated chromatin, but that
SCML2 may exist inside the nuclues in ribonucleoprotein complexes whose interaction with
chromatin is stabilised by RNA, which may act as intermolecular scaffolds. Along this line of
argumentation, RNA may also be needed for recruitment of polycomb complexes to SCML2
coated chromatin. In this event, SCML2 would mark nucleosomes for setup and spreading of
heterochromatic marks after the maintenance DNA methylation process is complete (Figure
4.2) [209].
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Conclusions and Perspectives
Histone ubiquitylation is the first post-translational modification which was identified on
histones. The modification changes the physical and chemical properties of the marked
histone. Until recently, using traditional endogenous purification protocols or in vitro ubiq-
uitylation strategies, only a handful of ubiquitylated histones could be prepared. The study
of low abundance histone ubiquitylation marks only became possible recently with the ad-
vent of expressed protein ligation. Using this method, we presented the preparation of
H2AK119ub, H3K18ub, H3K23ub and H3K18/23ub2 histones which were successfully incor-
porated into nucleosomal arrays. The optimised strategy which we described for preparation
of H2AK119ub and H3K18/23ub can be expanded to synthesise several other site-specific
ubiquitylation marks on any of the core histone proteins.
Several histone, mononucleosome and chromatin affinity purification experiments were cou-
pled with quantitative mass spectrometry to understand the requirements of histone ubiqui-
tylation readouts. First, we showed that, for recognition of the ubiquitylation mark beyond
the direct reader, histones need to be imbedded minimally within a nucleosome. Second, we
showed that the different ubiquitylation marks generally recruit unique proteins and protein
complexes to the nucleosomal arrays. These observations suggest that, in the presence of
the nuclear extract, in parallel to the readout process, several biochemical transactions and
structural changes occur, which specify the identity of the interacting proteins and the bi-
ological process they are involved in. The mass spectrometry analyses found several novel
ubiquitylation-specific factors. In addition to this, network analyses suggested many novel
associations between the enriched proteins. Further experiments would be needed to dissect
the roles of the newly identified factors, the functional relevance of the suggested protein
associations and the importance of the accompanying biochemical reactions in relaying sig-
nalling events downstream.
To verify the mass spectrometry identifications, we focused on the N-terminal ubiquitylation
of histone H3, where we described the reproducible enrichment of DNMT1, Usp7 and SCML2
on the modified chromatin. We showed that DNMT1 recruits Usp7 and SCML2 to the
marked chromatin, where SCML2 stimulates Usp7’s activity, an effect which we found to be
inhibited by DNMT1. Using crosslinking mass spectrometry we showed that SCML2 and
DNMT1 compete for the same binding surface on Usp7 and found that SCML2 positions
Usp7 close to the N-terminal tail of histone H3. We proposed that SCML2 controls DNMT1
recycling from H3 ubiquitylated chromatin by stimulating Usp7’s deubiquitylation activity.
To test this hypothesis, we suggest two complementary lines of experiments. On one hand,
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the levels of ubiquitylated H3 and the levels of CpG methylation in live cells would need to
be measured in the presence and absence (transient knock-down or knock-out) of SCML2. In
addition, nuclear extracts devoid of SCML2 may be used to further study Usp7’s activity on
recombinant H3 ubiquitylated chromatin. On the other hand, an in vitro methylation assay
that can distinguish between a processive and a distributive DNMT1 methylation behaviour
can be developed. Such an assay makes use of ubiquitylated nucleosomal arrays, where the
density of ubiquitin and the positioning of the ubiquitylated nucleosome(s) can be controlled.
The influence of Usp7 and/or SCML2 on DNMT1 activity can directly be monitored as a
function of the methylation throughput. The necessity of additional nucleosomal remodeling
or histone chaperoning for DNMT1 activity, can also be experimentally addressed in such
an assay.
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